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GENERAL ABSTRACT 
Introduction: In sub-Saharan Africa, available World Health Organization  data indicate an 
increase in the prevalence rate of non-communicable diseases such as diabetes and hypertension. 
Dwindling economies, rising costs of orthodox conventional medicines (OCM) and a lack of health 
care facilities in indigenous communities have led to the patronage of Traditional Medicine (TM) 
by the general population, with the assistance of traditional health practitioners (THPs) to combat 
these chronic conditions. However, the nonexistence of standardized and formalized Tswana and 
Zulu diabetes and hypertension treatment guidelines for THPs indicates the need to compare their 
methods and treatments approaches in the two culturally diverse environments. Understanding the 
similarities and differences of their methods and treatment approaches could serve as the basis of 
affirming evidence-based practice in TM that will lead to the development of a framework to assist 
in managing these two diseases in indigenous African communities. This study aimed to develop 
a framework for the standardization of traditional health practices to manage diabetes and 
hypertension among Tswanas and Zulus THPs in the North-West and KwaZulu-Natal (KZN) 
Provinces, South Africa. 
Methods: A comparative cross-sectional descriptive study with mixed-method (embedded) 
approach was conducted in the uMgungundlovu and uThukela Districts of KZN, and the Bojanala 
and Dr. Ruth Sekgopomati Districts of the North-West Province. Phase 1A entailed a series of 
focus group discussions (FGDs) with 67 THPs in KZN and 40 in the North-West Provinces about 
their management of diabetes and hypertension in three geospatial areas (urban, traditional/tribal 
and farm areas), the data being analysed using thematic content analysis. 
In Phase 1B, a researcher-administered questionnaire was used to conduct face-to-face interviews 
about the management of diabetes and hypertension among 437 THPs in KZN and 426 in North 
West Province. The qualitative data was analysed using thematic content analysis while the 
quantitative data was examined and reported using descriptive statistics. 
In Phase 2,  an analytical approach was used to develop a modified interventional tool that was 
adapted from the Ayurveda treatment guidelines for both diabetes and hypertension based on 
findings from Phases 1A and Phase 1B.    OCM and Ayurveda health traditions experts’ opinion 
regarding the developed diabetes and hypertension guidelines were sought after their validation 
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process that led to the development of a framework for the standardization of traditional health 
practices regarding the two conditions. 
Results: This study found that most Zulu and Tswana THPs acquired their knowledge and training  
from one of the following ways: by a family member, other person, and gift from birth, a calling 
without any form of training and through professional training. The majority of Zulu THPs 
acquired their knowledge as a gift from birth, while the majority of Tswana THPs acquired their 
knowledge and training via family members. Acquisition of knowledge as a gift from birth entails 
a call to practice via ancestral spirits initiation, while from family members involves training 
received from other experienced THPs in the family. There were similarities in the Zulu and 
Tswana THPs cultural understanding of both diabetes and hypertension. Most THPs regarded 
diabetes and hypertension as the same condition, as one (having diabetes) leads to the other 
(hypertension). The following symptoms: weight loss, sweating easily, shortness of breath, feeling 
dizzy, and difficulties in breathing, excessive hunger and eyesight problems, were the most 
commonly reported clinical features for both diabetes and hypertension by the THPs.  
Ethnopharmacological modalities and treatment approaches used by the Zulu and Tswana THPs 
to manage both diabetes and hypertension diseases were mainly the use of herbal mixtures, with 
Aloe vera as a major constituent. Besides, the following medicinal plants: Hypoxis hemerocallidea, 
Persea americana, Sutherlandia frutescens and Harpagophylum procumbens were used by both 
groups of THPs in its management. 
Commonalities in their responses from the findings in Phase 1A and Phase 1B compared to adapted 
Ayurveda treatment guidelines for both diabetes and hypertension led to the development of 
treatment guidelines for both conditions. The developed framework to manage diabetes and 
hypertension for use by Zulu and Tswana THPs was validated by experts in the field of OCM and 
Ayurveda health traditions. 
Conclusion: Some similarities were noted between the Zulu and Tswana THPs and OCM in terms 
of the description of clinical features of diabetes and hypertension. The use of several medicinal 
plants by the Zulu and Tswana THPs to manage the two diseases has been proving scientifically 
to be effective against them. 
The interventional tool will assist Tswana and Zulu THPs to manage diabetes and hypertension 
within traditional African communities. Recommendations, including signing of intellectual 
xxii 
 
property (IP) agreement between the Department of Science and Technology (DST) legal experts 
and THPs, will help OCM researchers to obtain samples of herbal mixtures to conduct scientific 
research through in vivo, in vitro and randomized control trials (RCT) studies to make a 
meaningful contribution to updated versions of the developed guidelines. 
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CHAPTER 1 
This chapter provides a background and a brief overview of literature of the proposed 
study. It includes the rationale of the study, research questions, the aims and objectives 
of the study and a summary of the methodology.  
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INTRODUCTION 
1.1 Background and context of the study 
Traditional Complementary and Alternative Medicine (TCAM) plays an important role in the 
healthcare delivery system of both developed and developing countries1. Statistics have shown that 
about 80% of the population in developing countries use Traditional Medicine (TM) for their health 
care needs 2, while alternative medicine is a growing market in developed countries. TM has 
contributed considerably to modern-day medicine, with many products being derived from 
medicinal plants 3. Approximately 60% of the children suffering from malaria in countries such as 
Ghana, Nigeria, Mali, and Zambia are treated with herbal preparations 4. Most Chinese people use 
herbal preparations, which accounts for 30-50% of the overall medicinal consumption. In Mexico, 
traditional health practitioners (THPs) are stationed in health centres built by the government to help 
in the treatment of diseases 5. Many people in industrialized countries also use TCAM, with 
relatively high percentages of consumption having been reported in countries such as England 
(47%), Canada (70%) and Germany (75%) 5. In this regard, TM is a viable alternative to orthodox 
medicine and therefore worthy to be investigated.  
An estimated 380 million people are projected to be diabetic by 2025, which is a major cause of 
premature mortality in various countries on the African continent 6. There has been an increase in 
diabetes mellitus (DM) patients in sub-Saharan Africa (SSA) 7, with a prevalence rate of 7% having 
been reported for countries such as Nigeria, Ghana, South Africa, Kenya, Guinea, and Cameroon 
due to poor dietary habit, obesity and inadequate physical activity as the main causative factors for 
type 2 diabetes amongst the adult population 8. Further, hypertension is one of the significant factors 
for heart disease 9. Hypertension and its associated health effect affects approximately  one billion 
people 9,10 and has been identified as one of the leading risk factors globally for mortality 11. The 
African Union (AU) described hypertension as a major health challenge facing the continent, with 
approximately 20 million people living in SSA being hypertensive 12.  
Zulus and Tswanas THPs are noted for their involvement and treatment of diseases in the 
communities where they live in13,14. This is evident in a study conducted in the North-West Province 
of South Africa which identified diabetes, high blood pressure, measles, asthma and whooping 
cough as some of the diseases managed by THPs in the region14. A similar study conducted in 
KwaZulu-Natal province found that 93% of diabetic patients believed in the effectiveness of herbal 
preparations that they were using to manage their disease 15. The perception of the patients regarding 
TM necessitate further investigation into its application. The application of TM by THPs in South 
Africa underscores its viability as a credible alternative to orthodox medicine. Studies have shown 
that THPs in South Africa are involved in the management of diabetes and hypertension16,17 by 
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applying TM. A study conducted in the former Northern province of South Africa(now Limpopo) 
revealed the use of herbal therapies by THPs in the management of diabetes 16. Similarly, a study 
conducted by Peltzer et.al (2001) in the Northern province of South Africa(now Limpopo) indicated 
the use of herbal mixtures by THPs in the management of hypertension 17. Ironically, there is a 
scarcity of information on studies conducted to establish commonalities in the methods and 
treatment approaches employed by THPs of different ethnic groups in the management of diabetes 
and hypertension. The aim of this study was therefore to develop a framework for the standardization 
of traditional health practices to manage diabetes and hypertension among Tswanas and Zulus THPs 
in North-West and KwaZulu-Natal Provinces, South Africa. A framework   was developed by 
modifying the standardized Ayurveda treatment guidelines for both diabetes and hypertension18,19. 
1.2 Brief overview of the literature 
This section provides a brief overview of the literature. A comprehensive literature review has 
been reported in chapter 2 of this thesis. 
1.2.1 Summary of application of TCAM in different parts of the globe 
According to the World Health Organization (WHO), “Traditional medicine refers to health 
practices, approaches, knowledge, and beliefs incorporating plant, animal and mineral-based 
medicines, spiritual therapies, manual techniques, and exercises, applied singularly or in 
combination to treat, diagnose and prevent illnesses or maintain well-being.” Furthermore, WHO 
defines complementary and alternative medicine (CAM) as a “broad set of health care practices 
that are not part of a country's tradition, or not integrated into its dominant health care systems” 2.  
In Latin America, the Pan American Health Organization (PAHO) promotes CAM, such as herbal 
therapy, acupuncture and massage amongst the population in the region 20. Most Universities in 
Cuba and the United States of America (USA) offer courses in TM 20. In the Asian region, where 
national policies regulate traditional health practice in most of the countries, approximately 80% of 
the population rely on alternative medicine, with some of the most notable practices being: 
Ayurveda, Unani, Traditional Chinese Medicine and spiritual therapy21. The practice of TM has been 
incorporated into the health care system in countries such as India, Myanmar, Nepal, and Thailand, 
with TCAM courses being taught in institutions of higher learning in most countries21. 
The incorporation of CAMs into the curriculum of education in Europe was accepted when it was 
recognized by European parliament. Most European countries have enacted policies to regulate and 
license CAM practitioners22. A case in point is the United Kingdom, where public sector hospitals 
have been established purposely to regulate the practice of CAM, such as homoeopathy22. 
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A survey conducted in Australia revealed that a fifth of its population used alternative medicine 23. 
This is evident in the exponential increase of patronage by patients despite a well-established 
medical health system, the situation is largely due to CAMs influence in  managing chronic 
conditions 24. Chronic diseases, such as diabetes and high blood pressure, are being managed using 
alternative medicine 25, with the economic impact in Australia estimated to be  four billion Australian  
dollars annually 26.  
Turning our attention to Africa, African Traditional Medicine (ATM) incorporates herbs and spiritual 
means in curing diseases27,28 and consists of approximately 5000 species of plants29. Within the past 
decade, the development and recognition of ATMs have received support from the WHO, with a 
resolution on ATM having been passed by World Health Assembly in 2003 that led to the declaration 
of August 31st each year as being ATM day2. In 2001, during an African Union(AU) summit, the 
various heads of state declared 2001-2010 as the ATM decade of excellence, which led to the 
formation of regulatory bodies for healers associations in some of the countries 30. 
1.2.2 Description of established and recognized systems of TCAM 
1.2.2.1 Ayurveda 
This traditional medicine system dates back to 1500 BC, it is widely known as the science of life. 
Ayurveda derived its name from these Sanskrit words Ayur (life) and Veda (Knowledge). Ayurveda 
describes a human being as a composition of water, fire, earth, air, and vacuum. Ayurveda placed 
much emphasis on the theory of tridoshas Vata(ether and air), pitta(fire) and Kapha(earth and water). 
Vata, Pitha and Kapha known as the three doshas in Ayurveda are the physiological units in human 
beings. It is significant to point out that a person achieves good health when the above mentioned 
three doshas are in equilibrium. According to Ayurveda, a person becomes sick when there is a 
disturbance in the three doshas due to internal or external factors such as emotional and physical 
stresses, weather conditions, diet, work and family relationships31. Treatment regime in Ayurveda 
comprises exercise, diets and lifestyle management on the part of individuals32 
1.2.2.2 Traditional Chinese Medicine (TCM) 
This important traditional medicine system dates to thousands of years and depends on the Yinyang 
and Wuxing concepts. TCM formula composed of different drugs that function together to produce 
a synergistic effect in an individual33. 
1.2.2.3 Unani 
Unani traditional medicine systems evolved from Greco-Arabic medicine over the past 2500 years. 
Unani therapy focusses on an individual’s body, soul and mind as a unit. Its philosophy is based on 
the fact that an individual acquires a disease as a result of a disorder in his or her temperament33.  
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1.2.2.4 Kappo traditional medicine 
This traditional medicine system evolved over the past 1400 years. Its philosophy leans on the fact 
that an individual acquires disease as a result of the psychic disorder as such its therapy focusses on 
an individual rather than the illness33. 
1.2.3 Traditional Health Practitioners (THPs) in Africa 
THPs employ culturally linked appropriate methods of healing of diseases on the African 
continent34. Studies have shown that the acquisition of knowledge and training of THPs assist them 
in the management of diseases. In a study carried out in Zambia, THPs stated that they acquired 
knowledge used in the management of diseases from other family members35. Similarly, THPs in 
Cameroun acquired knowledge of medicinal plants used in the management of diseases from other 
family members36. In Lesotho, approximately 34% of THPs interviewed in a study conducted 
revealed that they acquired their knowledge used in the management of diseases from ancestral 
spirits37. In South Africa, 27 THPs who were interviewed in the five regions of the Limpopo 
province stated that they acquired their knowledge and training through other THPs, elders in their 
families and ancestral spirits via dreams 38. Studies conducted in Africa have shown that THPs 
acquired knowledge used in the management of diseases through professional training. In 
Cameroun, 36 out of 106 THPs who were trained about diabetes and its management were accessed 
eight months after the workshop to find out if they were applying the knowledge they acquired 
during the workshop. Findings from the study revealed that most of the 36 THPs could remember 
what they were taught during the workshop39. In South Africa, about 51 THPs who took part in at 
least one of the three diabetic workshops organized in the Nelson Mandela Metropole within 17 
months had a basic understanding of diabetes and its complications when they were accessed via 
individual interviews after the study period40. Regarding diagnosis, THPs in Lusaka, Zambia stated 
that they relied on spiritual guidance for diagnostic purposes in the management of hypertension41. 
Similarly, some THPs in the Northern Province of South Africa (now Limpopo) relied on spiritual 
guidance via ancestors for diagnosis purposes42. In Nigeria, THPs in a study conducted in stated that 
they relied on the signs and symptoms reported by patients seen by them in the management of 
diabetes43. 
Studies in Africa have shown that most THPs employ the use of herbal mixtures in the management 
of diseases. A study conducted in Kenya revealed that THPs prescribed herbal mixtures to their 
patients for the management of diabetes44. Similarly, THPs in the Nelson Mandela Metropole of 
South Africa prescribed herbal mixtures in the management of hypertension45.  
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1.2.4 Relevance of THPs on health care in Africa 
Many people living in Sub-Saharan Africa (SSA) consult THPs for their health care needs 46,47. The 
need to recognize THPs in the broader health care system has been emphasized as they are often 
accessible to the communities they serve 48. The ratio of Medical Practitioners (MPs) to patients is 
remarkably high than that of patients and THPs49. Table 1 presents the ratios of MPs and THPs to 
patients in selected African countries. 
 
Table 1 Ratios of MPs and THPs to patients in selected African countries. 
Country MPs: Patient THPs: Patient Reference 
Ghana 1:6250 1: 200 49 
Uganda 1:25000 1:700 49 
Swaziland 1:10000 1:100 49 
South Africa 1:1000 1:170 50,51 
Uganda 1:25,000 1:700 49 
Zimbabwe 1:6,250 1:600 49 
 
In Nigeria, a study including 388 people in Lagos showed that herbal therapy recommended by 
THPs is the preferred mode of treatment for diabetes 52. A study conducted in Uganda reported the 
usage of TM with the help of THPs amongst inhabitants in the Iganga and Bugiri Districts due to its 
affordability and the scarcity of diabetic drugs in clinics and pharmacies 53. Research carried out in 
selected South African communities revealed the usage of TM with the assistance of THPs to 
manage hypertension among mainly female participants 54.  
1.2.5 Traditional Health Practice in South Africa 
THPs in South Africa provided services long before the Dutch colonised the Cape in the 17th century 
55. Under colonial rule, THPs were not allowed to practice freely due to the enactment of a 
Witchcraft Suppression Act, which came into force in 1957 56. However, this did not prevent them 
from providing services and being given recognition in the societies where they operated. THPs 
continue to be consulted as they are readily available and accessible, and understand the culture of 
the people in the communities in which they live, being able to assist their patients accordingly 57. 
The enactment of the Traditional Health Practitioners Act in 2007 established the Interim Traditional 
Health Practitioners Council (THPC) in South Africa (Act No 22 of 2007)58. This act recognises 
four main categories of practitioners who should undergo a minimum period of training within a 
stipulated time to practice: diviner (12 months), herbalist (12 months), traditional birth attendant (12 
months) and traditional surgeon (5 years) 59. 
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1.2.5.1 Diviner (sangoma,umthandazi or amagqirha) 
Sangoma is an indigenous isiZulu term for a THP who had been called by ancestors to practice as a 
healer. Most of these THPs are females and diagnose patients with the help of ancestral spirits. They 
rely on throwing of bones to ascertain what is wrong with an individual and application of 
appropriate remedy to heal an individual as well as prediction of the future of a client(patient) in 
consultation for their services60.  Umthandazi  is a person known as a faith healer in isiZulu culture 
whiles amagqirha is a faith healer in isiXhosa culture.  Umthandazi or amagqirha relies on divine 
intervention to heal people from their diseases60. 
 
Herbalist (izinyanga/amaxhwele) 
These THPs are predominantly males and possess extensive knowledge about the curative properties 
of medicinal plants and herbs in the treatment of diseases. Most of these THPs use parts of medicinal 
plants (roots, the bark of trees and leaves), herbs and animal parts to treat diseases61. 
1.2.5.2 Traditional birth attendant (ababelethisi or abazalisi)  
These THPs are predominantly females who perform the roles of midwives in local communities 
within the African continent. THPs assist in the delivery of babies when women are in labour in 
indigenous communities across the African continent 61. 
1.2.5.3 Traditional surgeon (iingabi) 
These are THPs who are responsible for male circumcision within African communities; they mostly 
perform their duties during the initiation of teenagers into adulthood organized by various tribes on 
the continent62 
 
1.2.6 Managing both diabetes and hypertension using OCM and TCAM methods 
1.2.6.1 Diabetes Mellitus (DM) 
DM is a chronic metabolic disorder associated with insulin deficiency. In summary, the 
pathophysiology of DM entails the following mechanisms: Insulin is responsible for the regulation 
of glucose to the cells of the body (liver, adipose, and muscle) except for smooth muscle. Insulin 
reaches the smooth muscle via insulin-like growth factor-1(IGF-1) which is a normal hormone in 
the blood responsible for the regulation of the effects of growth hormone. The supply of glucose to 
the body is obtained from the intestinal absorption of food and the disintegration of glycogen to 
glucose in the liver and non-carbohydrate substrates. To maintain glucose levels in the body, insulin 
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is needed to inhibit the breakdown of glycogen, stimulate the transportation of glucose to the fat 
tissues and muscles and store glucose in the form of glycogen. Insulin defect and insensitivity of its 
receptors play a major role in the formation of diabetes because of poor regulation of glucose in the 
human body63. 
Type1 and Type 2 (Insulin resistance) are the two main types for DM 64. Type 1 diabetes is 
characterised by β-cell annihilation typically immune mediated resulting to complete insulin 
deficiency while Type 2 diabetes is characterised by hyperglycaemia in relation to progressive 
resistance to the action of insulin resulting to the loss of  β-cell function with time thereby affecting 
insulin secretion65,66. 
Type 1 is mostly associated with children, while Type 2 is commonly diagnosed with adults 67. 
Contributory factors of Type 1 diabetes are as follows: the annihilation of the beta cells associated 
with the pancreas, the manifestation of antibodies to islet cells, genetic disposition and 
environmental factors, while obesity, high blood pressure and limited physical activity are the major 
contributory factors associated with an individual acquiring Type 2 diabetes65,67,68. 
Other forms of diabetes have been identified these include gestation diabetes mellitus (GDM), 
maturity-onset diabetes of the young (MODY) and latent autoimmune diabetes in adults (LADA). 
GDM is detected during pregnancy caused by varying degrees of glucose intolerance 69, while 
MODY is caused by monogenic disorders as a result of β-cell dysfunction 70. LADA occurs in older 
adults as a result of the type 1 process showing similar clinical phenotype as Type 2 diabetes 71. 
According to the American Diabetic Association (ADA), the signs and symptoms that indicate a 
person to be diabetic include: loss of sight, tiredness, slow healing of wounds, frequent urination 
and thirst 72,73. Diabetes is diagnosed when a test conducted revealed an average plasma 
concentration within a period (≥6.5%), or a two-hour plasma of glucose (≥11.1mmol/l) and fasting 
plasma glucose (≥7.0 mmol/l) via an oral glucose tolerance test (OGTT) 74. 
Type 1 diabetes is mostly treated with insulin, with hypoglycemia and weight gain is some of the 
side effects 75. Metformin, glibenclamide, statins, and fibrates are used by patients to treat type 2 
diabetes, with ophthalmic and cerebrovascular conditions being some of its complications 76-78. The 
use of drugs depends on the nature of diabetes, the persons' age and other factors of an individual 
diagnosed with the disease. Concerns have, however, been raised over the usage of anti-diabetic 
drugs due to their side effects, such as gastrointestinal (GI) complications and hypoglycemia 79.  
Owing to the side effects of orthodox medicine, people have resorted to using alternative medicine 
to treat diabetes and its complications. Unlike conventional medicine, which establishes how a 
disease is manifested, TM explains the reason why an individual is affected by a disease at a specific 
point in time and introduces the cosmological part of a disease cause 80. THPs knowledge about 
 
 
9 
 
diabetes in Kenya revealed that ‘sugar disease’ was a common terminology used to describe this 
chronic condition by traditional healers 44. Chege et al. (2015) reported that THPs associated 
diabetes with worm infestation, stress and poor diet habits. Treatment approaches employed by 
THPs in Kenya included parts of plants, animals, and minerals (dispensed in the form of powder or 
suspension to patients) accompanied by lifestyle management advice to patients 44. 
In Cameroun, THPs believed that diabetes was caused by witchcraft and could only be cured by 
supernatural powers and not biomedical trained health professionals, who can only treat the 
symptoms of diseases 39. In South Africa, a study among THPs revealed that their knowledge about 
diabetes was as a result of information received from the ancestors through spiritual means 42. THPs 
in the northern province of South Africa (now Limpopo) described diabetes as a ‘disease of sugar', 
and mentioned a decrease in weight, headache and constant urination as some of the signs and 
symptoms 42.  
A study conducted in Nigeria identified 115 plants with hypoglycemic effects, such as Aloe vera, 
Allium sativum and Momordica charantia 81. Approximately 23 plants are widely used by the 
Basotho tribe (Free State Province) to manage diabetes, these plants (Panax ginseng, Allium 
sativum, Papaver somniferum, and Taraxacum officinale) are being used to treat diabetes 
complications 82,83. Medicinal plants (Euclea undulata, Schkuhria pinata and Elaeodendron 
transvaalense) purchased from THPs in various locations across South Africa have shown 
hypoglycaemic activities 84. 
1.2.6.2 Hypertension 
Hypertension is clinically diagnosed in a patient having (≥140/90 mmHg) confirmed by a successive 
ambulatory blood pressure monitoring day time average or home blood pressure monitoring 
average((≥135/85 mmHg)85.  In summary, the pathogenic mechanism involves an elevation of 
cardiac output (CO) or total peripheral vascular resistance (TPR), with both being elevated in most 
hypertensive patients86. The important physiological mechanisms actively involved in the 
development of hypertension are as follows: First, the Autonomic nervous system: in regulating 
blood pressure, the autonomic nervous system plays a significant role, with an increase in peripheral 
sensitivity to norepinephrine in hypertensive patients. In addition, hypertensive patients are 
susceptible to a higher rate of responsiveness to stressful stimuli in their daily activities86 Secondly, 
Sodium and water excretion: retaining sodium and water results from an unhealthy relationship 
between pressure and sodium excretion due to a reduced renal blood flow while a steadily rise of 
angiotensin causes an increase in blood pressure86. 
Thirdly, the role of vasodilators: potential vasodilators, such as bradykinin and nitroxide, help to 
regulate blood pressure87. The deactivation of bradykinin by angiotensin-converting enzymes (ACE) 
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leads to an increase in blood pressure87. Last but not the least, the Renin-angiotensin system: the 
secretion of renin from the juxtaglomerular apparatus associated with the kidney leads to the 
conversion of substrate renin (angiotensinogen) to angiotensin I. Angiotensin I, which is 
physiologically inactive, is quickly converted to Angiotensin II, specifically in the lungs. This 
potential vasoconstrictor, such as Angiotensin II, causes an increase in blood pressure87 Essential 
and secondary are the two major types of hypertension, the former being most frequently diagnosed, 
with secondary being caused by a reversible factor, sometimes being curable 88.  
The signs and symptoms of hypertension include a feeling of dizziness, headache in the morning 
and blurred vision 89. It has been reported that to control and prevent hypertension, lifestyle 
modification is very important 90, with the blood pressure (BP) needing to be checked every 3-6 
months to control hypertension 91. Hypertension is treated mostly with ACE inhibitors, diuretics, 
beta-blockers and calcium antagonists 92. The side effects of anti-hypertensive drugs have been 
reported and include depression, headache and swollen ankles 93.  
In Zambia, THPs described hypertension as a disease associated with weakness in the body, 
breathing rapidly and fast flowing of blood in the body 41. THPs in the above study also stated that 
information received from the spiritual realm helps them to diagnose a patient; they mentioned 
stroke and enlargement of the heart as some of the complications associated with this chronic 
condition and preferred herbal therapy for the management of the disease 41  
In another study on hypertension in South Africa, THPs mentioned hypertension as a disease related 
to high blood pressure in their local dialect 94. Feeling of dizziness and pains in a person's body were 
some of the symptoms associated with hypertension. Furthermore, THPs also stated that they 
obtained diagnostic information about this disease from ancestors in their dreams 94. 
A study found that 96% per cent of the people living in SSA used herbal medicine to treat 
hypertension.95 In a survey conducted in Nigeria, about 21% of the urban population used garlic 
(Allium sativum) in the management of hypertension 96.  
 
1.2.7 Relevance of guidelines used in the management of diabetes and hypertension. 
In the management of diabetes and hypertension, there are standard treatment guidelines that have 
been developed to assist practitioners in OCM and Ayurveda health traditions to treat patients 
affected by this chronic conditions18,19,97,98. These developed treatment guidelines contain 
information about causes, signs and symptoms, steps to follow in diagnosing a patient, 
complications of diabetes and hypertension, pharmacological and non-pharmacological approaches 
to be adopted in the management of these two diseases.  
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These guidelines are normally updated annually by a committee of experts involved in the 
management of both diabetes and hypertension. Ayurveda practitioners and BHPs are taking 
through to acquaint themselves with current information from updated versions of these standard 
treatment guidelines for effective management of both diabetes and hypertension. It is significant 
to point out that unlike Ayurveda treatment guidelines for both diabetes and hypertension 
(Appendix XIX and Appendix XX) which assist Ayurveda practitioners to manage diabetes and 
hypertension, there is a non-existent tool to assist Zulu and Tswana THPs in the management of 
diabetes and hypertension. 
 
1.3 Rationale of the study 
An estimated 438.4 million people with diabetes will be globally disease-ridden by 2030 99. A study 
conducted in South Africa revealed a high prevalence rate of diabetes among the adult population 
100. Hypertension has been identified as one of the leading risk factors (globally) for mortality 11. 
Poor health outcomes associated with allopathic medicine for chronic conditions encourage many 
people to rely on alternative medicine 54,101.  
Approximately 80% of the population in sub-Saharan Africa consult THPs for their health care needs 
who do not have a standardized protocol for their practice 102. The general acceptance of TM in 
modern science is still not encouraging yet little has been done to ascertain its reliability and 
effectiveness in terms of practice 103. Even though TM legitimacy and treatment approaches have 
been challenged 104, its usage in modern-day Africa is on the ascendancy without much documented 
adverse effects 105. 
About 400 plants with anti-diabetic effects such as Allium sativum, Gymnema Sylvestre and 
Momordica charantia and medicinal plants with antihypertensive properties (Olea europaea, 
subspecies Africana leaves) have been documented106,107 Clinical trials research conducted with 
patients confirmed the effectiveness of alternative medicine in the management of diabetes and 
hypertension108-111. A controlled clinical study in India found that herbal extracts helped in the 
reduction of blood sugar levels of patients diagnosed with type 2 diabetes 112.  
The practise of traditional healing is associated with the culture and environment within which THPs 
operate. However, similarities and differences in treatment approaches employed by THPs in 
different cultures and environments are not well documented. Some studies have reported the use of 
herbal mixtures for the management of diabetes and hypertension16,17,113 Comparison and outcomes 
of treatments similarities or differences among THPs from different cultures and environment may 
as well be used as ways for affirming the evidence base of practice which could lead to 
standardization of treatment approaches. A well-documented framework may serve as a guide to 
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researchers who are interested in traditional practices and treatment approaches used by THPs from 
Tswana and Zulu cultures. The development of a framework will assist policymakers in the 
regulation of traditional practices about the management of diabetes and hypertension as well as 
curriculum development for the training of THPs. Besides, it will help health authorities in various 
countries to evaluate and monitor the management of diabetes and hypertension among THPs. 
Health promotion and awareness about TM methods and practices among the general population 
will be greatly enhanced. These developed guidelines to be used by THPs in the management of 
diabetes and hypertension will boost the confidence people have in this health tradition that is 
culturally appropriate to their health needs and cost-effective. More importantly, for the industry to 
self-regulate which will motivate formal research into the medicinal properties of the formulations 
but with intellectual property protection to THPs. Lastly, it will assist researchers to obtain credible 
information from patients who seek THPs treatment care options for randomised control trial (RCT) 
purposes. This study aims to develop a framework for the standardization of traditional health 
practices for the management of diabetes and hypertension following perspectives from Tswanas 
and Zulus THPs in North-West and KwaZulu-Natal Provinces, South Africa.  
 
1.4 Conceptual framework 
The conceptual framework (Figure 1) will focus on the factors contributing to the lack of 
standardization of management of diabetes and hypertension by THPs. These factors are assembled 
under bio-physiological, education and research, interventions as well as socio-cultural causative 
groups. 
 
Figure 1. A conceptual framework for the study developed from the extant literature. 
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Legend: ATM: African traditional Medicine; EP: ethnopharmacology; THP: traditional health 
practitioners; IP: intellectual property. 
 
 
 
 
1.5 Research questions, aims, and objectives 
1.5.1 Research questions 
The general question that this study aims to answer was as follows: “what are the factors contributing 
to the standardization of management for diabetes and hypertension by traditional healers amongst 
Zulus and Tswanas?” Our specific questions were as follows: 
1. How do Tswanas and Zulus THPs acquire their knowledge and training on the management 
of diabetes and hypertension? 
2. What are the similarities and differences in the cultural understanding of the above two 
diseases amongst Tswanas and Zulus THPs? 
3. What are the similarities and differences in the description of clinical features of diabetes 
and hypertension amongst Tswanas and Zulus THPs? 
4. What are the similarities and differences in the ethnopharmacological and treatment 
approaches used by Tswanas and Zulus THPs for diabetes and hypertension? 
5. How can an intervention framework help for the standardisation of management of diabetes 
and hypertension by Tswanas and Zulus THPs? 
1.5.2 Aims and objectives of the study 
This study aimed to determine the factors contributing to the standardization of management for 
diabetes and hypertension by traditional healers. The specific objectives were as follows:  
1. To establish whether Tswanas and Zulus THPs acquire specific knowledge and training on 
the management of diabetes and hypertension. 
2. To determine similarities and differences in the cultural understanding of diabetes and 
hypertension amongst Tswanas and Zulus THPs. 
3. To evaluate similarities and differences in the description of clinical features of diabetes and 
hypertension amongst Tswanas and Zulus THPs. 
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4. To determine similarities and differences in the ethnopharmacological and treatment 
approaches used by Tswanas and Zulus THPs for diabetes and hypertension 
5. To develop an intervention framework for the standardization of treatment approaches of 
diabetes and hypertension by Tswanas and Zulus THPs. 
 
 
1.6 General methodology 
1.6.1 Study design 
A comparative cross-sectional study was carried out amongst Tswanas and Zulus THPs managing 
and treating diabetes and hypertension in using the mixed-method (embedded) approach, whereby 
the interview guide and questionnaire had the same focus114.  The interview guide and the 
questionnaire seek to elucidate the same response from the THPs included in this study. This study 
was carried out in different phases described below: 
Phase 1. Mixed qualitative and quantitative approaches:  
Phase 1A. Focus Group Discussions (FGDs) consisting of not more than 14 Tswana or Zulu THPs 
as recommended by these researchers115 was carried out about the management of diabetes and 
hypertension, using an interview guide among THPs, in the three geospatial areas (urban, traditional 
or tribal and farm areas). 
Phase 1B. A researcher administered questionnaire was conducted using face- to- face interviews 
about the management of diabetes and hypertension amongst Tswanas and Zulus THPs. 
Phase 2. An analytical approach was undertaken to develop an interventional framework based on 
standardized Ayurveda treatment guidelines for diabetes and hypertension18,19. 
Description of study sites 
Figure 2 illustrates the sites where the study was carried out in South Africa. 
 
1.6.2 Study areas 
KwaZulu- Natal province has a population of about 10 million and occupies 7.7 percent of the 
Country's land area. Its capital is Pietermaritzburg and Durban is the economic hub for the province. 
The province shares a border with the Kingdom of Eswatini116. 
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The North-West province has 8.7% of South Africa’s land area. It has a population of about 3.5 
million. Its Capital is Mahikeng with Potchefstroom as a major city. The province shares a border 
with Botswana116 (www.brandsouthafrica.com). 
 
Figure 2. Map of South Africa showing study areas with red arrows a: North-West; b KwaZulu-
Natal117 (www.castserve.com). 
 
1.6.3 Study population, inclusion and exclusion criteria  
In both phases, 1A and 1B, the inclusion criteria for participants was a minimum of aged 18 years 
with more than one year’s experience in managing diabetes and hypertension. Those eligible THPs 
with less than one year of experience in the management of both diabetes and hypertension were 
excluded from the study. 
1.6.4 Recruitment and selection of participants 
Zulu and Tswana THPs were recruited based on our inclusion and exclusion criteria relevant to the 
study research questions. A researcher needs to find a sample that matched the established criteria.  
1.6.5 Sample size and sampling technique 
Phase 1A: This study included Zulu and Tswana THPs aged 18 years old and above, irrespective of 
gender. THPs were drawn from urban, traditional or tribal, and farm areas in both uMgungundlovu 
and uThukela Districts in KwaZulu-Natal (KZN) Province, and Bojanala, Dr Ruth Sekgopomati 
Districts, North-West Province, South Africa. THPs experienced in the management of diabetes and 
hypertension were eligible for this study. Purposive sampling was used to select participants118. 67 
Zulu and 40 Tswana THPs took part in Phase 1A of this study. 
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Phase 1B: A snowball sample method was employed to recruit participants for the study119. Each 
participant who took part in the face-to-face interviews was used to refer to other THPs for the study. 
 
 
The calculation of sample size: 
A sample size with a statistical power of 80% was computed using the following statistical 
parameters: Effect size equals 0,33type 1 error(α) equals 0,05(the probability of falsely rejecting the 
null hypothesis equals to 5% and a type 2 error (β) equals 0.02 (the probability of falsely failing to 
reject the null hypothesis equals 20%). Based on the above parameters a minimum sample size of 
93 participants (THP’s) was computed for each geospatial location in each municipality in the North 
West and KZN provinces. To maintain the precision across the 12 selected geospatial locations, the 
total sample size was computed for 1,116(93x12) participants in this study, with 558 participants in 
each province respectively 120. A sample size of 1,116 THPs, from both North-West and Kwa Zulu-
Natal provinces, was targeted for the face-to-face interviews. A total of 863 THPs comprising of 
437 Zulus and 426 Tswanas representing 77, 33% of the targeted population of 1,116 took part in 
the study. 
Phase 2: In phase 2, an analytical approach was undertaken to develop an interventional framework 
based on standardized Ayurveda treatment guidelines for diabetes and hypertension18,19. 
 
1.6.6 Data collection techniques and tools 
The data collection methods employed in Phase 1A and Phase 1B were as follows: 
Phase 1A: FGDs with the help of developed interviewed guide (Appendix V) were held in both 
uMgungundlovu and uThukela Districts in KwaZulu-Natal (KZN) Province, and Bojanala, Dr Ruth 
Sekgopomati Districts, North-West Province, South Africa to find Zulu and Tswana THPs to find 
Zulu and Tswana THPs about the management of both diabetes and hypertension. It is significant to 
point out that the interview guide employed in the FGDs held in both uMgungundlovu and uThukela 
Districts in KwaZulu-Natal (KZN) Province, and Bojanala, Dr Ruth Sekgopomati Districts, North-
West Province, South Africa was translated from English to isiZulu and Tswana languages by 
experts for content validity. 
Phase 1B: This phase was a mixed-method (embedded approach) study and involved researcher 
administered interviews. Face-to-Face interviews with Zulu and Tswana THPs were conducted with 
the help of semi-structured questionnaire (Appendix VIII) which was translated from English to 
isiZulu and Tswana languages by experts for content validity. The semi-structured questionnaires 
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employed in Phase 1B of the study collected information on the socio-demographics of the 
participants. In addition, the research administered questionnaire contained questions on cultural 
understanding of both diabetes and hypertension diseases, training and acquisition of knowledge for 
the management of diabetes and hypertension, signs and symptoms of diabetes and hypertension, 
medical complications of both diabetes and hypertension, treatment modalities and approaches used 
in the management of diabetes and hypertension, challenges faced in the management of diabetes 
and hypertension and recommendations to improve diabetic and hypertensive care in South Africa. 
Zulu and Tswana THPs were visited in their homes, place of work and sometimes during their 
monthly meetings. The study was conducted concurrently, between September 2018 and September 
2019 in both KwaZulu-Natal and North-West provinces.  
Phase 2: In phase 2, findings from Phase 1A and Phase 1B and an adapted modified Ayurveda 
treatment guidelines for both diabetes and hypertension (Appendix XIX   and Appendix XX) led to 
the development of a modified interventional tool to be used by Zulu and Tswana traditional health 
practitioners in the management of diabetes and hypertension 
 
1.6.7 Data analysis 
Phase 1A: Qualitative data from the FGDs carried out in both uMgungundlovu and uThukela 
Districts in KwaZulu-Natal (KZN) Province, and Bojanala, Dr Ruth Sekgopomati Districts, North-
West Province, South Africa were analysed following Tesch’s recommendation of identifying 
themes and sub-themes in the raw transcribed data. The following steps were followed: First, 
transcriptions were read thoroughly, and general ideas were written down; second, an attempt was 
made to get a general understanding of the statements made by THPs in the study; third, similar 
topics were clustered together; fourth, topics were abbreviated, and the codes were written down. 
Topics identified from step 4 were turned into categories. A decision was taken on each abbreviated 
category and codes were alphabetized. The final step, a preliminary analysis, was performed to 
arrange data belonging to each category. 
Phase 1B: Qualitative data from the mixed-method (embedded) study approach carried out in both 
uMgungundlovu and uThukela Districts in KwaZulu-Natal (KZN) Province, and Bojanala, Dr Ruth 
Sekgopomati Districts, North-West Province, South Africa were analysed following Tesch’s 
recommendation of identifying themes and sub-themes in the raw transcribed data as described in 
Phase 1A of this study. For quantitative data analysis, data was captured on an excel sheet and 
analysed using the software package for social sciences (SPSS) version 20 for windows121. A 
descriptive statistics analysis was performed using frequencies and percentages. Categorical 
variables was presented using tables and graphs. 
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Phase 2: 
In Phase 2, an analytical approach was used to develop a modified interventional tool that was 
adapted from the Ayurveda treatment guidelines for both diabetes and hypertension based on 
findings from Phases 1A and Phase 1B.    OCM and Ayurveda health traditions experts’ opinion 
regarding the developed diabetes and hypertension guidelines were sought after their validation 
process that led to the development of a framework for the standardization of traditional health 
practices regarding the two conditions. 
 
1.6.8 Ethical considerations 
The study has received approval from the Biomedical Research Ethics Committee (BREC) of the 
University of KwaZulu-Natal under reference number: BE 567/17. The purpose of the study and 
procedural formalities were explained to participants. Participation was voluntary; in the various 
FGD sessions participants were requested to give informed consent before being interviewed.  
1.7 Layout of the dissertation/structure of the dissertation 
The dissertation is entitled “Development of a framework for the standardization of management of 
diabetes and hypertension: The case of Tswanas and Zulus of South Africa”. 
This study employing a mixed methods study approach has been conducted in both uMgungundlovu 
and uThukela Districts in KwaZulu-Natal (KZN) Province, and Bojanala, Dr Ruth Sekgopomati 
Districts, North-West Province, South Africa. 
The dissertation comprises of: 
 Chapter 1: Provides a background and a brief overview of the literature of the proposed 
study. This chapter highlights an overview of the rationale of the study, research questions, 
the aim, and objectives of the study. A general methodology has been included to achieve 
aim and different objectives of the study. 
 Chapter 2: Consists of a literature review published in Indian Knowledge of Traditional 
Knowledge (2018) under the title “Clinical relevance and application of traditional 
complementary and alternative medicine for the management of diabetes and hypertension 
on the African continent, 2000-2017: A narrative review”.  
 Chapter 3: Provides an original manuscript article published in Ethiopian Journal of Health 
and Development (2019), under the title “Management of diabetes and hypertension among 
Zulu traditional health practitioners: A study of focus groups”. 
 
 
19 
 
 Chapter 4: Comprises an original manuscript article published in Pan African Medical 
Journal (2019) under the title “Tswana traditional health practitioners’ perspectives on the 
management of diabetes and hypertension: a qualitative study using focus group 
discussions”. 
 Chapter 5: Consists of an original manuscript published in African Journal of Biomedical 
Research (2020) under the title “Management of diabetes and hypertension among Tswana 
and Zulu THPs: a comparative cross-sectional study using mixed methods approach”.  
 Chapter 6: Provides an original manuscript submitted to Indian Journal of Traditional 
Knowledge (2019) under the title “Development of a modified interventional tool for the 
management of diabetes and hypertension among Tswana and Zulu Traditional Health 
Practitioners in South Africa”.  
 Chapter 7: Provides the synthesis which includes general conclusions, strengths and 
limitations of the study then recommendations. 
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CHAPTER 2 
A narrative review was carried out to find the clinical relevance and the management of 
diabetes and hypertension on the African continent. The review was carried out to ascertain 
the use of Traditional  Medicine and the role played by traditional health practitioners in 
the management of diabetes and hypertension on the African continent. The findings are 
published in the Indian Journal of Traditional Knowledge. The final version of the article 
is presented in chapter 2. 
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CHAPTER 3 
The narrative review published and presented  in chapter 2 revealed the use of traditional 
medicine with the assistance of traditional health practitioners in the management of 
diabetes and hypertension on the African continent. Hence, a study was carried out in 
KwaZulu-Natal to find out Zulu traditional health practitioners perspectives in the 
management of diabetes and hypertension using focus group discussions with the help of 
an interview guide (Appemdix V ). The findings are published in the Ethiopian Journal 
of Health and Development. The final version of the article is presented in chapter 3. 
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CHAPTER 4 
Employing the same interview guide (Appendix V) used in chapter 2,  focus group 
discussions were held in the North-West province to find Tswana traditional health 
practitioners perspectives in the management of diabetes and hypertension in this study. 
The findings are published in the Pan African Medical Journal. The final version of the 
article is presented in chapter 4. 
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Abstract 
Introduction: the literature suggests the involvement of Traditional Health Practitioners (THPs) perspectives in treating diabetes and hypertension in 
Africa. This study sought the perspectives of Tswana THPs in the management of both diabetes and hypertension. Methods: using a semi- 
structured interview guide, four Focus Group Discussions (FGDs) sessions were held with 40 THPs; FGD1 (12) FGD2 (6); FGD3 (13) and FGD4 (9) who 
were purposely selected from Bojanala and Dr. Ruth Sekgopomati Districts in the North-West Province of South Africa. Results: Tswana THPs perceived 
diabetes as a “sugar” disease and described hypertension as a disease associated with the abnormal flow of blood in a patient's body. In addition, 
some of the signs and symptoms of both diabetes and hypertension mentioned by Tswana THPs agreed with scientific literature. Tswana THPs employed 
the use of the following plants: borago officinalis, ziziphus mucronata, hypoxis hemerocallidea, sutherlandia frutescens, senna italica, urginea sanguinea 
and eucalyptus globulus in the management of diabetes and hypertension. Conclusion: some of the medicinal plants employed by THPs in the 
management of both diabetes and hypertension has been proven scientifically to be effective against these chronic conditions. 
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Introduction Methods
 
In most African communities where access to hospitals and clinics 
remains a challenge, patronage of Traditional Medicine (TM) with the 
help of Traditional Health Practitioners (THPs) offer people the 
opportunity to manage certain diseases affecting their wellbeing and 
health in general [1]. According to the World Health Organization 
(WHO), "traditional medicine refers to health practices, approaches, 
knowledge and beliefs incorporating plant, animal and mineral-based 
medicines, spiritual therapies, manual techniques, and exercises applied 
singularly or in combination to treat, diagnose and prevent illnesses or 
maintain well-being" [2]. Furthermore, WHO defines Traditional Health 
Practitioner(THP) as, “a person who is recognised by the community 
where he or she lives as someone competent to provide health care by 
using plant, animal, mineral substances and other methods based on 
social, cultural and religious practices” [3]. In South Africa, a study 
reported that there were four groups of THPs recognized by the South 
African traditional healers act, namely: herbalists (izinyanga or 
amaxhwele), diviners (izangoma, umthandazi or amagqirha), traditional 
surgeons (iingcibi) [4]. The role played by THPs in the treatment and 
management of these two diseases (diabetes and hypertension) across 
the African continent has been documented [5, 6]. A research carried 
out in South Africa revealed the treatment of diabetes among THPs and 
faith healers in the northern province of South Africa [5]. Similarly, a 
study conducted in Zambia reported the treatment of hypertension 
among THPs in Zambia [6]. The two leading causes of cardiovascular 
diseases and their complications are diabetes and hypertension. 
Globally, it has been   estimated   that   1.39   billion   people   are   
affected   by hypertension [7] while 300 million people are estimated to 
be diabetic by the year 2025 [8]. The present study sought Tswana 
THPs perspectives about the management of diabetes and 
hypertension. The specific objectives were: to determine Tswana THPs 
cultural understanding of both diabetes and hypertension; to determine 
the Tswana THPs description of clinical features for both diabetes and 
hypertension; to determine ethnopharmacological and treatment 
modalities employed by Tswana THPs in the management of both 
diabetes and hypertension. 
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Study design and setting: an exploratory descriptive study, using 
four FGDs, was conducted among THPs in urban, traditional and 
farmland areas in the Bojanala and Dr. Ruth Sekgopomati Districts of 
North West district in South Africa to obtain quantitative and qualitative 
data. It is significant to point out that FGDs are used to gather opinions 
in qualitative research [9]. In the Bojanala District, FGD session 1 was 
held in the living room of a traditional leader in Boitekong, while FGD 
session 2 was held in the local community hall in Montsana. FGD 
sessions 3 and 4 in Dr. Ruth Sekgopomati Districts (Pampierstadt and 
Manthe) were held in the living rooms of THPs leaders. 
Study population and sample: purposive sampling was used to 
identify THPs who could provide information based on their availability 
and willingness to co-operate [10]. The four FGD sessions (12 in 
FGD1); (6 in FGD2); (13 in FGD3) and (9 in FGD4) had no more than 
14 subjects based on the recommendation of Gill P et al. [11]. The 
inclusion criteria for participants was a minimum of aged 18 years with 
more than one year experience in managing diabetes and 
hypertension. Those eligible THPs with less than one-year experience 
in the management of both diabetes and hypertension were excluded. 
With regards to recruitment and selection of THPs leaders of various 
associations of THPs in the area of study (North West Province, South 
Africa) were contacted to obtain their support and assistance in making 
contact with appropriate practitioners. Furthermore, they helped to 
recruit eligible THPs to join FGDs held during business hours in the 
respective districts. 
Ethics approval: this study obtained approval from the Biomedical 
Research Ethics Committee (BREC) of the University of KwaZulu-Natal 
under reference number BE 567/17. Participation in this study was 
voluntary for THPs included in the final analysis. The purpose of this 
study was explained to the participants and they were allowed to ask 
questions before each FGD session started. Those THPs who 
volunteered to be part of the study gave written consent before joining 
FGDs. 
Data analysis: there were simultaneous data collection and analysis 
with the help of two research assistants who were fluent in the Tswana 
language, the FGDs were audiotaped and transcribed verbatim. The 
raw transcribed data were analysed following Tesch's recommendation 
for identifying themes and sub-themes as presented 
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in a table below with the help of independent qualitative research 
experts. A meeting was held between the principal researchers to 
discuss the codes identified after data analysis [12]. The quantitative 
data were analysed using SPSS version 2.0 and thematic content 
analysis was used to analysed qualitative data [13, 14]. Descriptive 
statistics were used to present socio-demographic characteristics of 
participants expressed in frequency and percentage; mean values with 
standard deviation were used for age and years of work experience. 
Results 
Table 1 presents the socio-demographic characteristics of participants 
included in this study. Majority of the respondents recruited for the 
study were females (27/40, 67.5%). The mean age and years of work 
experience were 42.87 (13.69) and 11.29 (10.58) respectively. Majority 
of the participants were single (22/40, 55%); had high school education 
(21/40, 52.5%) and stated following both traditional and Christian 
religions 20/40 (50%). Many THPs 31/40 (77.5%) in this study used 
both divination and herbal practices. Most of the participants 36/40 
(90%) were registered with both the South African Traditional Health 
Practitioners Council (SATHPC) and the local district associations (THA). 
It is significant to point out that 8 themes and 15 sub-themes emerged 
from the study (Table 2). 
Tswana THPs perceptions towards diabetes and hypertension: 
THPs perspectives in the management of diabetes and hypertension 
are based on their understanding of these two diseases whether it is 
curable or manageable. Besides, how they were able to identify a patient 
affected by diabetes and hypertension was also taken into 
consideration. Last but not the least, Tswana THPs emphasized on the 
perceived causes and major complications of these two diseases. 
Understanding diabetes and hypertension: most Tswana THPs 
believed that diabetes is a “sugar disease” and described hypertension 
as a disease associated with a patient having an abnormal flow of blood 
in a patient’s body. "It is a sugar disease; the basic level of sugar is 
not the way is supposed to be in one's blood.” Female   1,   GP1. 
“It i s  a  s u g a r  d isease….” Female   3, GP4. “Hypertension is 
when there is a lot of pressure in your blood system, your blood is not 
flowing according to a normal way.” Female 
2, GP4. 
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Diabetes and hypertension are they curable or manageable? 
Most of the THPs were of the assertion that diabetes and hypertension 
could be cured following an appropriate treatment regimen. "Yes, both 
diseases are curable, with relevant treatment.” Female 2, GP2. It is 
significant to point out that all the participants in (GP2) voiced out that 
they agreed with what she said. “Yes. They are curable.” ***All the 
THPs in GP4. “Yes, these two diseases are curable.” ***All t h e  
T H P s  i n  G P  3 . “Both sugar diabetes and hypertension can be 
brought under control.” *** All the THPs in GP1. 
Identifying a person with diabetes and hypertension: majority 
of the THPs based their diagnosis on the knowledge of the signs and 
symptoms of these two diseases or signs and symptoms reported by 
patients seen by them. Tswana THPs mentioned the following: 
frequent urination, excessive sweating, frequent thirst, excessive 
desire to eat, as possible signs and symptoms of the two diseases. A 
few relied on BHPs and ancestral spirits for diagnosis. “A person 
suffering from d i abe t es  urinates now an d  t h en ." Female   1, 
GP4. “Diabetic person sweats a lo t .” Male 2 , G P 3 . "There are 
symptoms that we pick up when a person has diabetes, firstly that 
person normally has dry skin, also his/her mouth dries up. A person 
with diabetes is always hungry and he/she gets extremely weak when 
he/she is hungry, and his/her hard palate is also very dry.” Female 8, 
GP1. “The person who suffers from hypertension has similar 
symptoms as the one with diabetes, but also sweating is the most 
common symptoms just like a TB patient. Just like diabetes a person 
suffering from hypertension has a very low sex desire. Hypertension 
sufferers are normally impatient and short-tempered as well.” Female 
1, GP 1. “Once the clinic or doctor has confirmed we can start with 
the treatment.” Male 2, GP1. “Our knowledge and also guidance from 
our ancestors.” Female 2, GP2. 
Perceived causes of diabetes and hypertension: Tswana THPs 
stated that poor diets (consumption of excess sugar, salt, fatty foods, 
and red meat) are the perceived causes of both diabetes and 
hypertension. “They must avoid fatty/oily food. Salty and spicy 
food.” Female 3, GP1. "They must avoid meat, especially fatty meat, 
they must also avoid red meat if it is chicken they must remove the 
skin." Female 4, GP3. 
Perceived complications of diabetes and hypertension: Tswana 
THPs indicated poor eyesight, wounds associated with diabetic 
patients that do not get healed, amputation, stroke and erectile 
dysfunction as some of the perceived medical complications for 
diabetes. “With sugar diabetes is…once you can have a minor
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scratch   or   a   wound…you d o n ’ t    get   healed.” Female    4, 
GP1. “Hypertension leads to stroke.” Male 3, GP3. “In men it causes 
erectile dysfunction.” Female 1, GP2. 
Treatment modalities: Tswana THPs employed both 
ethnopharmacological and non-pharmacological treatment approaches 
in the management of these two diseases 
Ethnopharmacological interventions: Tswana THPs employed 
the use of herbal mixtures in the management of both diabetes and 
hypertension. “We use the following herbs, for both diabetes and 
hypertension, both diseases normally go together, meaning often you 
find a person suffering from diabetes also having hypertension as 
well. So we use ditserempepe, matlhare a se-rooiboom, aloe 
and mositakgomo.” Female 2, GP2. "For treatment, I mix lekgala, 
and lerumo la madi, I also take mosibeletswane and boil it, 
afterward I pour in two-litre bottle for the patient to drink at 
home." Male 1, GP4. Tswana THPs recommended the use of herbal 
mixtures with the composition of these medicinal plants borago 
officinalis, ziziphus mucronata, hypoxis hemerocallidea, sutherlandia 
frutescens, senna italica, urginea sanguinea and eucalyptus globulus. 
Non-pharmacological interventions: Tswana THPs stated the 
significance of exercise in the management of both diabetes and 
hypertension. “They must exercise regularly, they must take care of 
their bodies.” Female 1, GP3. 
Prescribing practices: Tswana THPs prescribed dosage leaned on 
the severity of a patient’s health condition and a patient’s ability to 
consume a certain amount of herbal mixtures. 
The severity of a patient's condition, high/low concentration of 
a mixture and age: THPs in this study relied on the age of a patient, 
severity of patients and the concentration of prescribed herbal mixtures. 
"It will depend and his/her condition, he/she might drink a quarter of 
a cup once, twice or three times a day." Female 4, GP1. "Yes, we do 
consider different age groups of patients as well as their conditions like 
pregnant women." Female 3, GP3. 
Effectiveness of prescribed TM: Tswana THPs argued about the 
effectiveness of their prescribed herbal mixtures compared to western 
medications. 
TM vs western medications: THPs believed that their prescribed 
herbal mixtures had no side effects when taken by their patients. "No, 
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our traditional medication does not have any side effects…." Female 
2, GP2. "There are no side effects." Male 2, GP4. 
Concurrent use of both prescribed medicines and western 
medications to avoid contraindications: Tswana THPs were not 
against taking these two forms of medications but advised their 
patients to take these two forms of medications (TM and conventional 
orthodox medication) but different times during the day to avoid 
contraindications. 
Encouragements when on these two forms of medications 
(prescribed herbal mixtures and western medications): 
Tswana THPs offered encouragements and advice to patients on both 
their prescribed medicines and western medications for the 
management of these two diseases. "Yes, they can take their herbal 
mixtures with western medication." Male 3, GP3. 
Avoidance of taken TM and western medication 
simultaneously: "If they take their clinic in the morning advise them 
to take their traditional medication in the evening or during the 
day." Male 3, GP2. "Also there must be a space between traditional 
medication and western medication, for example, if the patient takes 
the western one in the morning, then he/she must take the traditional 
one in the evening, alternatively the patient must ensure that there's 
four hour interval between the time he/she took the one medication 
before he/she can take another one. "Female 3, GP3. 
Feedback    and    monitoring    of    patients: Tswana    THPs 
acknowledged the significance of monitoring the progress of the 
patients seen by them. 
Positive feedback report from patients: some of the THPs 
contended that they do follow-ups by calling their patients over the 
phone. "There's constant communication between us and our 
patients, they always tell us and also we can see them, again often 
when they go for their check-ups at the clinic, they are always told 
whether their conditions have improved or not." Female1, GP4. 
Challenges faced in managing these two diseases: Tswana 
THPs spoke about the lack of scientific tools to help them with 
diagnostic purposes. 
Inaccessibility of medical tools for diagnosis: Tswana THPs 
bemoaned inaccessibility of scientific tools in the management of both 
diabetes and hypertension. "Western doctors have the equipment to
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check whether a patient is diabetic or not, with us, we only depend 
on signs." Male  2,  GP3. "The only thing is that they have the 
equipment to detect these diseases and we only rely on the signs and 
guidance from our ancestors." Male 3, GP2. 
Recommendations to improve diabetic and hypertensive care in  
South  Africa: Tswana  THPs  highlighted  the  significance  of 
collaboration with BHPs to assist in the management of both diabetes 
and hypertension. The proposed partnership with BHPs was intended to 
assist in managing diabetes and hypertension. 
Collaboration   with   biomedically   health   professionals: "I 
believe that if all South African medical health practitioners both 
traditional and western, must work together, traditional healers must 
also be allowed to see and treat patients in hospitals, I think that can 
improve not only diabetic and hypertension care but the health care in 
general." Female 3, GP4. 
The need for a two-way referral system of patients: Tswana 
THPs suggested the implementation of a two-way referral system of 
patients in the management of both diabetes and hypertension. They 
believed that BHPs were the ones against the two-way referral system. 
"The clinic and western doctors seem to be the ones who have 
problems to refer patients to us." Female 2, GP3. 
Endorsements and recognition from the government: Tswana 
THPs appealed to the government to give them the same attention as  
the  BHPs  working  in  the  hospitals. "Government must also 
intervene because we are realizing that western doctors are highly 
respected as opposed to us, African healers. We always give solutions to 
some of the health problems in this country, but we hardly get any 
recognition or credit." Female 3, GP1. 
Discussion 
Tswana THPs in this study description of diabetes as a "sugar disease" 
agrees with a similar study conducted in the Northern province of South 
Africa where THPs described diabetes as a sugar disease [5]. Regarding 
hypertension, Tswana THPs associated the disease with a patient 
having an abnormal flow of blood in his or her body. This is in 
agreement with a research carried out by Goma et al. in Zambia where 
some of the THPs in Lusaka described hypertension as a disease 
associated with blood flowing fast in a patient’s body [6]. 
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Tswana THPs in this study had varied opinions on whether 
hypertension and diabetes were curable or could only be managed. 
The assertion about the curability of diabetes and hypertension by 
THPs in FGDs 2, 3 and 4 is in agreement with the statements of THPs 
in the northern province of South Africa which indicated that diabetes 
was curable using African Traditional Medicine [5]. In a similar study 
conducted   in   Nigeria,  THPs   believed   that   hypertension   was 
curable [15]. However, in FGD 1, the THPs stated that diabetes and 
hypertension could only be managed but not cured completely. THPs 
in FGD 1 assertion that these two diseases cannot be cured completely 
is in agreement with scientific literature as opposed to the statements 
made by THPs in FGDs 2, 3 and 4 which seem to suggest that these 
two diseases could be cured completely following appropriate 
treatment regimen [16, 17]. It is therefore worth noting that 
participants were confident in their submissions regarding the 
management of diabetes and hypertension. 
Most of the THPs in this study based their diagnosis on the signs and 
symptoms reported by patients seen by them, while a few relied on 
ancestral spirits for diagnosis. A similar study conducted in Nkonkobe 
Municipality in South Africa reported that THPs relied on the signs and 
symptoms reported by their patients for diagnosis [18]. This finding 
may suggest that THPs in this study relied on the signs and symptoms 
reported by patients to affirm their diagnosis. Signs and symptoms 
(frequent urination, excessive sweating, frequent thirst, excessive 
desire to eat) reported by THPs in this study are in agreement with 
those signs and symptoms commonly reported in the scientific 
literature about diabetes and hypertension [19, 20]. Some of the 
THP's in this study stated with regards to a spiritual diagnosis that, 
upon receiving patients to their shrine "bidime" in "Tswana language" 
during consultations, ancestors revealed to them the problem troubling 
an individual and appropriate measures to be undertaken to improve 
his or her condition. This finding above is in agreement with another  
study  which  stated  that  ancestors  have  the  power  to heal [21]. 
Furthermore, indigenous epistemology suggests that an individual 
becomes ill as a result of weaknesses in his or her protective (spiritual) 
immunity [22]. 
Perceived causes (too much sugar and salt, excessive consumption of 
red meat and alcohol, and lack of regular exercises) of diabetes and 
hypertension described by THPs in this study are in agreement with 
the scientific findings commonly reported for diabetes and 
hypertension [23, 24]. Regarding perceived complications of diabetes 
and hypertension, the THPs specifically mentioned the following: 
erectile dysfunction, poor eyesight, wounds associated with diabetic
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patients that do not get healed, leading to stroke and amputation, 
this being the last intervention for limb preservation in diabetic patients 
with foot ulcers [25]. A multi-ethnic cohort study in the USA revealed a 
diabetic retinopathy prevalence rate of 33.2% among the studied 
population [26]. Erectile dysfunction, as stated by THPs in this study, is 
one of the major complications associated with diabetic patients and 
agrees with scientific literature. The prevalence rates of erectile 
dysfunction reported among diabetic men conducted in the following 
countries were as follows: USA (more than 50%), Saudi Arabia (80-
90%), Netherlands (41%) and Mexico (30-80%) [27]. 
Although most of the THPs were not ready to disclose information about 
the herbal formulation they used to manage the two diseases, some      
named      the      following      herbs      and      plants: buffalo-thorn 
(mokgalo), eland's-pea (sebetebete), sutherlandia (lerumo-la-
madi/phetola/mhetola), blue-gum tree (bluekom), red slangkop   
(sekaname),   African   potato   (labatheka),   star-flower (tshuko-ya-
poo), aloe vera (mokgopha), dwarf buffalo-thorn (sekgalofatshe). To 
prepare a herbal mixture some said they took fresh aloe, a handful of 
dried powder form of star-flower, a handful of tlhokwa-la-tsela (yellow 
medicinal grass-like plant) and a secret plant (often given a funny term) 
known only to them. A mixture of the above-mentioned plants was 
poured into a pot and allowed to boil. The boiled herbal mixture is taken 
off the fire and allowed to cool off before they poured into a 2-litre clean 
bottle to be given to patients. Scientific findings have revealed the 
potency of some of the named plants reported in this study for 
regulating blood sugar levels and decreasing blood pressure in both 
humans and animals. Approximately  sixty type 2  diabetic  patients  
in  India  who  were administered with a supplement (aloe vera gel 
powder, 100/200mg) daily over three months recorded a significant 
reduction in their blood glucose  and  blood  pressure  levels [28].  
Crude leaf extracts of starflower (borago officinalis) administered in 
rabbits caused a decrease in both atrial force and rate of contractions 
in their hearts [29]. Experimental results revealed a decrease in 
intestinal glucose uptake (p<0.001 at 1-hour intervals) in diabetic wistar 
rats when the animals were administered with sutherlandia frutescens 
for over eight weeks [30]. In a similar study, an aqueous extract of 
African potato (hypoxis hemerocallidea) (100-800 mg/kg p.o) 
administered to streptozin diabetic rats caused a reduction in the 
animal's blood glucose concentrations (30.20% and 48.54%) [31]. In 
vitro studies using 0.2% 2, 2-diphenyl-2-picrylhydrazyl (DPPH) assay 
revealed antioxidant properties exhibited by acetone extracts of the root 
of elands pea (Senna italica) [32]. Buffalo-thorn (ziziphus mucronata), 
red  slangkop  (urginea  sanguinea),  blue  gum  tree  (eucalyptus 
globulus), were also reported to be used by THPs in South Africa to 
manage diabetes and hypertension [33-35]. 
THPs in this study revealed that lifestyle modifications on the part of 
patients were a major contributor to manage these two diseases, with 
brisk walking having been established to be effective in reducing 
arterial blood pressures [36]. A study reported that hypertensive 
patients (under 8 weeks stress management programme) recorded a 
significant reduction in systolic blood pressures, even without taken 
their antihypertensive medications within that period [37]. THPs 
expressed confidence in their prescribed TM and were not aware of 
any side effects, with the dosage given depending on the severity of 
a patient's condition. This is in agreement with a similar study 
conducted in Kenya, where THPs stated that their prescribed herbal 
mixtures had no side effects [38]. Some of the THPs in this study were 
not against the concurrent use of TM and conventional orthodox 
medication by their patients. However, instructions were given 
regarding different times their prescribed medications should be 
taken to achieve the best possible health outcomes. Interestingly, 
studies reported that to avoid adverse effects regarding the use of 
both TM and conventional medications, these forms of medications 
should be taken at different times by a patient [39]. Some of the THPs 
in this study believed that extra care should be taken when prescribing 
medications for pregnant women, as strong herbal mixtures could 
affect the fetus. They gave an example of how some of their clients 
(women) who had taken birth control pills concurrently with their 
prescribed medications fell pregnant. Tswana THPs made it a priority 
to monitor the health conditions of their patients after they had given 
them medical assistance. In this study, some of the THPs who had the 
phone numbers of their clients called them to find out whether their 
health conditions had improved. Regarding the issue of collaboration 
between THPs and BHPs to assist in managing these two conditions, 
they were not against this initiative but bemoaned the lack of co-
operation from BHPs. Similarly, a study reported the reluctance of 
BHPs in referring patients to THPs for cancer treatment in KwaZulu-
Natal [40]. They confirmed the significance of collaboration between 
THPs and BHPs to improve diabetic and hypertensive care in South 
Africa. Most of the THPs were willing to learn to use scientific tools, 
such as a sphygnometer and glucometer, for diagnosing patients 
affected by these chronic conditions. 
Limitations of the study: the study took place in two districts in 
the North West Province, and the findings, therefore, may not be 
generalized for the entire population of THPs in the North West 
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province and the rest of South Africa. Medicinal plants available in the 
two districts under study may not be found elsewhere in other parts of 
South Africa. 
Implications of results: THPs in this study claimed that their 
prescribed medications had no side effects and should be researched to 
establish the efficacy and side effects of their herbal mixtures. A 
research carried out in South Africa revealed that a combination of 
prescribed herbal and conventional medications was effective against 
complications associated with antimicrobial therapy [41]. Conversely, a 
similar study reported that herbal medications could increase or 
decrease the pharmacological actions of prescribed drugs in patients 
with weak immune systems [42]. 
Conclusion 
Most of the THPs in this study (regardless of their geospatial locations 
urban, traditional and farmland areas) believed that diabetes is a sugar 
disease and referred hypertension as a disease associated with the 
abnormal flow of blood in a patient’s body. Some of the signs and 
symptoms associated with these two diseases mentioned by Tswana 
THPs agreed with scientific literature. Medicinal plants such as starflower     
(borago    officinalis),    African     potato     (hypoxis 
could be using the same treatment approaches and methods in 
the management of both diabetes and hypertension. 
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Tables
hemerocallidea) and elands pea (senna italica) used by Tswana THPs                 
to manage diabetes and hypertension have been proven scientifically
to be effective against them [30-32]. 
What is known about this topic 
 The involvement of THPs in the management of diabetes 
and hypertension on the African continent; 
 Many people on the African continent rely on TM with 
the assistance of THPs because it is a cheaper 
alternative compared to OCM; 
 Possible side effects associated with OCM encourage 
people to patronize TM for these chronic conditions. 
What this study adds 
 Tswana THPs description of clinical features such as 
frequent urination, excessive sweating, frequent 
thirst associated with diabetes and hypertension 
agreed with scientific literature; 
 Tswana THPs employed in this study (regardless of 
their geospatial locations urban, traditional and 
farmland areas) 
Table 1:  socio-demographic  characteristics  of  THPs  purposely 
selected for this study 
Table 2: major themes and sub-themes 
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Table 1: socio-demographic characteristics of THPs purposely selected for this study 
Variables Mean ± SD n % 
Age(years) 42.87(13.69) NS 
Years of experience 11.29(10.58) NS 
Gender Female 27(67.5) 
Male 12(30) 
Not specified 1(2.5) 
Marital status Cohabitation 2(5.0) 
Married 13(32.5) 
Single 22(55) 
Widow 1(2.5) 
Religion Christian 5(12.5) 
Traditional 15(37.5) 
Traditional and Christian 20(50) 
Education Nil 1(2.5) 
Primary school 5(12.5) 
Tertiary 11(27.5) 
High school 21(52.5) 
Other (middle school) 2(5.0) 
Kind of practice: Both divination and herbal 31(77.5) 
Divination 9(22.5) 
Type of Practicing Fulltime 38(95) 
Part time 2(5.0) 
Place of practice Home 40(100.0) 
Home and market 0(0.0) 
Office 0(0.0) 
Registration (SATHPC) No 4(10.0) 
 Yes 36(90.0) 
Registration (THA) No 4(10.0) 
 Yes 36(90.0) 
Legend a: SATHPC (South African Traditional Health Practioners Council); National 
body; b: THA (Traditional Healers Association; Local association in respective 
district; c: SD (Standard deviation); d:NS (Not stated)  
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Table 2: major themes and sub-themes 
Theme 1: Perceptions towards diabetes 
and hypertension 
Understanding diabetes and hypertension 
Is diabetes and hypertension curable or manageable 
Identifying a person with diabetes and hypertension 
Perceived causes of diabetes and hypertension 
Perceived major complications of diabetes and 
hypertension 
Theme 2: Treatment modalities for 
diabetes and hypertension 
Ethnopharmacological interventions 
Non pharmacological interventions Theme 3: Prescribing practices for 
diabetes and hypertension 
Sev ity of a patient’s condition, high/low 
concentration of a mixture and age Theme 4: Effectiveness for prescribed 
medications 
TM vs western medications 
Theme 5: Concurrent use of prescribed 
medicines with western medications to 
avoid contraindications 
Encouragements and instructions to follow when on 
these two medications 
Avoidance of taken TM and western medication 
simultaneously 
Theme 6: Feedback and monitoring Feedback report from patients 
Theme 7: Challenges faced in the 
management of diabetes and 
Hypertension 
Inaccessibility of medical tools for diagnosis 
Theme 8: Recommendations to improve 
diabetic and hypertensive care in South 
Africa 
Collaboration with biomedically health professionals 
The need for a two-way referral system of patients 
Endorsement and recognition from government  
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CHAPTER 5 
Findings from chapter 3 and chapter 4 revealed similarities in statements made by Zulu and Tswana THPs regarding the cultural understanding of both diabetes and 
hypertension. Regarding cultural understanding of diabetes some of the selected verbatim quotes made by Zulu THPs were as follows: “It is a sugar disease.”Female 1, GP1. 
“Diabetes can be one of the high sugar levels or low blood sugar levels.”Female 3, GP2. 
Statements made by Tswana THPs regarding cultural understanding about diabetes were as follows: "It is a sugar disease; the basic level of sugar is not the way is supposed to 
be in one's blood”. Female 1, GP1. 
“It is a sugar disease”. Female3, GP4. 
Regarding THPs cultural understanding about hypertension, statements made by Zulu THPs were as follows: “Diabetes and blood pressure (BP) are related. It is a norm that 
people who suffer from high BP are also affected by diabetes because of the imbalance between sugar and salt in the body”. Female 2, GP1. 
 Statements made by Tswana THPs in support of their cultural understanding about hypertension were as follows: 
“Hypertension is when there is a lot of pressure in your blood system, your blood is not flowing according to a normal way”. Female 2, GP4. 
Regarding the description of clinical features of diabetes as a disease, these were the statements made by Zulu THPs.  
“People with BP or diabetes sweat a lot.”Male 3, GP4. 
Loses weight, sweats a lot, eyes become affected too.”Female 3, GP1. 
Tswana THPs description of clinical features of diabetes were as follows: 
A person suffering from diabetes urinates now and then". Female 1, GP4. 
Zulu THPs description of clinical features of hypertension were as follows: 
“People with BP or diabetes sweat a lot.”Male 3, GP4. 
Tswana THPs description of clinical features of hypertension were as follows: 
“The person who suffers from hypertension has similar symptoms as the one with diabetes, but also sweating is the most common symptoms just like a TB patient. Just like 
diabetes a person suffering from hypertension has a very low sex desire. Hypertension sufferers are normally impatient and short-tempered as well”. Female 1, GP 1. 
Regarding Ethnopharmacological preparations and treatment approaches employed by Zulu THPs to combat both diabetes and hypertension were as follows: We mix different 
herbs according to the level of illness. These are very bitter to taste but they help. However, we use different mixtures because we learn how to do so differently.”Female 1, 
GP1 
“Reduce salt intake, drink lots of water, regular exercise, eat fruits (apples), spinach, other vegetables, and avoid using cooking oil or fat when cooking.”Male 3, GP5. 
“Mixture of various herbs,‘amakhambi’,are used to control these conditions; also garlic is used to control these conditions.”Male 2, GP1“Aloe and garlic are used for this 
disease.”Male 4, GP4. Tswana THPs stated the following as the ethnopharmalogical preparations used to combat both diabetes and hypertension: “We use the following herbs, 
for both diabetes and hypertension, both diseases normally go together, meaning often you find a person suffering from diabetes also having hypertension as well. So we use 
ditserempepe, matlhare a se-rooiboom, aloe and mositakgomo”. Female 2, GP2. 
"For treatment, I mix lekgala, and lerumo la madi, I also take mosibeletswane and boil it, and afterward I pour in two-litre bottle for the patient to drink at home". Male 1, GP4. 
A critical analysis regarding statements made by Tswana and Zulu THPs revealed that there were no major differences regarding Zulu and Tswana THPs cultural understanding 
of diabetes and hypertension, description of clinical features , ethno pharmacological and treatment approaches used in the management of both diabetes and hypertension 
diseases. To conclude, Objectives 2, 3, 4 of this thesis were covered. The core objectives of the study were to determine similarities and differences the acquisition of 
knowledge,cultural understanding of diabetes and hypertension,description of clinical features of these two conditions and ethnopharmacological and treatment modalities 
employed by Zulu and Tswana THPs in the management of diabetes and hypertension. To build on chapter 3 and chapter 4,  a comparative cross- sectional study using face-
to-face interviews with the help of semi-structured questionnaire(Appendix VIII) were undertaken to establish similarities and differences in the methods and treatment 
approaches employed by Zulu and Tswana THPs in the management of diabetes and hypertension. The findings are published in  the African Journal of Biomedical Research.   
The final version of the manuscript is presented in chapter 5. 
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CHAPTER 6 
Findings from chapter 3, 4 and 5 and an adapted modified Ayurveda treatment 
guidelines for both diabetes and hypertension (Appendix XIX   and Appendix XX)  
led to the development of a modified interventional tool to be used by Zulu and 
Tswana traditional health practitioners in the management of diabetes and 
hypertension. The final version of the manuscript is presented in chapter 6. It has 
been arranged and submitted following the author’s recommendations of the 
Indian Journal of Traditional Knowledge. The manuscript is presently under 
review with the registration number:IJTK-1020.  This chapter addresses objective 
5 of the study. 
 
74 
 
Development of a modified interventional tool for the management of diabetes and 
hypertension among Tswana and Zulu Traditional Health Practitioners in South 
Africa. 
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Africa. 
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Abstract 
Introduction: Orthodox Conventional Medicine (OCM) and Ayurveda literature suggest the 
availability of treatment guidelines used by practitioners in these two healthcare systems in 
the management of diabetes and hypertension. African Traditional Medicine (ATM) has 
been involved in the management of chronic diseases, namely diabetes, and hypertension; 
however, practitioners of this Traditional Medicine (TM) do not have documented 
guidelines. This study aimed at the development of a modified interventional tool based on 
information collected among Tswana and Zulu Traditional Health Practitioners (THPs) in 
the management of diabetes and hypertension in their respective local communities.  
Methods: An approach consisting of four steps was used to develop a modified tool for the 
management of diabetes and hypertension by THPs. Step 1 consisted of an extensive OCM 
and Ayurveda literature search which led to an interventional tool (Ayurveda treatment 
guidelines for both diabetes and hypertension) to be modified. Step 2 involved the use of 
Focus Groups Discussions (FGDs) and face-to-face interviews to find the perspectives of 
Tswana and Zulu THPs in the management of diabetes and hypertension. An analytical 
approach was used in Step 3 to develop a modified interventional tool adapted from the 
Ayurveda guidelines in step 1 and findings from Tswana and Zulu traditional health 
practitioners in step 2. Expert opinions were sought in step 4 to ensure the validity of the 
developed interventional tool.  
Results: A modified interventional tool was developed and adapted from the Ayurveda and 
OCM treatment guidelines for the management of diabetes and hypertension based on 
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cultures of Tswana and Zulu THPs. Recommendations and suggestions from experts were 
used to validate the developed modified interventional tool. 
Conclusion: This interventional tool will assist Tswana and Zulu THPs in the management 
of diabetes and hypertension within Traditional African communities. 
Keywords: Diabetes; Hypertension; Ayurveda; Orthodox conventional medicine; Traditional Health Practitioners; 
Interventional tool. 
 
Introduction 
Orthodox Conventional Medicine (OCM) and Ayurveda (originated from India) health 
traditions have developed standard treatment guidelines for both diabetes and hypertension 
that helps their practitioners to treat patients affected by these chronic conditions 1-4. Diabetes 
and hypertension are a major threat to the health and cause of considerable illness and 
premature deaths 5, with African governments spending large sums of money to provide 
health care services to combat them 6. The causes of illness, and therefore the types of healing 
needed, are understood differently across the continent, with one method of healing and 
treatment not necessarily being appropriate for all cultures. To provide people with the type 
of healing, at an accessible location, by someone who speaks their language and understands 
their traditions is an important component of ensuring wellbeing. There is, therefore, the 
need to understand the treatment provided by Tswana and Zulu Traditional Health 
Practitioners (THPs) to the communities they serve. These developed guidelines for diabetes 
and hypertension management were informed by Ayurveda treatment guidelines for these 
two diseases 3,4, with the content being based on the information provided by Tswana and 
Zulu THPs in North -West and Kwa Zulu-Natal Provinces in South Africa, respectively. 
They also include relevant information from OCM literature regarding managing diabetes 
and hypertension1,2, with scientific studies supporting the use of some of the plants in 
managing these chronic conditions 7,8. Based on the findings of the use of TM by THPs of 
the Tswana and Zulu cultures for the management of diabetes and hypertension in South 
Africa 9,10, and the ongoing problems with managing diabetes and hypertension in many rural 
communities where access to OCM is often limited 11, has resulted in the need to explore 
treatment options that are culturally appropriate and cost-effective. However, the absence of 
standardized and formalized Tswana and Zulu treatment guidelines for THPs indicated the 
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need to identify their various options within the context of OCM as well as Ayurveda 
practices. OCM diabetes and hypertension management practices have been extensively 
researched and form the basis of most medical school curriculum 1,2. Ayurveda remedies 
have a long history of use and instruction in formal institutions on the Indian sub-continent 
but are less widely used globally, although it is increasingly being acknowledged as an 
important alternative to OCM.  
While there is no formal institutional instruction of the Tswana and Zulu forms of TM, there 
is a growing body of evidence about their use of medicinal plants to manage diabetes and 
hypertension 9,10. Medicinal plants are widely used by THPs, although the benefits of their 
use have not been supported by scientific literature, with research being needed to identify 
any medicinal properties. These guidelines are intended for THPs who want to provide the 
optimal treatment formulations for diabetes and hypertension, and for other health 
practitioners who want to understand the role they play in their patients' care options. It is 
anticipated that they will assist in delivering primary health care in indigenous communities 
where many people rely on TM due to its accessibility, affordability and cultural acceptance 
12. Furthermore, it is anticipated that they will increase the confidence of the general 
population in TM methods and approaches, and provide people with options to treat their 
chronic conditions 13,14.  
The guidelines also provide recommendations for further research that will lead to a formal 
standardized blueprint document for managing diabetes and hypertension across South 
African cultures. It is anticipated that they will provide evidence to encourage African 
governments to include TM as part of their public health care services for improved 
recognition and acceptance and to be implemented in both the OCM and TM systems. 
Besides, it will assist researchers to develop a curriculum for the training of THPs to deliver 
quality and affordable care to those who seek their services 15.  
 
Methods 
Step 1 OCM and Ayurveda literature search about the management of diabetes and 
hypertension 
An extensive literature search was conducted from Google scholar, the web of science, Pub-
med and Cochrane library electronic databases 16 to find out the relevant information about 
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the management of diabetes and hypertension from OCM and Ayurveda perspectives which 
led to adapted Ayurveda treatment guidelines for both diabetes and hypertension. Specific 
keywords used to search were Ayurveda and diabetes, Ayurveda and hypertension, 
Ayurveda guidelines used in the management of diabetes and hypertension, medicinal plants 
used in Ayurveda for both diabetes and hypertension and OCM guidelines used in the 
management of diabetes and hypertension. A literature review is an appraised summary of 
other research relevant to a study to be conducted in a specific area of interest 17. Research 
articles with the needed information relevant to our study were appropriately referenced in 
the main text of the manuscript. 
 
Step 2 A study conducted in different phases with Tswana and Zulu THPs to find their 
perspectives about the management of diabetes and hypertension 
 
A study was conducted in both KwaZulu- Natal and North West provinces (Figure 1) to find 
out the perspectives of THPs in managing diabetes and hypertension in two phases. 
 
 
Figure 1. Map of South Africa showing study areas with red arrows a: North-West; b 
KwaZulu-Natal18 
Phase 1A was carried out about the management of diabetes and hypertension, using an 
interview guide among THPs, in the three geospatial areas (urban, traditional or tribal and 
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farm areas) in both KwaZulu- Natal and North-West provinces. 67 THPs in KwaZulu- Natal 
and 40 from North West provinces voluntarily took part in the study. 
 
Phase 1B A researcher administered questionnaire was conducted using face-to-face 
interviews about the management of diabetes and hypertension among Tswana and Zulu 
THPs in the three geospatial areas (urban, traditional or tribal and farm areas) in both 
KwaZulu- Natal and North-West provinces. 437 THPs in KwaZulu-Natal and 426 THPs in 
North West provinces voluntarily took part in this study. 
THPs perspectives about managing diabetes and hypertension were sought in these broad 
topics concerning the objectives of our study: 
 THPs cultural understanding about diabetes and hypertension diseases 
 Identifying a person with diabetes and hypertension (signs and symptoms) 
 Perceived causes of diabetes and hypertension 
 Complications of diabetes and hypertension 
 Treatment modalities 
 Prescribing practices 
 Effectiveness of prescribed TM 
 Concurrent use of TM and OCM 
 Contraindications of medications 
 Feedback and monitoring of patients 
 Challenges faced in managing these two diseases 
 Recommendations to improve diabetic and hypertensive care in South Africa 
 
Step 3 Analytical approach employed for the development of diabetes and hypertension 
guidelines to be used by Tswana and Zulu THPs 
 
To develop treatment guidelines for both diabetes and hypertension to be used by Tswana 
and Zulu THPs, an analytical approach was undertaken to develop a modified interventional 
tool adapted from Step 1 based on the findings from step 2 1,2. Reported statements by 
Tswana and Zulu THPs employed in our previous studies (personal communication: FGDs 
and face-to-face interviews with Tswana and Zulu THPs) that were in agreement with 
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disseminated information (signs and symptoms causative factors, medical complications and 
non-pharmacological management of these two diseases) from OCM and Ayurveda 
perspectives formed the basis of our developed guidelines to be used by Tswana and Zulu 
THPs in managing both diabetes and hypertension3,4 . More importantly, taken into 
consideration how certain medicinal plants made the list and were included in documented 
Ayurveda treatment guidelines for both diabetes and hypertension3,4 , medicinal plants are 
known to Tswana and Zulu THPs reported in our survey (personal communication: FGDs 
and face-to-face interviews with Tswana and Zulu THPs) and scientifically proven to be 
effective against diabetes and hypertension (cross-referenced with literature) have been 
included in the ethnopharmacological sections of our developed guidelines to be used by 
Tswana and Zulu THPs.  
 
Step 4 Validation of the developed diabetes and hypertension guidelines to be used by 
Tswana and Zulu THPs by experts and practitioners in the field of OCM and Ayurveda health 
traditions  
Experts' opinion were sought to ensure the validity of the interventional tool to be used by 
Tswana and Zulu THPs in the management of these two diseases. 
 
Results 
Step 1 OCM and Ayurveda literature search about the management of diabetes and 
hypertension 
An adapted Ayurveda treatment guideline for both diabetes and hypertension 3,4 served as a 
reference which led to the development of an interventional tool to be used by Tswana and 
Zulu THPs in the management of diabetes and hypertension. 
 
Step 2 A study conducted in different phases with Tswana and Zulu THPs to find their 
perspectives about the management of diabetes and hypertension 
Data collected from the above-mentioned broad topics (Step 2 under the methodology 
section) were in line with the objectives of our study. Findings from our previous studies 
(personal communication: FGDs and face-to-face interviews with Tswana and Zulu THPs) 
compared to adapted modified Ayurveda treatment guidelines for both diabetes and 
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hypertension 1,2 led to the development of an interventional tool to be used by Tswana and 
Zulu THPs in the management of diabetes and hypertension.  
 
Step 3 Analytical approach employed for the development of diabetes and hypertension 
guidelines to be used by Tswana and Zulu THPs 
Using an analytical approach and based on the information obtained from Step 1 and findings 
from (Step 2) these guidelines to be used by Tswana and Zulu THPs for the management of 
diabetes (A) and hypertension (B) were developed. 
These developed guidelines (A. Diabetes) and (B. Hypertension) for both diabetes and 
hypertension to be used by Tswana and Zulu THPs, will be translated into Tswana and 
isiZulu languages and then distributed to the offices of relevant traditional healers 
association in both KwaZulu-Natal and North-West provinces. 
 
 
A. Developed diabetes guidelines to be used by Tswana and Zulu THPs 
Diabetes 
Brief history 
Aratus of Cappodonia first introduced the term 'diabetes' in 81-133 AD in Greece, meaning 
'a siphon' (or run through), this being an apt description of diabetes, as he realized that an 
affected person never stops drinking water. A physician named Sushruta and a surgeon 
named Charaka identified the two types of diabetes that became known as Type 1 and Type 
2 19-21. Thomas Willis of Great Britain coined the term 'Mellitus' in 1675, literally meaning 
'honey-sweet' when he discovered the sweetness of both the blood and urine in patients. 
Another British national in 1776 discovered that the cause of the urine and blood sweetness 
of diabetic patients was their high levels of blood sugar 22,23. Research carried out by Claude 
Bernard (French National) in 1857 confirmed that diabetes is caused by an excess in glucose 
production, and paved the way for its research in medicine 22. The treatment of diabetes in 
humans improved substantially with the development of appropriate medication from the 
early part of the 19th century. These medications insulin, metformin, a thiazolidinedione, 
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pramlintide, and alogliptin were highly effective in managing diabetes because of their 
specific pharmacological actions 24. 
 
Prevalence 
Diabetes is one of the leading causes of human death 25, with Africa currently spending 7% 
of its annual healthcare budget on managing the disease 26, and an estimated 34.2 million 
people in sub-Saharan Africa (SSA) being likely to be affected by 2040 26. Type 2 diabetes, 
which affects adults, accounts for approximately 95% of all cases in SSA, with 5% being 
Type 1, which affects children 27. 
 
Brief introduction 
Diabetes is a disease associated with abnormal blood glucose levels that are commonly 
referred to as a ‘sugar disease’. Humans need constant blood glucose levels to maintain 
healthy living, with upper and lower limits, above and below which causes problems in the 
body. Blood glucose is a kind of sugar that is obtained from consuming foods high in 
carbohydrates and fruit. The food that a person eats is broken down into tiny pieces with the 
help of acids and enzymes that are produced by the body, which enables the components of 
the food to be released into forms that the body and absorb and use. These components 
include minerals, vitamins, fats and sugar, the last one being released as glucose. This 
glucose is absorbed by the intestines and moves through the body in the blood system to the 
cells with the help of insulin, the levels of which also need to be regulated by the body. Blood 
glucose is important as it gives the body the energy it needs to go about the daily activities, 
including for the brain, with additional energy often being required for activities that use up 
extra energy, such as running 28,29. Presented in Table 1 is the summary of blood glucose 
levels in humans. 
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Table 1. Blood glucose Levels30 
Target levels by 
Type 
Upon waking Before meals (pre-
prandial) 
At least 90 minutes 
after meals 
(postprandial) 
Non-diabetic N/A 4.0 to 5.9 mmol/L under 7.8 mmol/L 
Type 2 diabetes N/A 4 to 7 mmol/L under 8.5 mmol/L 
Type 1 diabetes 5 to 7 mmol/L 4 to 7 mmol/L 5 to 9 mmol/L 
Children with type 
1 diabetes 
4 to 7 mmol/L 4 to 7 mmol/L 5 to 9 mmol/L 
Legend: mmol/L (millimoles per litre); N/A(Not Applicable) 
 
Causative factors of diabetes 
THPs should note that factors that cause diabetes are often diet-related, with diets that consist 
of too many carbohydrates, which mean that the body is unable to use up all the energy 
provided by the food that is eaten, specifically food high in starch (bread, cereal, and 
potatoes) and too much fat. Vegetables, other than potatoes, have much fewer carbohydrates 
than starches and are therefore much better at not overloading the blood system with too 
much glucose. Besides, the lack of regular and sufficient exercise results in the body not 
spending the energy it consumes, building up muscles that are needed for general wellbeing, 
or generally being healthy. The following are some of the major causative factors for 
diabetes: 
 too much sugar intake 
 using too much salt  
 too much consumption of fatty foods 
 excessive consumption of red meat  
 lack of exercises 
 
Signs and symptoms of diabetes 
The following are the signs and symptoms of diabetes:  
 frequent urination  
 often sweating  
 often thirst  
 wounds that turn septic and will not heal 
 often feeling hungry and wanting to eat 
 unexpected weight loss  
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 shortness of breath, problems with breathing  
 eyesight problems 
 
Diagnosing diabetes  
THPs are encouraged to identify specific signs and symptoms when diagnosing diabetes and 
to refer them to the nearest clinic or hospital to test for the condition before they start 
implementing their treatment options. The correct diagnosis is important, as the person may 
or may not have the disease, and the wrong treatment may affect their health and wellbeing. 
Under treating could result in the person getting very ill, while over-treating could cause 
unintended health problems. 
 
Complications of diabetes 
THPs should know that when not treated or managed, diabetes can lead to these 
complications: 
 poor eyesight,  
 Wounds that do not heal, leading to amputation. 
 stroke 
 erectile dysfunction 
 breathing complications 
 uncontrolled weight loss 
 dehydration due to excessive water loss 
 
Managing diabetes 
As diabetes is caused by poor diet and a lack of exercises, THPs should advice patients to 
eat food rich in vegetables that do not contain too much starch, and regular consumption of 
fruits, and to participate in regular exercises to keep them healthy. 
 
Managing diabetes using plant preparations 
THPs can use the following plants (Table 2) to prepare herbal mixtures for their patients, 
these being the commons ones reported for use among their local professionals. Some of 
these plants that have been proven scientifically to be effective in managing diabetes, these 
being indicated by the names of the people who have conducted the studies. However, please 
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note that the plants, or the names by which they are referred to, may be specific to the study 
areas in KwaZulu-Natal and North-West Provinces. 
 
Table 2. Medicinal plants effective in the management of diabetes. 
isiZulu name Tswana 
name 
Scientific name  Common 
English 
name  
Parts used Phytochemical constituents 
Inhlaba Mokgopha Aloe vera Aloe leaves Tannins, Saponins, and 
Flavonoids31,32 
Inkomfe Labatheka Hypoxis 
hemerocallidea 
African 
potato 
root Phytostreols, 
Norlignaneglycosidehypoxoside, 
Aglycon rooperol33,34 
Inkalane N/A Aloe 
arborescens 
Mountain 
bush aloe 
leaves Sinapic acid, Chlorogenic acid, 
and Aloin35 
Intshungo N/A Momordica 
foetida 
Bad-
smelling 
Leaves Flavonoids,Foetidin36,37 
Indumbahlozi 
ye avocado 
N/A  Persea 
americana  
Avocado Leaves, 
fruits, seeds 
Saponins,Tannins,Flavonoids38,3
9 
Dagga N/A Cannabis sativa Medicinal 
cannabis 
Leaves Cannabinol,delta-9-
tetrahydrocannabidiol40 
NA Mokgalo Ziziphus 
mucronata 
Buffalo 
thorns 
Leaves Phenol, Flavonoids, 
Proanthocyandins41,42 
NA Sengaparil
e 
Harpagophylum 
procumbens 
Devils claw Roots Harpagoquinones, Flavonoids, 
Phytosterols, Amino acids43-46 
NA Tlhokwa  
Letsela 
Dianthus 
basuticus 
Lesotho 
carnation 
Roots Alkaloids, Tannins, Saponins, 
Cardiac glycosides47,48 
NA Lerumo-
la-madi/ 
Phetola/ 
Mhetola 
Sutherlandia 
frutescens 
 
 
Cancer bush Bark, leaves Flavonoids, Saponins, 
Triterpernoids, Pinitol49-52 
Legend: N/A (Not applicable). NB: Recommended plants and their corresponding isiZulu 
or Tswana names are specific to the study areas in KZN and North-West Provinces. 
 
Mode of preparation: Concoction and decoction 
The mode of preparation of herbal mixtures might differ from one THP to the other. 
Basically, THPs prepare herbal mixtures from a single or a combination of some of these 
medicinal plants (fresh/dried powdered forms) using different parts of identified medicinal 
plants. THPs are strongly advised to prepare herbal mixtures made up of three or more 
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medicinal plants because polyherbal formulations have been proven to be more effective 
than single herbs in Ayurvedic medicine.53 
Example: To prepare a herbal mixture a few said they took fresh aloe (Aloe vera), a handful 
of dried powder form of Tshuko-ya-poo (Borago officinalis), a handful of tlhokwa-la-tsela 
(Dianthus basuticus) and a secret plant (often given a funny term) known only to them. A 
mixture of the above-mentioned plants was poured into a pot and allowed to boil. The boiled 
herbal mixture is taken off the fire and allowed to cool off before they poured into a 2-litre 
clean bottle to be given to patients (personal communication: FGDs and face-to-face 
interviews with Tswana and Zulu THPs). 
 
Route of administration: Oral forms mainly liquids (herbal mixtures).  
 
Dispensing herbal mixtures 
THPs are encouraged to prepare herbal mixtures using relevant plants as their baseline, but 
including other plants and herbs that could boost the immune system, as these will helps 
people to fight diseases in general 54. Medicinal plants available to THPs that are regarded 
as being effective to manage diabetes, based on the successes achieved with their clients, 
should be given in the necessary consideration, with the dosage be carefully explained to 
patients in detail to ensure that they understand when and how to take them. This is necessary 
for the following reasons: 
 To avoid health problems that may arise when people use OCM and herbal 
preparations, the two preparations needed to be taken at different times of the day to 
avoid the chance of their affecting each other, as has been shown by scientific research 
55. 
 Patients need to be encouraged to take the prescribed dosage, and the THPs should 
consult them over the phone if necessary to monitor their health status.  
 As doses tend to be determined by age and weight, children should not be given the 
same dose as adult patients.  
 Care needs to also be taken for preparations prescribed to older patients (60 years and 
above) due to a weakened kidney as a result of old age 56. 
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 A pregnant woman should be referred immediately to the nearest health care facility 
to check the effect on the herbal preparations on the unborn child 57. 
 
Dosage 
The prescribed dosage quantity administered to adults and children should be based on the 
potency of the chosen medicinal plants and success rate achieved, using the same cup or 
tablespoon measurements, depending on the age and weight of the patients. 
 
 For adults, the prescribed dosage of herbal mixtures (quantities) in millilitres (mls) by 
THPs (personal communication: FGDs and face-to-face interviews with Tswana and 
Zulu THPs) were not more than half of a standard South African cup size (250 mls), 
irrespective of the number of times and when (before or after meals) the mixture was 
taken during the day.  
 For children, the maximum recommended dosage was not more than 3 teaspoons 
(15mls) (South African standard teaspoon size) within a day.  
 
These above herbal mixture quantities (in mls) have been suggested to scientific researchers 
to find out if patients are at any health risk, and the results of the studies will be made 
available as soon as they are available. This will allow the quantities to be adjusted to ensure 
that the patients benefit from the most suitable doses.  
 
General recommendations  
THPs need to manage their patients’ overall wellbeing as well as treat diabetes to ensure 
long-term optimal health. Ensuring that patients maintain healthy lifestyles is an important 
part of them having a sense of control over and being responsible for their condition. As 
diabetes is often associated with other conditions, THPs are advised to manage their patients 
holistically, and to, therefore, consider the following:  
 Encourage their patients to manage their weight by not consuming sugary beverages, 
eating very little fried fatty food, and eating lots of fruit and vegetables.  
 Encourage children to be physically active, and to take part in activities both at school 
and when at home and not to spend too much time sitting at home. 
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 Monitor their patients’ blood and sugar levels regularly to prevent complications  
 Limit the consumption of alcohol and stop smoking, as these have been shown to help 
with managing diabetes 58,59. 
  People with diabetes need to exercise regularly to manage their weight and any 
associated conditions such as hypertension and to ensure that they are generally 
healthy. 
 Pregnant women should be encouraged to enroll in the antenatal course at a local health 
care facility to ensure a healthy pregnancy and prevent diabetes complications.  
 Patients using OCM medications at the same time as herbal mixtures should be 
encouraged to take a prescription from qualified health care providers. 
 
B. Developed hypertension guidelines to be used by Tswana and Zulu THPs. 
 
Hypertension 
 
Brief history 
The literature suggests that in ancient times, physicians relied on the quality of an 
individual’s pulse felt by gentle palpation to determine the condition of a cardiovascular 
system. In modern times, an Irish-Indian physician, Dr. Frederick Akbar Mahomed, who 
worked in Guy’s hospital in London, identified conditions related to this disease that became 
known as ‘essential hypertension’ or high blood pressure (BP). He stated that high blood 
pressure was more prevalent in older patients and that various organs (heart, kidney, and 
brain) could be affected by 60. In the 20th century, the invention of the mercury 
sphygmomanometer helped physicians to check the BP of patients without struggling to 
establish the diastolic and systolic pressures using the stethoscope. Hypertension was not 
considered as a disease until the untimely death of the 32nd president of the USA, Franklin 
D. Roosevelt, who died of disease-related complications due to negligence on the part of his 
personal physician, who did not regard him as ill, despite recording a BP of ~220/120. 
Franklin D. Roosevelt’s autopsy report enabled his successor, Harry Truman, to sign the 
National Heart Act Law of 1948, which paved the way for extensive research into heart 
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diseases. The first major study related to heart diseases (Framingham heart study) conducted 
in the United States of America (USA) established that strokes and heart failure were linked 
to hypertension. As late as the 1960’s, the medical community was still finding it difficult to 
combat this chronic condition, as the medications available were ineffective due to poor 
health outcomes recorded with their use. The development of these medications (ACEI, β 
blockers, calcium channel blockers) has assisted greatly in combating this chronic 
condition60.  
Prevalence 
An estimated 9.4 million deaths due to hypertension are reported annually around the world 
14. The available literature suggests a prevalence rate for hypertension of 38% among the 
studied population in sub-Saharan Africa (SSA)14. An estimated amount of US $11.6 billion 
was spent on cardiovascular diseases and its related complications in Africa in the year 2000 
61. 
Brief introduction 
For effective blood circulation to take place within the body, the pressure is required to 
move blood through the body from the heart to the brain and other parts repeatedly so that 
the body can function. This pressure is called blood pressure (BP), which has upper and 
lower levels, with too much pressure resulting in the arteries becoming hard over time. 
This makes blood circulation difficult and it becomes difficult for the heart to pump blood 
effectively due to the weakened heart muscle, this process leading to hypertension (hyper 
meaning ‘above’ the normal tension). It is difficult for people to know if they have the 
disease, which is why in the medical field it is known as the ‘silent killer’ 62. It is often 
associated with diabetes and conditions associated with unhealthy lifestyle, obesity, and 
stress, and needs ongoing management to prevent premature mortality and ongoing ill-
health.  
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Classification of hypertension63 
Table 3. Classification of hypertension 
Stage Systolic BP 
(mmHg) 
Diastolic BP 
(mmHg) 
Normal < 120 < 80 
Optimal 120–129 80–84 
High normal 130–139 85–89 
Grade 1 140–159 90–99 
Grade 2 160–179 100–109 
Grade 3 ≥ 180 ≥ 110 
Isolated systolic ≥ 140 < 90 
Legend: mmHg (millimeters of mercury). 
 
 
Causative factors of hypertension 
THPs should note that hypertension is a lifestyle disease and that some choices, such as 
eating foods rich in fat, excessive alcohol intake, smoking and a lack of exercise. The major 
causative factors for hypertension are: 
  stress,  
 thinking too much,  
 eating too much salt  
 eating fatty foods 
 excessive alcohol intake 
 sedentary lifestyles  
 
Signs and symptoms of hypertension 
The following signs and symptoms are likely to be observed:  
 sweating easily 
 anxiety 
 shortness of breath 
 low sexual desire 
 ill-tempered 
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 unstable body temperature 
 
Diagnosing hypertension 
Hypertension can be difficult to diagnose, as patients may present with symptoms that could 
also be associated with other conditions. It is therefore recommended for THPs to refer 
patients to the nearest clinic or hospital to confirm a diagnosis of hypertensive, and to do this 
before any treatment is provided to assist patiently. 
 
Complications of hypertension 
THPs should note that when not treated or managed properly, hypertension can lead to the 
following major complications: 
 nerve damage 
 heart diseases  
 stroke 
 erectile dysfunction 
 sexual dysfunction on the part of women 
 
Managing hypertension 
Knowing that hypertension is caused by poor lifestyle choices, such as drinking too much 
alcohol, smoking and lack of exercise means that THPs can advise their patents about what 
lifestyle changes can be made to reduce the BP levels. As the effects of lifestyle changes can 
take time to reduce hypertension, medication or plant preparations may be required to reduce 
pharmacologically the BP levels in human beings. 
 
Managing hypertension using plant preparations 
THPs can use some of the following plants (Table 4) to prepare herbal mixtures for their 
patients. Some have been tested scientifically and shown to be effective in the management 
of hypertension. 
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Table 4. Medicinal plants effective in the management of hypertension. 
isiZulu name Tswana 
name 
Scientific 
name 
Common 
name 
Parts used Phytochemical constituents 
Insukumbilii N/A Senecio 
serratuloides  
Two-day 
cure 
Leaves Alkaloids, Flavonoids, Phenols64-
66 
Imbozisa N/A Plectranthus 
hadiensis 
Hairy spur 
flower 
Leaves, 
Roots 
Flavonoids, Alkaloids, Phenols, 
Tannins,Saponins, Glycoside, 
Cardiac glycosides, Phenolic 
acids67,68 
Ugalga N/A Allium 
sativum 
Garlic Bulbs Allicin, Diallyl, Disulphide, S-
allyl cysteine and Diallyl 
trisulfilde7,69 
NA Sekaname Urgine 
singuinea 
Sea onion Bulbs Salicylic acid, Phloroglucinol70-72 
NA Sebetebete Senna italica Italian 
senna 
Leaves, 
seeds, roots 
Flavonoids, Phenols73,74 
NA Tsuko ya 
poo 
Borago 
officinalis 
Starflower Leaves Pyrrolizidine alkaloids,Licosamin, 
Sopinin, Sopindian75 
Ugobho N/A Gunnera 
perpensa 
River 
pumpkin 
Roots Tannins, Phenols, Flavonoids76 
Inhlaba Mokgopha Aloe vera Aloe Leaves Tannins, Saponins, and 
Flavonoids31,32 
Legend: N/A (Not applicable). NB: Recommended plants and their corresponding isiZulu 
or Tswana names are specific to the study areas in KZN and North-West Provinces. 
 
Mode of preparation: Concoction and decoction 
To prepare a herbal mixture a few THPs said they took fresh inhlaba (Aloe vera), a handful 
of leaves of Insukumbilii (Senecio serratuloides) and a handful of roots of Ugobho (Gunnera 
perpensa). The medicinal plants are transferred to a pot and boiled together. The boiled 
herbal mixture is poured into a 1 or 2-litre clean plastic bottle to be given to patients. 
THPs are strongly advised to prepare herbal mixtures made up of three or more medicinal 
plants because polyherbal formulations have been proven to be more effective than single 
herbs in Ayurvedic medicine.53 
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Route of administration: Oral forms mainly liquids (herbal mixtures). 
Dispensing herbal mixtures 
THPs are encouraged to prepare herbal mixtures using some of these plants as their baseline 
together with other plants and herbs that could boost the immune system because a strong 
immune system of a patient helps him or her to fight diseases 54. Medicinal plants available 
to THPs that are regarded as being effective to manage diabetes, based on the successes 
achieved with their clients, should be given in the needed consideration. Herbal mixtures 
dosage should be explained to patients in reasonable detail.  
 To avoid health problems that may arise with the concurrent use of OCM and herbal 
preparations by patients seen by THPs, the medication prescribed by OCM 
practitioner and the medication prescribed by a THP should be taken at different 
times of the day. Scientific research has shown that to avoid possible OCM 
medications and herbs interactions that could affect the health of a patient these forms 
of medications should be taken at different times 55. 
 THPs need to ensure that their patients adhere to and comply with their prescribed 
dosage and should consult them over the phone if necessary to keep track of the 
progress of their health status.  
 Children should not be prescribed dosage recommended for adult patients, and their 
age and weight need to be taken into consideration.  
 THPs should be careful with the dosage prescribed to older patients (60 years and 
above) due to a weakened kidney as a result of old age 56. 
 Pregnant woman taking THP prescribed herbal preparations should be referred 
immediately to the nearest health care facility to check the effect on the herbal 
preparations on the unborn child 57. 
 
Dosage 
The prescribed dosage quantity administered to adults and children should be based on the 
potency of the chosen medicinal plants and success rate achieved, using the same cup or 
tablespoon measurements, depending on the age and weight of the patients. 
 
 
93 
 
 For adults, the prescribed dosage of herbal mixtures (quantity in mls) by THPs 
(personal communication: FGDs and face-to-face interviews with Tswana and Zulu 
THPs) were not more than half of a standard South African cup size (250 mls), 
irrespective of the number of times and when (before or after meals) the mixture was 
taken during the day.  
 For children, the maximum recommended dosage was not more than 3 teaspoons 
(15mls) (South African standard teaspoon size) within a day.  
 
These above herbal mixture quantities (in mls) have been suggested to scientific researchers 
to find out if patients are at any health risk, and the results of the studies will be made 
available as soon as they are available. This will allow the quantities to be adjusted to ensure 
that the patients benefit from the most suitable doses.  
 
General recommendations  
THPs need to be mindful of how to manage the wellbeing of hypertensive patients other than 
simply ethnopharmacological preparations. Ensuring that patients maintain healthy lifestyles 
is an important part of enabling them to have some sense of control over and responsibility 
for their condition. As hypertension is often associated with other conditions THPs are 
advised to manage their patients holistically, and therefore, consider the following:  
 Parents should be encouraged to send their children to a medical doctor who is an 
expert in managing hypertension in children for regular blood pressure monitoring. 
 Parents of children with high BP should be encouraged to help their children achieve 
a healthy body weight to manage and avoid complications associated 77. 
 Parents need to feed their children a diet with lots of fruit, vegetables, and low-fat 
meat, and limit the intake of sugar-based drinks and fast-foods. 
 Parents should make sure that their children take part in sports-related activities such 
as running and swimming in schools. 
 Adults should be encouraged to monitor their blood and sugar levels regularly. 
 Adults should watch their weight by limiting fatty food and sugary drinks and asking 
for advice about a healthy diet. 
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 Adults should be encouraged to limit the consumption of alcohol and the cessation 
of smoking. Scientifically moderate alcohol intake and smoking cessation have been 
proven to be effective in managing hypertension78,79.  
  Adults and children need to take time to exercise regularly throughout the week. 
 Adults and children should be encouraged to participate in stress-free activities that 
are available in their areas, be it joining social groups, or spending time on their 
own.  
 Pregnant women should be given the needed attention by encouraging them to enroll 
in the antenatal course in a local health care facility to check the effect on the herbal 
preparations on the unborn child 57. 
 Patients using OCM concurrently with herbal mixtures should be encouraged to take 
a prescription from qualified health care providers. 
 
Step 4 Validation of the developed diabetes and hypertension guidelines to be used by 
Tswana and Zulu THPs by experts and practitioners in the field of OCM and Ayurveda health 
traditions 
 
The developed modified interventional tool for the management of diabetes and hypertension 
to be used by Tswana and Zulu THPs was validated by these experts (PD, NJ, SS, SK, and 
UL) in the field of OCM and Ayurveda health traditions. Initials are used to hide the 
identities of these experts. The experts’ comments and recommendations regarding the 
developed modified interventional tool to be used by Tswana and Zulu THPs in the 
management of both diabetes and hypertension have been incorporated into the tool for its 
enrichment. Find below are the summary of experts’ comments: 
 
Expert 1 (PD): The tool is very good and will be easily followed by the healers once 
translated into their languages!!! I went through the document and found just typo and 
spacing mistakes. The researcher needs to consult the plant scientists to give him the English 
names of the plants.  
Expert 2(NJ): I have gone through the treatment protocol suggested by the research scholar 
for treating Diabetes and HT by applying both Indian Ayurvedic System as well as the 
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African system. The approach should only to maintain the blood sugar within the normal 
range as the same in the case of HT (Systolic /Diastolic). Good initiative and further research 
is needed.  
Expert 3(SS): The recommendation given in the draft is although good and can be 
considered. However, it can be improved a bit by referring to the attached documents.  
https://mohfw.gov.in/sites/default/files/Guidelines%20and%20Training%20Mannual%20o
n%20Integration%20of%20%20Ayurveda%20in%20NPCDCS.pdf 
http://www.ccras.nic.in/sites/default/files/viewpdf/faq/HYPERTENSION.pdf 
 
Expert 4(SK): The guidelines developed for the traditional healers/ practitioners to manage 
diabetes and hypertension are looking interesting. In my opinion, there should be added some 
more plants used for the treatment of diabetes and hypertension. Moreover, their method of 
preparation and form of intake like dry powder, decoction, tincture, etc. should be included 
in these guidelines. 
 
Expert 5(UL): An expert opinion report on the study entitled “Development of a modified 
interventional tool for the management of diabetes and hypertension among Tswana and 
Zulu Traditional Health Practitioners in South Africa” by Ebenezer Kwabena Frimpong. 
There is no mention of Ayurvedic Formulations in the entire report. Please refer to Ayurvedic 
Formulary of India (AFI) and search the formulations used for Diabetes. Gymnema sylvestre 
(gurmar) is extensively used in the management of diabetes in the Indian sub-continent. 
There is no mention of that in the report, although the candidate has referred Central Council 
for Research in Ayurvedic Sciences (CCRAS).  
 Inclusion of the map of the actual site where the survey has been carried out should be 
included in the report.  
 Physiological part of hypertension and diabetes physiology inclusion is required in the 
report. This will help the candidate to understand the gap between the traditional system of 
medicine and modern medicine and bridge the gap between them.  
 Correlation of the plant material used in the management of disease with their constituents:  
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The identified plant material used for the management of diabetes and hypertension should 
correlate with their constituents. The candidate is advised to go through the photochemistry 
of the plants with the disease. 
 
Discussion 
Generally, an extensive literature search into OCM and Ayurveda health traditions 1-4 led to 
adapted Ayurveda treatment guidelines for both diabetes and hypertension which served as 
a reference for the development of an interventional tool for the management of diabetes and 
hypertension3,4 to be used by Tswana and Zulu THPs. Development of this interventional 
tool was made possible based on findings from research carried out in both North West and 
KwaZulu-Natal provinces involving Tswana and Zulu THPs in two different phases. Phase 
1 was carried out using a semi-structured interview guide for FGDs while face-to-face 
interviews using semi-structured questionnaires were employed in Phase 2 for data 
collection. 
Commonalities in the responses of Tswana and Zulu THPs employed in our previous studies 
(personal communication: FGDs and face-to-face interviews) compared to an adapted 
Ayurveda treatment guidelines for both diabetes and hypertension led to the development of 
these treatment guidelines for both diabetes (A)and hypertension (B) to be used by Tswana 
and Zulu THPs. Interestingly, practitioners of OCM, Ayurveda and TM traditions have their 
understanding of diabetes and hypertension diseases, which sets the framework of their 
management. According to OCM, diabetes mellitus (DM) consist of a group of metabolic 
diseases that are influenced by hyperglycemia (high blood sugar) as a result of defects in 
insulin secretion, action or both 80. The summary of the pathophysiology of diabetes are as 
follows: food taken inside humans are broken down into smaller units. Carbohydrates and 
sugary foods are broken down into glucose. The glucose produced serve as an energy source 
for the body. Insulin which is a hormone secreted by the beta cells of the pancreas is 
responsible for the regulation of glucose in the blood. To maintain glucose levels in the body, 
insulin is needed to inhibit the breakdown of glycogen, stimulate the transportation of 
glucose to the fat tissues and muscles and storage glucose in the form of glycogen. Insulin 
defect and insensitivity of its receptors play a major role in the formation of diabetes because 
of poor regulation of glucose in the human body81. There are two major types of diabetes 
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from OCM perspectives; Type 1: characterized as a result of autoimmune destruction of 
insulin-producing pancreatic β-cells that affects glucose metabolism in peripheral tissues 82 
while Type 2 is described by insulin resistance and/or abnormal insulin discharge, either of 
which may dominate 83. Diabetes from an Ayurvedic perspective is caused by an aggravation 
of the Kapha (mucus) and vitiates meda dhatu (fat) in the body. Diabetes occurs because of 
a disorder of Kapha, which spreads throughout the system. The Kapha mixes with fat before 
entering the urinary system, which interferes with normal urine excretion 84. Under 
Ayurvedic traditions, diabetes is divided into four types namely: Kapha type: urine mostly 
clear, white cold and odorless, almost resembling water; Pitta: urine characterized by smell 
and tastes like a solution of alkali. Vata type: characterized by urine with muscle fat; Juvenile 
diabetes: as a result of unhealthy practices of /or sins committed by a child’s parents in the 
past. 84. Tswana and Zulu THPs (personal communication: FGDs and face-to-face 
interviews) refer diabetes as a sugar disease mainly caused by poor diets (excess intake of 
sugar, excess intake of salt and regular consumption of fatty foods. The major types have 
been high or low sugar levels in humans. Regarding the causative factors for diabetes, all 
three health traditions including THPs (personal communication: FGDs and face-to-face 
interviews) acknowledge similar causative factors of diabetes, these being diet-related such 
as high intake of sugar-based soft drinks, excessive consumption of fatty foods and low fiber 
diet 85,86. 
The health professions (OCM, Ayurveda, and THPs) have identified several similar signs 
and symptoms, specifically frequent urination, excessive thirst and sweetness of urine 84,87,88. 
Regarding diagnosis, OCM practitioners use various scientific testing methods. Firstly, 
Fasting Plasma Glucose (FPG), this test is conducted, when an individual must have fasted 
for at least 8 (overnight) but not more than 16 hours to obtain correct laboratory results. Also, 
blood glucose (more than 126 mg) should be observed in the blood samples (2 or more times) 
on different days 89. Secondly, Oral Glucose Tolerance Test (OGTT), this test is also 
conducted when a random plasma glucose test (RPGT) reveals 160-200 mg/dl and serves as 
the basis for a person to be confirmed as diabetic 89,90. Thirdly, a random plasma glucose test 
(RPGT), this test does not use fasting as a measure and can be conducted at any time. Blood 
glucose of 200 mg/dl or more must be observed, with the test only being valid when it has 
been reconfirmed by FPG or OGTT 89. Last but not the least, glycosylated hemoglobin 
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(HgA1c) this diagnostic criterion was developed by an expert committee on diabetes which 
indicates how well blood sugar levels (>6.5%) have been controlled in 3 months. This test 
requires the person to have fasted for at least 8 but not more than 16 hrs. It is conducted when 
the RPGT and OGTT are 160-200mg/dl and 110-125 mg/dl respectively and is used to 
evaluate a body’s response to glucose 89. Interestingly, to clinically diagnose diabetes, the 
Ayurveda practitioners and THPs (personal communication: FGDs and face-to-face 
interviews) rely mainly on the knowledge and the description of the signs and symptoms by 
patients seen by them. Similar major complications of diabetes have been identified by the 
OCM practitioners, Ayurveda practitioners and THPs (personal communication: FGDs and 
face-to-face interviews), the common ones being poor eyesight, diabetic wounds that are 
difficult to heal and erectile dysfunction 84,91-93. There is an acknowledgment by OCM, 
Ayurveda, and THPs (personal communication: FGDs and face-to-face interviews) about the 
importance of eating fruit and vegetables and exercising regularly to manage their weight 
and general wellbeing 54,88,94,95. While the OCM practitioners rely on pharmacological 
preparations such Metformin, sulfonylureas, acarbose, thiazolidinediones, gliflozin 96,97, the 
Ayurveda and THPs (personal communication: FGDs and face-to-face interviews) use 
mainly medicinal plant/herbal preparations Momordica charantia, Pterocarpus marsupium 
and Trigonella foenum graecum which have been proven scientifically to possess anti-
hyperglycemic potentials 98. Medicinal plants employed by THPs in managing diabetes 
(personal communication: FGDs and face-to-face interviews) included in our developed 
guidelines (A and B) have been cross-referenced with literature to examine its anti-diabetic 
potential. For example, experimental results revealed the effect of Aloe vera in the reduction 
of blood sugar levels of type 1 and type 2 diabetic rats99. In this study, Zulu and Tswana 
THPs (personal communication: FGDs and face-to-face interviews) mentioned the 
preparation of herbal mixtures using Aloe vera in the management of both diabetes and 
hypertension. Interestingly, a decoction of Aloe vera is used in Ayurvedic medicine for the 
management of diabetes100 
From OCM perspectives, BP can be measured through various standardized mechanisms 
that enable a comparative understanding of the systolic and diastolic pressure measurements. 
The arm cuff band method is still used in many health settings with a mercury barometer 
gauge and stethoscope, although these have been replaced by more reliable digital methods. 
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Hypertension is characterized by>140 mmHg systolic and/or >90 mmHg diastolic pressure 
101. The pathogenic mechanism involves an elevation of cardiac output (CO) or total 
peripheral vascular resistance (TPR), with both being elevated in most hypertensive patients 
102. 
The pathophysiology of hypertension entails the following: First, the Autonomic nervous 
system: in regulating blood pressure, the autonomic nervous system plays a significant role, 
with an increase in peripheral sensitivity to norepinephrine in hypertensive patients. In 
addition, hypertensive patients are susceptible to a higher rate of responsiveness to stressful 
stimuli in their daily activities103 Secondly, Sodium and water excretion: retaining sodium 
and water results from an unhealthy relationship between pressure and sodium excretion due 
to a reduced renal blood flow while a steadily rise of angiotensin causes an increase in blood 
pressure103. Thirdly, the role of vasodilators: potential vasodilators, such as bradykinin and 
nitroxide, help to regulate blood pressure104. The deactivation of bradykinin by angiotensin-
converting enzymes (ACE) leads to an increase in blood pressure104. Last but not the least, 
Renin-angiotensin system: the secretion of renin from juxtaglomerular apparatus associated 
with the kidney leads to the conversion of a substrate renin (angiotensinogen) to angiotensin 
I. Angiotensin I, which is physiologically inactive, is quickly converted to Angiotensin II, 
specifically in the lungs. This potential vasoconstrictor, such as Angiotensin II, causes an 
increase in blood pressure104. The major types being primary which is not associated with 
any causative factor likely to be caused by a combination of environment and genetic factors) 
and secondary: caused by another medical condition 105. 
Hypertension from an Ayurvedic perspective is characterized by the inclusion of all the three 
doshas, heart and blood vessels. Observation of signs and symptoms of hypertension is a 
result of disturbance of Vata dosha which stimulates and regulates mana 106. Types of 
hypertension in Ayurveda is not clearly defined. Hypertension from the THPs (personal 
communication: FGDs and face-to-face interviews) perspectives is referred to as a disease 
like diabetes, as one condition leads to the other. They described hypertension as a disease 
associated with stress, and an individual thinking too much is highly likely to acquire this 
disease. The major types being low or high depending on the rate at which an individual's 
heartbeats during breathing. An individual heart beats faster than normal means he or she 
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has high hypertension while a heart beats slower than normal corresponds to low 
hypertension. 
OCM, Ayurveda, and THPs (personal communication: FGDs and face-to-face interviews) 
practitioners have all indicated that poor dieting (high intake of salty food and fatty foods) 
as major causative factors for hypertension 106-108. Similar signs and symptoms are known to 
OCM, Ayurveda practitioners and THPs (personal communication: FGDs and face-to-face 
interviews) with the common ones being (excessive sweating, shortness of breath and 
headache)106,109. To diagnose a patient, OCM practitioners make use of scientific testing 
methods: 24-hour ambulatory blood pressure monitoring, liver function tests, 
electrocardiography, urine sample to detect protein, blood, and glucose, serum electrolytes 
110. Ayurveda practitioners and THPs (personal communication: FGDs and face-to-face 
interviews) rely mainly on the knowledge of the description of the signs and symptoms 
reported by patients seen by them. The major complications identified by OCM, Ayurveda, 
and THPs (personal communication: FGDs and face-to-face interviews) are a stroke, heart 
diseases, erectile dysfunction 106,111. To manage hypertension OCM, Ayurveda and THPs 
acknowledge the significance of eating fruit, vegetables, and exercising regularly to manage 
stress and hypertension. While OCM practitioners rely on pharmacological preparations 
Angiotensin-converting enzymes inhibitors (ACEI) e.g. lisinopril; β blockers e.g. atenolol; 
α blockers e.g. doxazosin; calcium channel blockers (CCB) e.g. verapamil; nifedipine; 
vasodilators e.g. methyldopa61, the Ayurvedic and THPs (personal communication: Focus 
Groups Discussions and face-to-face interviews) use mainly ethnopharmacological 
preparations with some of the following plant constituents Sarpagandha (Rauwolfia 
serpentine), Jatamansi (Nardostachy jatamansi), Arjuna (Terminalia arjuna), Gurmar 
(Gymnema sylvestre) and Rasona (Allium sativum) 112-114. These above mentioned medicinal 
plants are also part of Ayurvedic formulations listed for diabetes and hypertension in 
Ayurveda and have been listed in Ayurvedic Formulary of India (AFI)115. 
These medicinal plants (Allium sativum, Urgine singuinea, and Senna italica) used by Zulu 
and Tswana THPs (personal communication: FGDs and face-to-face interviews) in the 
management of hypertension, have been cross-referenced with literature to establish their 
anti-hypertensive potential. For example, a study conducted in Nigeria shown a reduction in 
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blood pressure and heart rates of both hypertensive and normotensive rates when both 
experimental animals were administered with Alluvium sativum extracts 7. 
Regarding prescribing practices available literature suggests a standard prescribed dosage to 
be followed to dispense medicinal drugs for patients in both OCM 1,2 and Ayurveda 3,4 health 
traditions. Conversely, information is scarce regarding a standard to be followed by THPs in 
different cultures to dispense their herbal mixtures. Findings from our previous studies 
(personal communication: FGDs and face-to-face interviews) have revealed that averagely 
Tswana and Zulu THPs were prescribing not more than half of a standard South African cup 
size (250 mls) to an adult patient, irrespective of the number of times and when (before or 
after meals) the mixture was taken during the day. With regards to prescribed dosage for 
children, averagely it was not more than 3 teaspoons (15mls) (South African standard 
teaspoon size) within a day. 
The consistency in the prescribed methods employed by Tswana and Zulu THPs is a 
significant information that will assist scientific researchers to use the same quantity in mls 
of herbal mixtures prescribed to adults and children by Tswana and Zulu THPs as a standard 
to conduct further studies in order to determine whether the quantities (mls) need to be 
adjusted to ensure that the patients seen by them benefit from the most suitable doses. The 
outcome of this study will be useful in the subsequent updated versions of our developed 
guidelines.  
OCM and Ayurveda health traditions experts opinion regarding this developed diabetes and 
hypertension guidelines to be used by Tswana and Zulu THPs sought after their validation 
process was taken into consideration that led to the final draft of this interventional tool. 
Recommendations 
To ensure that the above-developed guidelines make a positive impact on the health care 
delivery system in the various communities, the following must be taken into consideration: 
 OCM/TM collaboration regular experts meetings supervised by the Department of 
Health (DOH) and Department of Science and Technology (DST) representatives to 
address issues raised by Tswana and Zulu THPs unwillingness to disclose the 
constituents of their herbal mixtures. Signing of intellectual property (IP) agreement 
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between the DST legal experts and THPs will help OCM researchers to obtain 
samples of herbal mixtures to conduct scientific research through in vivo, in vitro 
and randomized control trials (RCT) studies to make a meaningful contribution to 
subsequent updated versions of the developed guidelines. 
 The major stakeholders in the health sector insurance companies, DOH, BHPs, 
THPs, OCM/TM researchers and the media(print and electronic) must be involved 
in the future process of an updated form of these developed guidelines. 
 Leaders of the various traditional healers association in the provinces should make 
sure that THPs update their knowledge about the use of these guidelines through 
regular interactive educational workshops. 
 The DOH should conduct regular checks to ensure that THPs adhere to the usage of 
these guidelines in the management of diabetes and hypertension and offer 
incentives to THPs who are very co-operative in this great initiative. 
 
Conclusion 
We have achieved our aim of developing diabetes and hypertension guidelines to be used by 
Tswana and Zulu THPs based on their perspectives in managing these two diseases. We 
strongly believe that these developed guidelines for both diabetes and hypertension will be 
of great assistance to THPs in both KwaZulu-Natal and North-West provinces in managing 
these two diseases in our various communities where people find it difficult to access clinics 
and OCM due to poor economic conditions. 
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CHAPTER 7 
This chapter highlights the key findings of this study,it provides general 
conclusion,strengths and limitations and recommendations for future studies. 
 
114 
 
7.1 Synthesis 
The aim and objectives of this study have been accomplished and the findings reported in 
five articles that have either been published, are under journal review or submitted to peer-
reviewed journals. The review article published and presented in chapter 2 has given some 
understanding into the use of TM by people with the assistance of THPs to manage diabetes 
and hypertension on the African continent 1. A prevalence rate of 17-84% of TCAM has 
been reported regarding the use among the studied population in Africa, with the application 
of main herbs and medicinal plants to manage both diabetes and hypertension 1. The 
published articles presented in chapters 3, 4 and 5 address Objectives 1, 2, 3 and 4 of this 
study. Generally, across the two cultural environments studied, the acquisition of specific 
knowledge by the Tswana and Zulu THPs to manage both diabetes and hypertension were 
not standardized. This is in agreement with other studies in African, which described how 
THPs in the various countries acquired their knowledge used in their profession. In Tanzania, 
41 THPs in Kilosa and Handeni districts stated that they acquired knowledge through 
ancestral spirits, other family members and apprenticeship (training) from other THPs 2. 
Similarly, 27 THPs who were interviewed in the five regions of Limpopo Province, namely 
stated that they acquired their management knowledge from ancestral spirits 3.  
Regarding the cultural understanding of both diabetes and hypertension, the Zulu and 
Tswana THPs described diabetes as a ‘sugar’ disease and hypertension as a disease 
associated with stress. Furthermore, they were both of the opinions that the two diseases 
were the same, as one condition leads to the other. A study carried out in the USA revealed 
that Type 1 (30%) and Type 2 (50-80%) diabetes patients were also diagnosed with 
hypertension 4. The Zulu and Tswana THPs in this study mentioned the following: excess 
sugar intake, using too much salt, excessive consumption of fatty foods, eating too much red 
meat and lack of exercises, as some of the causes of diabetes. Regarding hypertension, they 
mentioned the following as some of the causes: stress, eating too much sugar and salt. Their 
causes are in agreement with OCM and Ayurveda literature regarding both diabetes and 
hypertension5-8. 
In this study, the Zulu and Tswana THPs reliance on spiritual guidance from ancestral spirits 
for diagnostic purposes are in agreement with studies that described the concept of healing 
from an African perspective 9. Bhikha and Glynn(2013) argued that in ATM, there is a 
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constant relationship between human beings and the spiritual realms and that the main 
underlying cause of a person acquiring a disease could be disobeying instructions from the 
ancestral spirits. To be able to heal a person from any disease, a THP must know the probable 
causes from both the physical world and spiritual realms 9. Also, for diagnostic purposes, 
some Zulu and Tswana THPs relied mainly on the knowledge of the signs and symptoms of 
diabetes and hypertension. This agrees with a similar study conducted in Nigeria, where 
THPs reported that they relied on the signs and symptoms of diabetes indicated by patients 
to diagnose diabetes 10. There was no significant difference in the description of clinical 
features (signs and symptoms) regarding diabetes and hypertension among Tswana and Zulu 
THPs. A few THPs reported that they refer their patients to the clinic/hospital to confirm 
whether they had diabetic or hypertensive. This is in agreement with a similar study 
conducted in Kenya, which revealed that some THPs relied on BHPs in a clinic to confirm 
whether a patient is diabetic or not 11.  
The common signs and symptoms reported by Tswana and Zulu THPs for diabetes were 
dryness of the mouth, frequent urination, excessive thirst, excessive hunger, wounds difficult 
in healing and impaired vision. The signs and symptoms agree with OCM and Ayurveda 
health traditions presented in the literature 12,13. Regarding hypertension, the common signs 
reported by Tswana and Zulu THPs include the following: sweating easily, anxiety, ill-
tempered and shortness of breath. These are in concurrence with the signs and symptoms for 
hypertension reported in the OCM and ayurvedic literature 14,15.  
Regarding medical complications associated with both diabetes and hypertension, the Zulu 
and Tswana THPs were of the opinion that both diabetes and hypertension, if not managed 
well, could lead to serious medical complications that will be disastrous to the health of 
affected individuals. Frequently cited medical complications for diabetes by the Tswana and 
Zulu THPs in this study were: poor eye-sight, erectile dysfunction, wounds that do not heal, 
leading to amputation, and that of hypertension: heart diseases, stroke, and nerve damage. 
The available scientific literature agrees with the statements made by the Zulu and Tswana 
THPs regarding the medical complications of both conditions 16,17 
Non-pharmacological and Ethnopharmacological methods and treatment approaches used 
by the Tswana and Zulu THPs were similar in this study, who recommended fruit, vegetables 
and medicinal plants, such as  apples, banana, spinach , Aloe vera and garlic found in their 
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socio-cultural environment, for managing diabetes and hypertension. The Zulu and Tswana 
THPs stressed the significance of exercises to manage these chronic conditions, in agreement 
with an argument posed by Mulatu and Berry (2001), who stated emphatically that a good 
understanding of people cultural background aids in a better understanding of the sickness 
and health of an individual 18. 
Regarding ethnopharmacological preparations, the Tswana and Zulu THPs use mainly 
medicinal plant/herbal preparations (concoctions or decoctions) to manage diabetes and 
hypertension. Similarly, studies across Africa revealed THPs were prescribing herbal 
mixtures to their patients for the two conditions 10,11,19,20. While the Tswana and Zulu THPs 
were using medicinal plants grown in their localities to manage these two conditions, Aloe 
vera and Allium sativum were commonly mentioned as being effective. Experimental studies 
carried out in India revealed a reduction in blood glucose levels and HbA1c when alloxan-
induced diabetic rabbits were administered with Aloe vera leaf extract after 21 days 21. 
Similarly, experimental research carried out in Kuwait within four weeks reported a 
reduction in the BP of rats that were administered with aqueous extract of allium sativum 22. 
It was difficult for Zulu and Tswana THPs to reveal the constituents of their herbal mixtures, 
with Ndhlahala et al. (2009) indicating that the resort to secrecy as a way of protecting their 
indigenous knowledge 23. Regarding the non-pharmacological treatments prescribed by the 
Zulu and Tswana THPs in their practices, they stressed the significance of a good dieting 
rich in fruit and vegetables, and the need for regular exercises, which is similar to OCM and 
Ayurveda practitioners 15,24-28. In addition, America, Japan, Canada, India, South Africa have 
standard treatment guidelines for both diabetes and hypertension that recommend the 
consumption of fruit, vegetables and exercises 29-32. 
Regarding prescribed herbal mixtures for their patients, the Tswana and Zulu THPs 
contended that their herbal mixtures were made of natural products and were therefore free 
from side effects, which was not the case for OCM medications. Findings from a similar 
study conducted in Ghana revealed that THPs believed herbal mixtures were free from side 
effects 33. In contrast, a study conducted in Democratic Republic of Congo reported that 
decoctions of Quassia africana, which was used as antihypertensive herbal therapy, 
exhibited high toxicity against MRC-5 cells, which is unsafe for human consumption 34. 
Furthermore, a clinical assessment study conducted in Scotland demonstrated that a patient 
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suffered from hyperkalemia and heart failure due to prescribed herbal medications that 
contained substantial quantities of cardiac glycosides 35. The assertion by the Zulu ad Tswana 
THPs that their prescribed herbal mixtures were without side effects cannot be verified due 
to the limited availability of studies that prove otherwise 34,35. This is the reason why the 
WHO has requested African Governments to consider standardization of TM for its 
acceptance and recognition in a broader scientific community 36.  
To avoid contraindications, the Tswana and Zulu THPs believed that OCM and herbal 
mixtures should be taken at different times of the day. Chen, X.-W. et al.(2012) emphasize 
the need for patients on both western and herbal medications to take them at different times 
37. Regarding the prescribed dosage of herbal mixtures quantity in millilitres (mls), the 
Tswana and Zulu THPs in this study recommended not more than half (0.5) a standard South 
African cup size (250 mls) for adult patients, irrespective of the number of times (before or 
after meals) within a day. Regarding children, the maximum recommended dosage by THPs 
in this study was not more than three teaspoons (15ml) (South African standard teaspoon 
size) within a day. These quantities of herbal mixtures will serve as the baseline for future 
studies to be carried out by scientific researchers through laboratory methods (using animal 
models). Further, it will be useful in randomized control trials (RCTs) to ascertain whether 
these recommended prescribed pose a health risk to patients. Studies will indicate the need 
to adjust the prescribed quantities (mls) for their patients. Most THPs were in support of 
collaborating with BHPs to assist in managing diabetes and hypertension in various societies. 
This is in an agreement with a study conducted in the Kilosa and Handeni Districts in 
Malawi, where most THPs involved in managing malaria were in support of collaboration 
with BHPs 2. 
An interventional tool was developed based on the findings from chapter 3, 4 and 5 using 
adapted Ayurveda treatment guidelines for both diabetes and hypertension 38,39 to address 
objective 5 of this study. The developed tool can be used by Tswana and Zulu THPs to 
manage diabetes and hypertension and was validated by experts involved in their 
management. The tool captured relevant information about causes, signs and symptoms, 
steps to follow in diagnosing a patient, complications of diabetes and hypertension, and the 
pharmacological and non-pharmacological approaches to be adopted to manage the two 
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diseases. Recommendations and suggestions have been offered to suggest that the THPs 
consider the advice provided in the tool to assist them to manage the two diseases. 
 
7.2 General Conclusions 
This study established that the majority of Zulu THPs acquired their knowledge as a gift 
from birth, while a majority of Tswana THPs acquired their knowledge via family members. 
Zulu and Tswana THPs had similar cultural understandings of both diabetes and 
hypertension. Frequently cited Signs and symptoms were weight loss, sweating easily, 
shortness of breath, feeling dizzy, and difficulties in breathing, excessive hunger and 
eyesight problems for both diabetes and hypertension, which agree with the scientific 
literature. Ethnopharmacological modalities and treatment approaches used by the Zulu and 
Tswana THPs to manage both diabetes and hypertension diseases were mainly the use of 
herbal mixtures with Aloe vera as a major constituent. Also, the following medicinal plants: 
Hypoxis hemerocallidea, Persea americana, Sutherlandia frutescens and Harpagophylum 
procumbens were used by both groups of THPs to manage the two conditions and have been 
proven scientifically to be effective against them. Commonalities in the responses of the 
Zulu and Tswana THPs regarding their cultural understanding of both conditions, the 
description of their clinical features as well as the ethnopharmacological preparations led to 
the development of a framework from an adapted and modified Ayurveda treatment 
guidelines for diabetes and hypertension. The developed tool was validated by experts and 
practitioners involved in managing the two both diabetes and hypertension. All the experts 
who validated the interventional tool to assist Zulu and Tswana THPs were of the opinion 
that the developed tool could be easily followed by THPs. Suggestions and recommendations 
have been communicated to the DOH to ensure that THPs consider adopting these guidelines 
to mitigate the effects of these chronic conditions. 
 
7.3 Strengths and limitations of the study 
A mixed-method approach utilizing both qualitative and quantitative data was employed in 
this study. This study established some similarities in Zulu and Tswana THPs cultural 
understanding of diabetes and hypertension, description of clinical features for both diabetes 
and hypertension and ethnopharmacological preparations employed by them in the 
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management of these two diseases. First, the study was carried out in both uMgungundlovu 
and uThukela Districts in KwaZulu-Natal Province, and Bojanala, Dr Ruth Sekgopomati 
Districts, North-West Province, South Africa. Therefore the findings may not be generalized 
for the entire population of THPs in KwaZulu-Natal and North West provinces and the rest 
of South Africa. Secondly, in both Phase 1 and Phase 2 of the study, Zulu and Tswana THPs 
were not willing to disclose the medicinal plants and constituents of their herbal mixtures 
employed by them in the management of these two diseases. Thirdly, this study was carried 
out to gather self-report from only Zulu and Tswana THPs who took part in this study. 
Perceptions of patients seen by Zulu and Tswana THPs in this study concerning the efficacy 
or non-efficacy of prescribed herbal mixtures were not sought. Moreover, experiments were 
not conducted in the laboratory by researchers to ascertain whether herbal mixtures 
employed by THPs in this study are without side effects and does not pose any health risk to 
human beings. For last, there may be impreciseness in the clarification of facts because of 
transcription of verbatim quotes by THPs in isiZulu and Tswana languages which were 
translated into English. However, these limitations do not affect the main findings of this 
study. 
 
7.4 Recommendations 
To effectively manage diabetes and hypertension in South Africa, the collaboration between 
THPs and BHPs should be given greater attention, with research having indicated the 
former’s willingness to refer patients to the latter for medical attention 40,41. However, 
research has shown BHPs averseness to collaborate with THPs, citing concerns regarding 
their treatment methods and approaches, as well as the safety and efficacy of their prescribed 
herbal mixtures2. It is therefore recommended that BHPs make a greater effort to work with 
THPs, as they are often the first point of call in delivering primary health care to the 
indigenous population across the African continent. Collaboration between BHPs and THPs 
is essential for managing diseases, with the proposed guideline (Figure 1) being provided to 
support this effort.  
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Figure 1. A graphical view showing suggested effective collaboration between BHPs and 
THPs. 
 
Training BHPs to become acquainted with the use of herbal therapies and their applications 
could be conducted by THPs, who could provide them with instruction about cultural 
appropriate methods for managing diseases to demystify their perceptions about TM 
methods and practices (Figure 1). Drozd (2000) and also Mulatu&Berry (2001), stressed the 
significance of knowing the influence of culture in chronic disease management 18,42. 
Studies conducted in South Africa, Trinidad and Tobago revealed that BHPs exhibited poor 
knowledge about the use of herbal therapies and their associated risks to treat diseases 43,44. 
Clement et al. (2005) suggested the need to assist BHPs to increase their knowledge about 
natural products and their applications, as well as the risk associated with their use6. They 
suggested the need for medical school’s curriculum to include herbal medications and their 
application to manage the disease during BHPs training, and to develop herbal 
pharmacopoeia to assist them to improve their knowledge about natural products6. Likewise, 
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THPs should also be given appropriate training by BHPs about how to use basic tools, such 
as a glucometer and sphygmomanometer, for diagnosing diabetes and hypertension 
respectively. The use of technology, such as downloading health apps on digital platforms 
that are associated with disease management, and sharing treatment modalities ideas via 
social media (Facebook, WhatsApp) between BHPs and THPs in the same community 
should be encouraged, as it will benefit both health professionals and their patients, as 
indicated in Figure 1. 
To ensure high quality research into TM and encourage its acceptability by the broader 
scientific community, the WHO TM committee suggested the need for member countries to 
mitigate some of the major challenges encountered by this health tradition, such as limited 
research data on, and a lack of funding and expertise to conduct quality research into TM, as 
well as insufficient mechanisms to regulate TM providers 45. Furthermore, the lack of 
standardized herbal products and validation of TM through quality scientific research is a 
major setback for this health tradition 46.  
The proposed guideline (Figure 2) serves as the baseline reference document for TM 
research-related activities in South Africa and beyond, and should be given the needed 
consideration by WHO member countries. 
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Figure 2. A graphical view showing proposed guidelines for effective TM/OCM 
collaborative research. 
 
In this study, Zulu and Tswana THPs were reluctant to provide information about the 
medicinal plants and composition of herbal mixtures they use to manage diabetes and 
hypertension for fear of losing it to the scientific community, which might commercialize it 
and make a profit out of their knowledge. More than 40 years after the Alma Ata declaration 
47, which paved the way for TM recognition as a significant health tradition for the 
advancement of primary health care delivery system, commitment to extending intellectual 
protection to traditional knowledge has not been given the consideration it needs by the 
World Intellectual Property Organization (WIPO) 48. In this regard, countries across the 
world may need to ensure that laws are enacted to protect indigenous knowledge. Tangwa 
(2007) stressed the need for extensive research into TM to clarify its therapeutic qualities 
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and ensure its protection through intellectual property (IP) laws 49. It is therefore 
recommended that the South African government enact laws to protect indigenous 
knowledge systems, which is the cause of worry to Zulu and Tswana THPs interviewed in 
this study. 
Generally, Zulu and Tswana THPs in this study believed their prescribed herbal mixtures 
had no side effects as they were made from natural products. The THPs believed that to avoid 
clashing contraindications, their patients should take their prescribed herbal mixtures and 
conventional medications at different times of the day. While a study conducted in South 
Africa revealed the compatibility of conventional and herbal medicine to act against diseases 
50, another study found that herbal medicines may enhance or decrease pharmacological 
actions in older patients with weak immune systems 51. It is recommended that further 
analysis (Figure 2) of the bioactive compounds isolated from the herbal mixtures should be 
tested for their biological activities to determine the efficacy of lowering the blood pressure 
and glucose levels in animal models and clinical trials in humans. Clinical laboratory 
analysis of blood and serum obtained from patients seen by THPS in this study should be 
tested for biochemical markers of toxicity and efficacy to determine the safety of the 
prescribed herbal mixtures. In vitro cell line work performed on defined cell lines could 
assist in determining the toxicity of the herbal mixtures on human cell lines.  
 
References 
1 Frimpong, E. & Nlooto, M. Clinical relevance and application of traditional 
complementary and alternative medicine for the management of diabetes and 
hypertension on the African continent, 2000-2017: A narrative review. Indian 
Journal of Traditional Knowledge 14, 635-644 (2018). 
2 Makundi, E. A., Malebo, H. M., Mhame, P., Kitua, A. Y. & Warsame, M.  Role of 
traditional healers in the management of severe malaria among children below five 
years of age: the case of Kilosa and Handeni Districts, Tanzania. Malaria Journal  5, 
58 (2006). 
3 Maluleka, J. R. & Ngulube, P. The preservation of knowledge of traditional healing 
in the Limpopo province of South Africa. Information Development  34, 515-525 
(2018). 
4 Landsberg, L., Molitch, M. Diabetes and hypertension: pathogenesis, prevention and 
treatment.  Clinical and Experimental Hypertension 26, 621-628 (2004). 
5 Marx, J. Unraveling the causes of diabetes. American Association for the 
Advancement of Science, Science 296  686-689  (2002). 
 
124 
 
6 Sharma, H., Chandola, H.M.  Prameha in ayurveda: correlation with obesity, 
metabolic syndrome, and diabetes mellitus. Part 1–etiology, classification, and 
pathogenesis. Journal of the Alternative and Complementary Medicine 17, 491-496 
(2011). 
7 Whelton, P. K.  Epidemiology of hypertension. Lancet 344, 101-106 (1994). 
8 Choudhary, K., Sharma, P., Sharma, V. B. Hypertension and its management through 
Panchakarma. Journal of Ayurveda and Holistic Medicine 3, 28-31 (2015). 
9 Bhikha, R. A. & Glynn, J. African traditional healing and Tibb.  (2013). 
10 Akharaiyi, F. et al. Some antidiabetic medicinal plants used by traditional healers in 
Ado Ekiti, Nigeria. Bratislava Medical Journal 118, 504-505 (2017). 
11 Chege, I. N., Okalebo, F. A., Guantai, A. N., Karanja, S. & Derese, S. Management 
of type 2 diabetes mellitus by traditional medicine practitioners in Kenya-key 
informant interviews. Pan African Medical Journal 22 (2015). 
12 Ramachandran, A. Know the signs and symptoms of diabetes. The Indian journal of 
medical research 140, 579 (2014). 
13 Mawale, M. P. & Sanket, V. P. Management of diabetes mellitus through Ayurveda. 
IJRAP 5, 622-624 (2014). 
14 Tanui, A. & Njambi, O. Lifestyle modification in prevention of hypertension: Patient 
empowerment, (Thesis submitted for the degree of Nursing, Faculty of Social and Health 
Care Seinajoki University of Applied Sciences,Finland),2015. 
15 Menon, M. & Shukla, A. Understanding hypertension in the light of Ayurveda. 
Journal of Ayurveda and integrative medicine 9 302-307 (2017). 
16 Chawla, A., Chawla, R., Jaggi, S. Microvasular and macrovascular complications in 
diabetes mellitus: distinct or continuum? Indian Journal of Endocrinology and 
Metabolism  20, 546 (2016). 
17 Biswas, S. et al. Complications of hypertension as encountered by primary care 
physician. Journal of the Indian Medical Association 101, 257-259 (2003). 
18 Mulatu, M. S. & Berry, J. W. in Handbook of cultural health psychology     45-61 
(Elsevier, 2001). 
19 Goma, F. et al. Indigenous knowledge systems for the treatment of hypertension in 
Lusaka, Zambia: perceptions, knowledge and practice. Medical Journal of Zambia 
43, 156-166 (2016). 
20 Peltzer, K. et al. Concepts and treatment for diabetes among traditional and faith 
healers in the northern province, South Africa. Curationis 24, 42-47 (2001). 
21 Gupta, A. et al. Evaluation of hypoglycemic and anti-atherogenic effect of Aloe vera 
in diabetes mellitus. Journal of Food Science and Technology  8, 1-4 (2011). 
22 Al-Qattan, K., Alnaqeeb, M. & Ali, M. The antihypertensive effect of garlic (Allium 
sativum) in the rat two-kidney–one-clip Goldblatt model. Journal of 
Ethnopharmacology  66, 217-222 (1999). 
 
125 
 
23 Ndhlala, A., Stafford, G., Finnie, J. & Van Staden, J.  In vitro pharmacological effects 
of manufactured herbal concoctions used in KwaZulu-Natal South Africa.  Journal 
of Ethnopharmacology 122, 117-122 (2009). 
24 Association, A. D. 4. Lifestyle management: standards of medical care in diabetes—
2018. Diabetes Care 41, S38-S50 (2018). 
25 Chong, S. et al. Lifestyle changes after a diagnosis of type 2 diabetes. Diabetes 
Spectrum 30, 43-50 (2017). 
26 Rajasekaran, A., Sivagnanam, G. & Xavier, R. Nutraceuticals as therapeutic agents: 
A Review. Res J Pharm Tech 1, 328-340 (2008). 
27 Appel, L. J. et al. Dietary approaches to prevent and treat hypertension: a scientific 
statement from the American Heart Association. Hypertension 47, 296-308 (2006). 
28 Bolbrinker, J., Touis, L. Z., Gohlke, H., Weisser, B. & Kreutz, R. European 
guidelines on lifestyle changes for management of hypertension. Herz 43, 352-358 
(2018). 
29 Ivers, N. M. et al. Diabetes Canada 2018 clinical practice guidelines: Key messages 
for family physicians caring for patients living with type 2 diabetes. Canadian Family 
Physician 65, 14-24 (2019). 
30 Haneda, M. et al. Japanese clinical practice guideline for diabetes 2016. Journal of 
diabetes investigation 9, 657-697 (2018). 
31 Nerenberg, K. A. et al. Hypertension Canada’s 2018 guidelines for diagnosis, risk 
assessment, prevention, and treatment of hypertension in adults and children. 
Canadian Journal of Cardiology 34, 506-525 (2018). 
32 Weber, M. A. et al. Clinical practice guidelines for the management of hypertension 
in the community: a statement by the American Society of Hypertension and the 
International Society of Hypertension. The journal of clinical hypertension 16, 14-
26 (2014). 
33 Asase, A., Akwetey, G. A. & Achel, D. G. Ethnopharmacological use of herbal 
remedies for the treatment of malaria in the Dangme West District of Ghana. Journal 
of Ethnopaharmacology 129, 367-376 (2010). 
34 Muganza, D. M. et al. In vitro antiprotozoal and cytotoxic activity of 33 
ethonopharmacologically selected medicinal plants from Democratic Republic of 
Congo. Journal of Ethnopharmacology 141, 301-308 (2012). 
35 Haden, M., Marshall, D. & Murphy, B. Toxic levels of glycosides in herbal 
medication: a potential cause of hyperkalaemia.  Scottish Medical Journal 56, 1-3 
(2011). 
36 Organization, W. H. National policy on traditional medicine and regulation of herbal 
medicines: Report of a WHO global survey.  (2005). 
37 Chen, X.-W. et al. Herb-drug interactions and mechanistic and clinical 
considerations.  Current drug metabolism 13, 640-651 (2012). 
 
126 
 
38  Central Council For Research in Ayurvedic Sciences guidelines for the management and  
prevention of diabetes https://www.ccras.nic.in/ As accessed on 11th 
November,2019. 
39 Ministry of Health and Family Welfare, India guidelines for the management of 
hypertension in Ayurveda https://www.nhp.gov.in/ As accessed on 11th November, 
2019. 
40 Peltzer, K., Mngqundaniso, N. & Petros, G. A controlled study of an 
HIV/AIDS/STI/TB intervention with traditional healers in KwaZulu-Natal, South 
Africa. AIDS and Behavior 10, 683-690 (2006). 
41 Nkosi, P. B. & Sibiya, M. N. Perceptions of traditional health practitioners and 
radiation oncologists regarding referral of cancer patients in a cooperative practice in 
KwaZulu-Natal province, South Africa. International journal of Africa nursing 
sciences 8, 117-121 (2018). 
42 Drozd, M. Cultural sensitivity in diabetes care. Home Health Care Management & 
Practice 12, 1-6 (2000). 
43 Mokgobi, M. Western-trained health care practitioners’ knowledge of and 
experiences with traditional healing. African journal for physical health education, 
recreation, and dance 2014, 1 (2014). 
44 Clement, Y. N. et al. A gap between acceptance and knowledge of herbal remedies 
by physicians: the need for educational intervention. BMC complementary and 
alternative medicine 5, 20 (2005). 
45 Qi, Z. WHO Traditional Medicine Strategy. 2014-2023. Geneva: World Health 
Organization (2013). 
46 Miller, L. G. et al. White paper on herbal products. Pharmacotherapy: The Journal 
of Human Pharmacology and Drug Therapy 20, 877-887 (2000). 
47 Baum, F. Health for All Now! Reviving the spirit of Alma Ata in the twenty-first 
century: An Introduction to the Alma Ata Declaration. Social Medicine 2, 34-41 
(2007). 
48 Patwardhan, B. & Mashelkar, R. A. Traditional medicine-inspired approaches to 
drug discovery: can Ayurveda show the way forward? Drug discovery today 14, 804-
811 (2009). 
49 Tangwa, G. B. How not to compare Western scientific medicine with African 
traditional medicine. Developing world bioethics 7, 41-44 (2007). 
50 Aiyegoro, O. & Okoh, A. Use of bioactive plant products in combination with 
standard antibiotics: implications in antimicrobial chemotherapy. Journal of 
Medicinal Plants Research 3, 1147-1152 (2009). 
51 Awang, D. V. & Fugh-Berman, A. Herbal interactions with cardiovascular drugs. 
Journal of Cardiovascular Nursing 16, 64-70 (2002). 
 
 
 
127 
 
                                                          APPENDICES 
APPENDIX I: BREC Approval letter 
 
128 
 
APPENDIX II: Letter of authorization to work with THPs from KZN traditional 
healers associations 
 
 
 
 
 
 
 
 
 
 
 
 
Tel: 031 311 3540 
 
 
 
 
1J/22/2017 
 
 
Cell:082 8342002 
 
 
 
 
Dear Sir/Madam 
9 Archie Gumede Place 
Durban 
 
4000 
 
RE: LETTER OF ACKNOWLEDGEMENT: AUTHORITY TO WORK WITH TRADITIONAL HEALTH PRACTIONERS 
 
This letter serves to confirm that Ms Zabalazile Makhoba and her team of EThekwini Traditional Health 
Practitioners (ETHP'S) are given authority to work with Westville team in finding perspectives about the 
management of diabetes and hypertension in North West and in KZN. 
Msawenkosi Cele 
Secretary General 
ETHP 
ceIemsa3ogmaiI.com 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chairperson — Mr T Hlongwane Deputy Chairperson — Mrs T. Ndlovu Secretary - Mr M. Cele 
Deputy Secretary — Mrs Z. Sithole Treasurer — Mrs A.B. Ndwandwe Spokesperson — Mr E. Gwala 
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APPENDIX III: Letter of authorization to work with THPs from North West 
traditional healers associations 
                                                                                                         Boitekong  
                                                                                                         Bojanala District 
Municipality 
                                                                                                          Rustenburg 
 
To whom it may concern 
 
The community of Boitekong and surrounding villages. After, consultation with Mr 
Ebenezer Frimpong. We have agreed to work with him and assist in any way possible in 
his research. 
More over we would like to thank him for the opportunity afforded to us by his project. 
May this lead to a fruitful relationship and empower us. 
Yours in community development 
(SIGNED) 
E. Theshwa  
                                                                                                  
 
                                                                                                  Sekhing 
                                                                                                 Dr Ruth Segomotso Mompati 
Taung 
                                                                                                 8584 
 
To whom it may concern 
We the community of Sekhing, in the area of Taung under Dr Ruth Segomotso Mompati 
District municipality, pledge our support to Mr. E. Frimpong. 
We will work with him in his research and will assist in any way we can 
Regards 
(SIGNED) 
K. ESSAU  
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APPENDIX IV: Certificate of Ethics 
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APPENDIX V: Interview guide employed in FGDs in English 
1. What are diabetes and hypertension in isiZulu or Tswana culture? Are these two 
diseases curable? 
2. How do you recognize a person suffering from diabetes and hypertension? 
3. How do you manage diabetes and hypertension? 
4. How effective are your prescribed medications? Are there any side effects? 
5. Do you advise your patients to take your medication together with western 
medication? Do you take into account contraindications? 
6. How do you monitor the health outcomes of your patients? 
7. What are some of the challenges you faced in managing diabetes and hypertension? 
8. What should be done to improve diabetic and hypertensive care in South Africa 
 
APPENDIX VI: Interview guide employed in FGDs in isiZulu 
1. Ngokwesintu, cela uchaze ukuthi yini isifo sikashukela nesomfutho wegazi? 
2. Umbona ngani umuntu onesifo sikashukela noma onesifo somfutho wegazi? 
3. Umelapha kanjani umuntu onesifo sekashukela nonesifo somfutho wegazi? 
4. Ngabe imithi yakho iyabasiza yini abantu abanesifo sikashukela kanye nesomfutho 
wegazi? 
5. Uyazivumela yini iziguli zakho ukuthi zisebenzise imithi yabelaphi bezizwe 
ngenkathi    zisasebenzisa imithi yakho? Ngabe uyakwazi ukubona uma isigula 
kungefanele ithatha imithi ethile? 
6. Uqapha kanjani isimo sempilo seziguli zakho? 
7. Iziphi izinkinga ohlangambezana nazo uma welapha isifo sikashukela nesomfutho 
wegazi? 
8. Yikuphi okuphakamisayo okungaphucula ukwelapha kwesifo somfutho wegazi 
nesifo sikashukela la eNingizimu Afrika? 
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APPENDIX VII: Interview guide employed in FGDs in Tswana 
1. Bolwetse ba sukiri le ba kgatelelo ya madi le bo bitsa eng ka setso? A malwetse ka 
bobedi a alafega? 
2. O bona jang motho yo o tshwerweng ke bolwetse ba sukiri le ba kgatelelo ya madi? 
3. O alafa jang bolwetse ba sukiri le ba kgatelelo ya madi? 
4. Melemo ya gago ya kalafi e dira go le kae/go fitlhelela fa kae? A e ka bakela molwetse 
malwetse mangwe? 
5. A o gakolola balwetse ba gago go tsaya melemo ya gago gammogo le melemo ya 
sekgowa? A o ela tlhoka gore melemo ka bobedi e ka thulana? 
6. O tlhokomela jang ditlamorago/dipholo tsa kalafi mo molwetseng? 
7. Ke dikgwetlho di feng tse o kopanang natso mo kalafing ya bolwetse ba sukiri le 
kgatelelo ya madi? 
8. Ke eng se se ka dirwang gore Afrika Borwa a tokafatse tlhokomelo ya bolwetse ya 
bolwetse ba sukiri le kgatelelo ya madi? 
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APPENDIX VIII: Semi-structured questionnaire used for face-to-face interviews in 
English 
APPENDIX VIII: Semi-structured questionnaire used for the face-to-face 
interviews 
 
Demographic data 
1. Age by the end of the year (Full years): ……………          
2.  Gender:  
Male  
Female  
                      
3. Marital Status:   
Single  
Married  
Living with a partner  
Divorced  
Widow/Widower  
 
 4. Ethnicity:   
Zulu  
Tswana  
Others (Specify)  
 
5. Religious denomination:    
Traditional  
Christian  
Islamic  
None  
Others (Specify  
 
6. Educational level:  
Nil  
Primary  
High school  
Tertiary  
Others (Specify  
 
7. Kind of practice 
Herbalist(inyanga)  
Divination (spiritual/sangoma)  
Both divination(sangoma) and herbalist(inyanga)  
Others (Specify)  
              
8. Place of practice:  
Office/Shop  
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Home  
 Market  
Others (Specify)  
 
9. Do you work as a full time or part-time? 
……………………………………………………………………………. 
10. If part-time, what else do you do for your living? 
…………………………………………………………………. 
11. Are you registered with South African Healers Traditional Council?   
Yes  
 No    
 
12. Are you registered with any Traditional Healers Association?                                    
Yes  
 No    
 
If yes, please name the association that you are part 
of………………………………………………………………… 
13. How long have you been in this profession? 
…………………………………………………………………………                
14. How many diseases other than diabetes or hypertension do you treat/heal? Please list 
them………………………………………… 
 
 
 
Questions for Objective 1 
15. A. Where did you get knowledge and information about diabetes as a disease? 
Trained  by the family member  
Trained by other person  
 A gift from my birth  
It is my calling  
I got a professional training  
Other (Specify)      
 
Please explain more on your answer above? 
…………………………………………………………………………. 
     
15.B. Where did you get knowledge and information about hypertension as a disease?  
Trained  by the family member  
Trained by other person  
 A gift from my birth  
It is my calling  
I got a professional training  
Other (Specify)      
 
 Please explain more on your answer above? 
…………………………………………………………………………. 
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……………………………………………………………………………………………………………………
……..     
 
Questions for Objective 2 
 
16. A.What is diabetes in your culture? Please explain your 
answer………………………………………………….. 
……………………………………………………………………………………………………………………
……. 
 
16.B. What is hypertension in your culture? Please explain your 
answer……………………………………………….. 
……………………………………………………………………………………………………………………
…….           
 
 
Questions for Objective 3 
17. A. Are you able to identify a person with diabetes in your profession? 
Yes  
 No    
 
Please explain your answer (signs and symptoms):  
……………………………………………………………………………………………………………………
… 
17B. Are you able to identify a person with hypertension? 
Yes  
 No    
 
Please explain your answers (signs and symptoms):  
……………………………………………………………………………………………………………………
…… 
 
18A. Do you use modern instruments to test diabetes? 
Yes  
 No    
 
Please explain your answer: 
…………………………………………………………………………………………. 
 
18B. Do you use modern instruments to test hypertension? 
Yes  
 No    
 
Please explain your answer: 
…………………………………………………………………………………………… 
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19. A. Are there different types of diabetes?   
Yes  
 No    
 
Please explain your answer: 
……………………………………………………..…………………………………….. 
 
19.B. Are there different types of hypertension?   
Yes  
 No    
 
Please explain your answer: 
………………………………………………………………………………………….. 
 
20A. Does diabetes have any danger in your culture?  
Yes  
 No    
 
Please explain your 
answer:……………………………………………………………………………………………. 
 
20B. Does hypertension have any danger in your culture? 
Yes  
 No    
 
Please explain your answer: 
……………………………………………………………………………………………………………………
…….. 
 
Questions for objective 4 
21 A. What herbs/animals or minerals do you use to treat and combat diabetes? Please list 
……………………………………………………………....................................................................................
........... 
……………………………………………………………………………………………………………………
…....... 
 
21 B. If you do not use herbs/animals or minerals please list what you use for diabetes 
……………………………………………………………………………………………………………………
……..  
21 C. What herbs/animals or minerals do you use to treat and combat hypertension? Please list 
...............................................................................................................  
  
21D. If you do not use herbs/animals or minerals please list what you use for 
hypertension……………………………………………………………………………………………………
…….. 
 
22 A.  What types of medical preparations do you use for diabetes?  
Concoctions  
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 Decoctions   
Other forms  
 
Please explain your 
answer:……………………………………………………………………………………………. 
 
22 B. What   types of medical preparations do you use for hypertension?  
Concoctions  
 Decoctions   
Other forms  
 
Please explain your 
answer:………………………………………………………………………………………….. 
 
23 A. What is the dosage do you recommend to your patient/s with diabetes from medical preparations listed 
above? 
................................................................................................................................................................................
.......... 
……………………………………………………………………………………………………………………
……... 
23 B. What is the dosage do you recommend to your patient/s with hypertension from medical preparations 
listed above?  
……………………………………………………………………………………………………………………
…….. 
……………………………………………………………………………………………………………………
…….. 
 
24 A. For how long do you treat a patient suffering from diabetes? 
 ……………………………………………… 
………………………………………………………………………… 
 
24 B. For how long do you treat a patient suffering from hypertension? 
……………………………………………………………………………………………………………………
……. 
     
25. Does your prescribed medicines possess any side effects? 
Yes  
 No    
 
Please explain your answer. 
……………………………………………………………………………………………………………………
…….. 
……………………………………………………………………………………………………………………
…….. 
………………………………………………………… 
 
26. Have you ever received a patient referred by biomedically trained 
doctors?............................................................ 
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27 A. Do you consider dietary regimen in the management of diabetes?   
Yes  
 No    
 
Please explain your answer…………………………………………….. 
 
27 B. Do you consider dietary regimen in the management of hypertension?   
Yes  
 No    
 
Please explain your answer…………………………………………….. 
 
28 A. Do you recommend any lifestyle changes to your diabetic patients? 
 Yes  
 No    
 
Please explain your answer: 
…………………………………………………………………………………………… 
  
28B. Do you recommend any lifestyle changes to your hypertension patients? 
Yes  
 No    
 
Please explain your answer: 
…………………………………………………………………………………………… 
 
................................................................................................................................. ...............................................
........ 
 
29. Do you allow your patients to use concurrently medicines prescribed by biomedically trained doctors with 
your traditional medical preparations?  
Yes  
 No    
                   
Please explain your answer: 
………………………………………………………………………………………….. 
     
30 A. What is the difference between the way biomedically trained doctors and traditional healers treat 
diabetes? 
……………………………………………………………………………………………………………………
……. 
……………………………………………………………………………………………………………………
…. 
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30 B. What is the difference between the way the way biomedically trained doctors and traditional way treat 
hypertension? 
……………………………………………………………………………………………………………………
….... 
……………………………………………………………………………………………………………………
….... 
 
31.  What advice can you give to the person living with diabetes or/and hypertension?     
……………………………………………………………………………………………………………………
…….. 
 
32 A. What do you think should be done to improve treatment and healing for diabetes by THPs?  
……………………………………………………………………………………………………………………
……. 
……………………………………………………………………………………………………………………
……. 
 
32 B. What do you think should be done to improve treatment and healing for hypertension by THPs? 
……………………………………………………………………………………………………………………
……. 
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APPENDIX VIV: Semi-structured questionnaire used for face-to-face interviews in 
isiZulu 
Le mibuzo yenzelwe ukuthola indlela abalaphi bendabuko abanakekela ngayo isifo sikashukela nomfutho 
wegazi 
Imininingwane yocwaningo. 
1.  Iminyaka egcwele: ……………          
2.  Ubulili :  
Owesilisa  
Owesifazane  
                      
3. Isimo somshado:   
Angishadanga  
Ngishadile  
Ngihlalisene  
Ngihlukanisile  
Umfelokazi/Umfelwa  
 
 4. Ubuhlanga:   
UmZulu  
UmTswana  
Obunye (Cacisa)  
 
5. Uhlobo lwenkolo:    
Isintu/Usiko  
UmKhrestu  
UmMozilemu  
Ayikho  
Enye (Cacisa)  
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6. Amazinga lwemfundo:  
Awekho  
Amabanga aphansi  
Amabanga aphezulu  
Imfundo yaseNyuvesi  
Amanye (Cacisa)  
7. Uhlobo lokwelapha 
Amakhambi  
Ngokomoya  
Ngokomoya namakhambi  
Okunye  (Cacisa)  
              
8. Indawo yokwelaphela:  
Ehhovisi/Esitolo  
Ekhaya  
 Emakethe  
Enye (Cacisa)  
 
9. Usebenza usuku lonke noma ingxenye yosuku? 
……………………………………………………………………………………………………………………
.. 
10.  Uma usebenza ingxenye yosuku ikuphi okunye okwenzayo kokuziphilisa?  
……………………………………………………………………………………………………………………
.. 
11. Ubhalisile kwinhlangano yabelaphi bendabuko baseMzansi Afrika?   
Yebo  
 Cha   
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12. A. Ikhona yini enye inhlangano yabelaphi bendabuko obhalise kuyo?                                    
Yebo  
 Cha    
 
12. B. Uma ikhona kucelwa ukuba udalule igama layo leyo nkampani 
…………………………………………… 
.…………………………………………………………………………………………………………………
…. 
13. Mingakhi iminyaka usebenza njengomelaphi wendabuko?   
…………………………………………………………..                
14. A.  Zikhona yini ezinye izifo ozelaphayo ngaphandle kwesifo sikashukela nomfutho wegazi? Kucelwa 
ukuba uzisho. 
 
Imibuzo ngokwenhloso yoku- 1 
15. A. Waluthola kuphi  ulwazi  ngesifo sikashukela? 
Ngaqeqeshwa ilungu lomndeni  
Ngaqeqeshwa omunye umuntu  
Isipho engazalwa naso  
Ubizo   
Ngaqeqeshwa ngokusemthethweni  
Okunye (Cacisa)      
 
Kucelwa uchaze ngempendulo yakho. 
……………………………………………………………………………... 
 
15. B. Waluthola kuphi ulwazi ngesifo somfutho wegazi? 
Ngaqeqeshwa ilungu lomndeni  
Ngaqeqeshwa omunye umuntu  
Isipho engazalwa naso  
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Ubizo   
Ngaqeqeshwa ngokusemthethweni  
Okunye (Cacisa)      
 
Kucelwa uchaze ngempendulo yakho.  
……………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………
…… 
Imibuzo ngokwenhloso yoku- 1 
16. A. Siyini isifo sikashukela ngokwesiko lakho? Cela uchazisise. 
……………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………
…… 
16. B. Siyini isifo somfutho wegazi ngokwesiko yakho? Cela uchazisise. 
………………………………………………........................................................................................................
........................................................................................................................................................ ........................
........ 
 
Imibuzo ngenhloso yesi- 3 
17. A. Uyakwazi ukubona umuntu onesifo sikashukela ngokomsebenzi owenzayo? 
Yebo  
 Cha    
 
Kucelwa uchaze impendulo yakho? 
……………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………
…… 
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17.B.  Uyakwazi ukubona umuntu onesifo somfutho wegazi  ngokomsebenzi owenzayo? 
Yebo  
 Cha    
 
Kucelwa ukuba uchaze impendulo yakho: 
…………………………………………... 
………………………………………………………………………… 
……………………………………………………………………………………………………………………
… 
18. A. Uyabusebenzisa yini  ubuchwepheshe besimanje ukuhlola isifo sikashukela? 
Yebo  
 Cha    
 
Kucelwa ukuba  uchaze impendulo yakho:  
……………………………………………………………………………………………………………………
… 
……………………………………………………………………………………………………………………
... 
18. B. Uyabusebenzisa yini  ubuchwepheshe besimanje ukuhlola isifo somfutho wegazi? 
Yebo  
 Cha    
 
Kucelwa uchaze impendulo yakho: 
……………………………………………………………………………………………………………………
. 
…………………………..………………………………………………………………………………………
… 
19. A. Kungabe zikhona izinhlobo zesifo sikashukela?   
Yebo  
 Cha    
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Kucelwa uchaze impendulo yakho: 
…………………………………….. 
……………………………………………………………………………… 
……………………………………………………………………………………………………………………
… 
19. B. Kungabe zikhona yini izinhlobo zesifo somfutho wegazi? 
Yebo  
 Cha    
 
Kucelwa uchaze impendulo yakho: 
…………………………………………………………………….……………………………………………
…. 
……………………………………………………………………………………………………………………
.. 
20. A. Ngokwesiko lakho bukhona yini ubungozi besifo sikashukela? 
Yebo  
 Cha    
 
Kucelwa uchaze impendulo yakho :  
........................................................................................................................ 
……………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………
…… 
20. B. Ngokwesiko lakho bukhona yini ubungozi besifo somfutho wegazi? 
Yebo  
Cha  
 
Kucelwa uchaze impendulo yakho: 
……………………………………………………………………………….. 
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……………………………………………………………………………………………………………………
… 
Imibuzo ngenhloso yesi- 4 
21. A. Yimaphi amakhambi noma izilwane ozisebenzisayo ukwelapha isifo sikashukela?  
................................................................................................................................................................................
.. 
21. B. Uma ungawasebezisi amakhambi noma izilwane ukwelapha lesifo usebenzisani? 
................................................................................................................................................................................
.... 
21. C. Yimaphi amakhambi noma izilwane ozisebenzisayo ukulapha  umfutho wegazi? 
…………………………………………………………………………………………………………………....
.... 
21. D. Uma ungawasebezisi amakhambi noma izilwane ukwelapha lesifo usebenzisani? 
……………………………………………………………………………………………………………………
… 
 
22. A. Yiluphi uhlobo lomuthi olisebenzisayo ukwelapha ushukela? 
Ukuxuba izinhlobo zamakhambi/inyamazane  
Ukucaphuna amanzi omuthi/ amafutha esilwane  
Ezinye izindlela (Cacisa)  
  
  
 
Kucelwa uchaze impendulo yakho: 
………………………………………………………………………………… 
22. B. Yiluphi uhlobo lomuthi olisebenzisayo ukulapha umfutho wegazi? 
Ukuxuba izinhlobo zamakhambi  
 Ukucaphuna amakhambi  
Ezinye izindlela (Cacisa)  
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23. A. Singakanani isikali osisebenzisayo ukwelapha isifo sikashukela? 
……………………………………………………………………………………………………………………
… 
23. B. Singakanani isikali osisebenzisayo ukwelapha umfutho wegazi? 
……………………………………………………………………………………………………………………
… 
……………………………………………………………………………………………………………………
… 
24. A. Ngabe kuthatha isikhathi esingakanani ukwelapha umuntu enesifo sikashukela? 
............................................……. 
……………………….......................................................................................... 
……………………………………………………………………………………………………………………
…    
24. B. Ngabe kuthatha isikhathi esingakanani ukwelapha umuntu onesifo somfutho wegazi?  
…………….……………………………………………………. 
…………………………………………………. 
……………………………………………………………………………………………………………………
… 
 25. Bukhona yini ubungozi  noma izinkinga ezibakhona uma umuntu esebenzisa amakhambi? 
Yebo  
 Cha    
 
Kucelwa uchaze impendulo yakho  
....................................................................................................................................... ...............................
..............…………………………………………………………………………………………………………
…………… 
……………………………………………………………………………………………………………………
. 
……………………………………………………………………………………………………………………
. 
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26. Kuyenzeka udokotela udlulisele isiguli kuwe?  
27. A. Ikhona yini indlela oyikhuthazangayo abantu abanesifo sikashukela ukuthi badle ukudla okunempilo? 
Yebo  
 Cha    
 
Kucelwa ukuba uchaze impendulo yakho.  
................................................................................................................................................................................
.... 
……………………………………………………………………………………………………………………
… 
27. B. Ikhona yini indlela okhuthazangayo abantu abanesifo somfutho wegazi ukuthi badle ukudla okunempilo? 
Yebo  
 Cha    
 
Kucelwa uchaze impendulo yakho:  
……………………………………………………………………………………………………………………
… 
……………………………………………………………………………………………………………………
… 
28. A. Uke uphakhamise umbono kuziguli zakho ezinesifo sikashukela ukthi zingaphila kanjani ngendlela 
enempilo? 
Yebo  
 Cha    
 
Kucelwa uchaze impendulo yakho:  
……………………………………………………………………………………………………………………
… 
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……………………………………………………………………………………………………………………
… 
28. B. Uke uphakhamise umbono kuziguli zakho ezinesifo somfutho wegazi ukthi zingaphila kanjani ngendlela 
enempilo? 
Yebo  
 Cha    
 
Kucelwa uchaze impendulo yakho:  
……………………………………………………………………………………………………………………
… 
……………………………………………………………………………………………………………………
… 
 
29. Uyazivumela yini iziguli zakho ukuthi zisebenzise imithi yabelaphi bezizwe ngenkathi zisasebenzisa imithi 
yakho?   
Yebo  
 Cha    
Kucelwa uchaze impendulo yakho 
…………………………………............................................................................................................................
.... 
……………………………………………………………………………………………………………………
… 
30. A. Ngabe ukhona yini umehluko phakathi kwabelaphi basemazweni (besilingu) nalabo abesintu 
ekwelapheni ushukela? 
Yebo  
 Cha    
 
Kucelwa uchaze impendulo yakho: 
……………………………………………………………………………………………………………………
… 
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……………………………………………………………………………………………………………………
… 
30. B. Kungabe ukhona yini umehluko phakathi kwabelaphi basemazweni nalabo abesintu ekwelapheni 
umfutho wegazi? 
……………………………………………………………………………………………………………………
… 
……………………………………………………………………………………………………………………
… 
31. Yisiphi iseluleko ongasinika umuntu ophila nesifo sikashukela okanye umfutho wegazi? 
……………………………………………………………………………………………………………………
… 
……………………………………………………………………………………………………………………
… 
32. A.  Yikuphi okuphakamisayo ukuphucula ukwelapha isifo sikashukela eNingizimu Afrika ngokwesiko? 
 ............................................................................................................................................................................... 
……………………………………………………………………………………………………………………
.    
32. B.  Yikuphi okuphakamisayo ukuphucula ukwelapha isifo somfutho wegazi eNingizimu Afrika 
ngokwesiko?  
…………………………................................................................................................................... .....................
.... 
................................................................................................................................................................................
.... 
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APPENDIX X: Semi-structured questionnaire used for face-to-face interviews in 
Tswana 
Demographic data 
Malotle a demokerafi 
Please kindly provide answers to the questions below tick the most suitable options. 
Tsweetswee araba dipotso tse di fa tlase, o tshwae dikarabo tse maleba go ya ka wena 
1. Age by the end of the year (Full years): 
    Dingwaga tsa gago ka botlalo fa ngwaga ono o fela ……………………….          
2.  Gender 
     Bong 
Male 
Motona/Rre 
 
Female 
Monamagadi/Mme 
 
                      
3. Marital Status: 
    Maemo a nyalo   
 
Single 
Moitshodi/Monosi 
 
Married 
Nyetse/Nyetswe 
 
Living with a partner 
Ke nna le molekane 
 
Divorced 
Tlhadilwe 
 
Widow/Widower 
Motlholagadi/Moswagadi 
 
 
4. Ethnicity 
     Lotso:   
Zulu  
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Mozulu 
Tswana 
Motswana 
 
Others (Specify) 
Tse dingwe (di bolele) 
 
 
5. Religious denomination: 
     Bodumedi    
Traditional 
Jwa setso 
 
Christian 
Mokeresete 
 
Islamic 
Mo-Islamo 
 
None 
Ga ke gope 
 
Others (Specify) 
Tse dingwe (di bolele) 
 
 
6. Educational level: 
    Thutego  
Nil 
Ga bo yo 
 
Primary 
Poraemari 
 
High school 
Sekolo-segoloe 
 
Tertiary 
Go feta Materiki/Yunivesithi 
 
Others (Specify) 
Tse dingwe (di bolele) 
 
 
 
 
 
153 
 
7. Kind of practice 
Mofuta wa bongaka 
 
Herbal 
Ngaka ya mesunkwane 
 
Divination (spiritual) 
Ngaka ya ditaola/badimo 
 
Both divination and herbal 
Ngaka ya mesunkwane le ditaola 
 
Others (Specify) 
E  mengwe (e bolele) 
 
              
8. Place of practice: 
Lefelo la tirelo  
Office/Shop 
Ofisi/Kantoro/Lebenkele 
 
Home 
Legae 
 
 Market 
Mmaraka 
 
Others (Specify) 
Gongwe gosele (Go bolele) 
 
 
9. Do you work as a full time or part-time 
A o bereka ka Motlha-otlhe kgotsa ka Motlha-orileng? 
……………………………………………………………………………………………………………………
.. 
10. If part-time, what else do you do for your living? 
Fa o bereka motlha-orileng fela, ke tiro efe e nngwe e o itshidisang ka 
yona?........................................................ 
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11. Are you registered with South African Healers Traditional Council? 
A o ikwadisitse le Lekgotla la Dingaka tsa Setso la Afrika Borwa? 
Yes 
Ee 
 
 No   
Nnyaa 
 
 
 
12. Are you registered with any Traditional Healers Association? 
A o ikwadisitse le Lekgotla lengwe fela la Dingaka tsa Setso? 
                                    
Yes 
Ee 
 
 No   
Nnyaa 
 
If yes, please name the association that you are part of………………………………………………………… 
Fa karabo e le “Ee” bolela lekgotla le o le ikwadiseditseng…………………………………………………… 
13. How long have you been in this profession?  
Ke dingwaga di le kae o ntse o le mo profešeneng eno ya 
bongaka?…………………………………………………………..       
 14. How many diseases other than diabetes or hypertension do you treat/heal? Please list 
them………………………………………… 
Ke malwetse a makae a o kgonang go a alafa ntle le bolwetse ba sukiri le ba kgatelelo ya 
madi?..................................................................... 
 
 
 
 
 
 
155 
 
Questions for objective 1 
Kaedi ya potso-therisano ya Morerwana 2 
 
15. A. Where did you get knowledge and information about diabetes as a disease? 
 O bone jang kitso le tshedimosetso ka bolwetse ba sukiri? 
Trained  by the family member 
Ka katisitswe ke o mongwe wa balelapa 
 
Trained by other person/ Ke katisitswe ke mongwe 
fela 
 
 A gift from my birth/ Ke neo ya tsalo  
It is my calling/ Ke pitso ya me  
I got a professional training/ Ke neilwe katiso ya 
profeshene 
 
Other (Specify)   / Go gongwe (tlhalosa)  
 
Please explain more on your answer above? Ka kopo tlhalosa go le gontsi mabapi le karabo ya gago e e fa 
godimo…………………………………………………………………………. 
     
15.B. Where did you get knowledge and information about hypertension as a disease? O bone jang kitso le 
tshedimosetso ka bolwetse ba kgatelelo ya madi? 
 
Trained  by the family member 
Ka katisitswe ke o mongwe wa balelapa 
 
Trained by other person/ Ke katisitswe ke mongwe 
fela 
 
 A gift from my birth/ Ke neo ya tsalo  
It is my calling/ Ke pitso ya me  
I got a professional training/ Ke neilwe katiso ya 
profeshene 
 
Other (Specify)   / Go gongwe (tlhalosa)  
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 Please explain more on your answer above? ? Ka kopo tlhalosa go le gontsi mabapi le karabo ya gago e e fa 
godimo …………………………………………………………………………. 
……………………………………………………………………………………………………………………
… 
Questions for objective 2 
Kaedi ya potso-therisano ya Morerwana 1 
 
16. A.What is diabetes in your culture? Please explain your answer? 
 Bolwetse ba sukiri ke eng/bo bidiea eng go ya ka setso sa gago? Ka kopo tlhalosa karaba ya 
gago………………………………………………….. 
…………………………………………………………………………………………………………………… 
16.B. What is hypertension in your culture? Please explain your answer 
Bolwetse ba kgatelelo ya madi ke eng/bo bidiwa eng ka setso sa gago? Ka kopo tlhalosa karabo ya 
gago?……………………………………………….. 
……………………………………………………………………………………………………………………
…          
Questions for objective 3 
Kaedi ya potso-therisano ya Morerwana  
 
17. A. Are you able to identify a person with diabetes in your profession? A o kgona go supa motho yo o 
tshwerweng ke bolwetse ba sukiri mo profesheneng ya lona? 
Yes/ Ee  
 No/ Nyaa  
 
Please explain your answer (signs and symptoms):  Ka kopa tlhalosa karabo ya gago (matshwao le ditshupo) 
…………………………………………………………………?  
…………………………………………………… 
 
 
157 
 
17B. Are you able to identify a person with hypertension? A o kgona go supa motho yo o tshwerweng ke 
bolwetse ba kgatelelo ya madi mo profesheneng ya lona? 
 
Yes/ Ee  
 No/ Nyaa   
 
Please explain your answers (signs and symptoms): Ka kopa tlhalosa karabo ya gago (matshwao le ditshupo) 
……………………………………………………………………………………………………………………
…… 
18. A. Do you use modern instruments to test diabetes? A le dirisa didiriswa tsa sesheng go tlhatlhoba bolwetse 
ba sukiri? 
Yes/ Ee  
 No/ Nyaa   
 
Please explain your answer: Ka kopo tlhalosa karabo ya gago 
…………………………………………………………………………………………. 
18.B. Do you use modern instruments to test hypertension? A le dirisa didiriswa tsa sesheng go tlhatlhoba 
bolwetse ba kgatelelo ya madi? 
Yes/ Ee  
 No/ Nyaa    
 
Please explain your answer: Ka kopo tlhalosa karabo ya gago 
…………………………………………………………………………………………… 
19. A. Are there different types of diabetes?  A gona le mefuta e e farologaneng ya bolwetse ba sukiri? 
Yes/ Ee  
 No/ Nyaa    
 
Please explain your answer: Tlhalosa karabo ya 
gago……………………………………………………..…………………………………….. 
 
 
158 
 
 
19.B. Are there different types of hypertension?  A gona le mefuta e e farologaneng ya bolwetse ba kgatelelo 
ya madi? 
 
Yes/ Ee  
 No/ Nyaa    
 
Please explain your answer: Tlhaloda karabo ya 
gago………………………………………………………………………………………….. 
 
20.A. Does diabetes have any danger in your culture?  A bolwetse ba sukiri bo kotsi go ya ka setso? 
Yes/ Ee  
 No/ Nyaa  
 
Please explain your answer: Tlhalosa karabo ya gago ka kopo 
……………………………………………………………………………………………………………………
……. 
20. B. Does hypertension have any danger in your culture? ?  A bolwetse ba kgatelelo ya madi bo kotsi go ya 
ka setso? 
…………………………………………………………………………………………………………………… 
Please explain your answer: Tlhalosa karabo ya gago 
 
Questions for objective 4 
Kaedi ya potso-therisano ya Morerwana 4 
 
21. A. What herbs/animals or minerals do you use to treat and combat diabetes? Please list 
 O  dirisa mere/diphologolo kgotsa diminerale di feng go alafa bolwetse ba sukiri? De neele ka kopo 
………………………………………………………………................................................................................
.... 
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……………………………………………………………………………………………………………………
… 
21. B. If you do not use herbs/animals or minerals please list what you use for diabetes 
 Ga o sa dirise mere/diphologolo kgotsa diminerale, neela se o se dirisang go alafa bolwetse ba sukiri 
…………………………………………………………………………………………………………………… 
21. C. What herbs/animals or minerals do you use to treat and combat hypertension? Please list 
 O  dirisa mere/diphologolo kgotsa diminerale di feng go alafa bolwetse ba ba kgatelelo ya madi? De 
neele ka kopo 
............................................................................................................... 
  
21.D. If you do not use herbs/animals or minerals please list what you use for hypertension 
Ga o sa dirise mere/diphologolo kgotsa diminerale, neela se o se dirisang go alafa bolwetse ba kgatelelo ya 
madi 
  
………………………………………………………………………………………………………….. 
22. A.  What types of medical preparations do you use for diabetes?  
 O dirisa metswako e feng ya kalafi ya bolowetse ba sukiri? 
Concoctions Motswako ya mere e e farologaneng 
 Decoctions  Dipitsana 
Other forms Mekgwa e mengwe 
 
Please explain your answer: Tlhalosa karabo ya gago ka kopo 
 ……………………………………………………………………………………………. 
22.B. What   types of medical preparations do you use for hypertension?  
 O dirisa metswako e feng ya kalafi ya bolowetse ba kgatelelo ya madi? 
 
Concoctions Motswako ya mere e e farologaneng 
 Decoctions  Dipitsana 
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Other forms Mekgwa e mengwe 
 
Please explain your answer Tlhalosa karabo ya gago ka kopo 
…………………………………………………………………………………………………………………… 
23. A.What is the dosage do you recommend to your patient/s with diabetes from medical preparations listed 
above?   
Ke seelo se se kae sa motswako wa kalafi  se o laelang balwetse ba gago ba sukiri go se tsaya? 
................................................................................................................................................................................
.... 
 
23.B. What is the dosage do you recommend to your patient/s with hypertension from medical preparations 
listed above?  
Ke seelo se se kae sa motswako wa kalafi  se o laelang balwetse ba gago ba kgatelelo ya madi go se tsaya? 
 
…………………………………………………………………………………………………………….. 
 
24. A. For how long do you treat a patient suffering from diabetes? 
 Balwetse ba sukiri ba tsaya kalafi ya bona sebaka se se kana kang?? 
 ……………………………………………………………………………………………………………… 
24.B. For how long do you treat a patient suffering from hypertension? 
Balwetse ba kgatelelo ya madi bona ba tsaya kalafi ya bona sebaka se se kana kang? 
……………………………………………………………………………………………………………………
…25. Does your prescribed medicines possess any side effects? 
 A kalafi ya lona e na le go ka bakela molwetse makoa a mangwe a a riling/ side effects? 
Yes/ Ee  
 No/ Nyaa   
 
Please explain your answer. Tlhalosa karabo ya gago ka kopo 
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……………………………………………………………………………………………………………………
… 
 
26. Have you ever received a patient referred by biomedically trained 
doctors?............................................................ 
A o kile wa nna le molwetse o a rometsweng ke ngaka ya sekgoa ko go 
wena?......................................................... 
 
27. A. Do you consider dietary regimen in the management of diabetes?   
A o akaretsa le mefuta/mekgwa e e rileng ya go ja mo tlhokomelong ya bolwetse ba sukiri? 
Yes/ Ee  
 No/ Nyaa  
 
Please explain your answer: Tlhalosa karabo ya gago ka kopo 
……………………………………………………………………………………………………………………
.. 
27. B. Do you consider dietary regimen in the management of hypertension?  A o tsaya tsiya mekgwa ya dijo 
tse di rileng mo tlhokomelong ya bolwetse ba kgatelelo ya madi? 
Yes/ Ee  
 No/ Nyaa    
 
Please explain your answer: Tlhalosa karabo ya gago ka kopo 
………………………………………………………………………………………………………………….. 
 
28. A. Do you recommend any lifestyle changes to your diabetic patients?  
A o tshitsinyetsa balwetse ba gago ba sukiri go latela mekgwa e e rileng ya maitsholo? 
Yes/ Ee  
 No/ Nyaa   
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Please explain your answer: Tlhalosa karabo ya gago ka kopo 
…………………………………………………………………………………………… 
  
28.B. Do you recommend any lifestyle changes to your hypertension patients? 
A o tshitsinyetsa balwetse ba gago ba kgatelelo ya madi go latela mekgwa e e rileng ya maitsholo? 
 
Yes/ Ee  
 No/ Nyaa  
 
Please explain your answer: Tlhalosa karabo ya gago ka kopo 
……………………………………………………………………………………………………………………
.. 
29. Do you allow your patients to use concurrently medicines prescribed by biomedically trained doctors with 
your traditional medical preparations?  
A o letlelela balwetse ba gago go tsaya kalafi ya setso le ya sekgoa ka nako e le nngwe? 
Yes/ Ee  
 No/ Nyaa  
                   
Please explain your answer: Tlhalosa karabo ya gago ka kopo 
……………………………………………………………………………………………………………………
… 
30. A. What is the difference between the way biomedically trained doctors and traditional healers treat 
diabetes? 
Mokgwa wa dingaka tsa setso wa go alafa bolwetse ba sukiri o farologana jang le wa dingaka tsa sekgoa? 
 
…………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………
…. 
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30. B. What is the difference between the way the way biomedically trained doctors and traditional way treat 
hypertension? 
Mokgwa wa dingaka tsa setso wa go alafa bolwetse ba kgatelelo ya madi o farologana jang le wa dingaka tsa 
sekgoa? 
……………………………………………………………………………………………………………………
…. 
……………………………………………………………………………………………………………………
… 
31.  What advice can you give to the person living with diabetes or/and hypertension?     
 Ke kgakololo e feng e o ka e neelang motho yo o nang le bolwetse ba sukiri kgotsa/le jwa kgatelelo 
ya madi? 
…………………………………………………………………………………………………………………… 
32. A.What do you think should be done to improve treatment and healing for diabetes by THPs?  
O akanya gore go ka dirwa eng go tokafatsa kalafi le phodiso ya bolwetse ba sukiri ke THPs? 
 
…………………………………………………………………………………………………………………… 
32. B. What do you think should be done to improve treatment and healing for hypertension by THPs? 
O akanya gore go ka dirwa eng go tokafatsa kalafi le phodiso ya bolwetse ba kgatelelo ya madi ke THPs? 
……………………………………………………………………………………………………………………
… 
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APPENDIX XI: Information letter in English 
 
Traditional Healers Association 
Province………………………. 
Date…………………………………….. 
Dear Sir/Madam, 
REQUEST FOR RESEARCH PARTICIPATION 
My name is Frimpong Ebenezer Kwabena from UKZN, School of Health Sciences, and 
Discipline of Pharmaceutical Sciences with student ID number 215068623. Contacts: 
pharmeben@gmail.com (0630439675);nlooto@ukzn.ac.za (031 2607030.  Please members 
of your organization are humbly being invited to consider participating in a study that 
involves research about development of a framework for the standardization of treatment 
management of diabetes and hypertension amongst traditional healers in both KwaZulu-
Natal and North West provinces.  
The study is expected to enroll 1,116 participants; 558 THPs each in both KwaZulu-Natal 
and North West provinces. It will involve the following procedures: Focus Group 
Discussions (FGDs) among traditional healers in both KwaZulu-Natal and North West 
provinces in phase 1. A researcher administered Face-to-Face interviews with traditional 
healers in both KwaZulu-Natal and North West provinces will be carried out in phase 2. Data 
will be collected six days a week. The duration of your participation if you choose to enrol 
and remain in the study will be an hour. The study is funded by the College of Health 
Sciences (CHS) scholarship. 
The study may not involve risks or uneasiness; it will be of great benefit to traditional healers 
about the management of diabetes and hypertension diseases.  No name, no ID of participants 
will be disclosed to third party or displayed on questionnaires and data collection forms.  
This study has been ethically reviewed and approved by the UKZN Biomedical research 
Ethics Committee (approval number_____).  
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In the event of any problems or concerns/questions you may contact the researcher at 
pharmeben@gmail.com (0630439675) or the UKZN Biomedical Research Ethics 
Committee, contact details as follows:   
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 
Tel: 27 31 2604769 - Fax: 27 31 2604609 
Email: BREC@ukzn.ac.za  
Phindile Nene, Postgraduate Officer, School of Health Sciences, Westville Campus  
031 2608280, Nenep1@ukzn.ac.za  
Supervisor: Dr. Manimbulu Nlooto at nlooto@ukzn.ac.za, contact number 031 2607030 
I hope that permission will be granted in good faith. 
 
Yours Sincerely, 
Ebenezer Frimpong 
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APPENDIX XII: Consent to participate in English 
I (…………..) have been informed about the study entitled “Development of a framework 
for the standardization of management of diabetes and hypertension: The case of Tswanas 
and Zulus of South Africa by (provide name of researcher/fieldworker). 
I understand the purpose and procedures of the study (add these again if appropriate). 
I have been given an opportunity to answer questions about the study and have had answers 
to my satisfaction. 
I declare that my participation in this study is entirely voluntary and that I may withdraw at 
any time without affecting any treatment or care that I would usually be entitled to. 
I have been informed about any available compensation or medical treatment if injury occurs 
to me as a result of study-related procedures. 
If I have any further questions/concerns or queries related to the study I understand that I 
may contact the researcher at (provide details). 
If I have any questions or concerns about my rights as a study participant, or if I am 
concerned about an aspect of the study or the researchers then I may contact: 
 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001  
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 
Tel: 27 31 2604769 - Fax: 27 31 2604609 
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APPENDIX XIII: Information letter in isiZulu 
Traditional Healers Association 
Province………………………. 
Date…………………………………….. 
 
Ngiyabingelela 
Isicelo sokuba nibe inxenye yocwaningo 
Igama lami ngingu Frimpong Ebenezer Kwabena ngiqhamuka esikhungweni semfundo 
ephakeme yaKwaZulu Natal, enxenyeni yezempilo egxile kakhulu ezifundweni kwezemithi 
okubalwa ukwakhiwa kwayo nokusetshenziswa kwayo, inombolo yami yasesikoleni ithi 
215068623. Ngiyatholakala kule imeyili adilesi pharmben@gmail.com nakulenombolo ethi 
063 043 9675, enye ithi 031 260 7030 ne imayili yakhona ethi nlooto@ukzn.ac.za 
Amalunga enhlangano ayacelwa ngenkulu intobeko ukuba abambe iqhaza ocwaningweni 
lokuthuthukiswa kwenzela okwelashwangayo isifo sikashukela ne BP phakathi kwabelaphi 
bendabuko ezifundazweni ezimbili okungesa-kwaZulu Natal nesase nyakatho 
nentshonalanga yezwe iNorth West. 
Kulindeleke ukuba abaholi bendabuko ababalelwa enkulungwaneni, nekhekhulu neshumi 
nesithupha (1116) okusho ukuthi inxenye engangesigamu sabo bazophuma KwaZulu Natal 
enye inxenye ibuye eNyakatho nentshonalanga. Esigabeni sokuqala salolucwaningo luzo 
hlanganisa abelaphi bendabuko ngokwehlukana kwabo bexoxe ngezindlela zokwelapha 
esigabeni sokuqala. Esigabeni sesibili bese kuba inkulumo esanhlolo khono ezophathwa 
umholi wocwaningo phakathi kwakhe nabelaphi abasuka ezifundazweni zombili 
lolucwaningo luzothatha izinsuku eziyisithupha kodwa umelaphi ngamunye limuthathe 
isikhathi esingangehora.  
Izindleko zocwaningo zixhaswe umfundaze ophuma ekolishi lezempilo. Lolucwaningo 
alunabungozi, kodwa futhi sinethemba ukuthi luzoba inzuzo enkulu kubelaphi bendabuko 
ekukwazini ukwelapha isifo sikashukela ne BP.  
Amagama abantu abazoba inxenye azogcinwa eyimfihlo, akuzukufuneka ngisho umazisi. 
Ucwaningo lubhekisiswe nayisikhungo semfundo ephakeme yaKwaZulu Natali ukuthi 
lungahlukumezi amalungelo abantu.  
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Uma kukhona imibuzo ekhona ungaxhumana nomphathi wocwaningo kule imayili ethi 
pharmben@gmail.com noma kwinombolo yocingo ethi 063 043 9675. 
APPENDIX XIV: Consent to participate in isiZulu 
ISIVUMELWANO (Hlela njengoba 
kudingeka)  
Mina (......) ngazisiwe ngocwaningo olunesihloko esithi "Ukuthuthukiswa kohlaka 
lokumiswa kokujwayelekile kwesifo sikashukela kanye nomfutho wegazi ophakeme”:  
Odabeni lama Tswana nabe Zulu ase Ningizimu Africa ngo (Faka igama 
lomcwaningi)  
Ngiyayiqonda inhloso nezinqubo zocwaningo (engeza futhi lokhu uma kufanele)  
Nginikezwe ithuba lokuphendula imibuzo mayelana nalolu cwaningo futhi ngithole 
izimpendulo ngokweneliseka kwami  
Ngiyavuma ukuthi ukubamba iqhaza kwami kulolu cwaningo kungokuzithandela 
ngokuphelele futhi ngingahoxisa nganoma yisiphi isikhathi ngaphandle kokuthinta noma 
yikuphi ukwelashwa noma ukunakekelwa engivame ukukuthola  
Ngatshelwa nganoma yisiphi isinxephezelo noma ukwelashwa okutholakalayo uma 
kwenzeka ngilimala ngenxa yezinqubo ezihlobene nokufunda  
Uma ngineminye imibuzo / ukukhathazeka ephathelene nocwaningo ngiyaqonda ukuthi 
ngingaxhumana nomcwaningi ku- (hlinzeka imininingwane)  
Uma nginemibuzo noma ukukhathazeka ngamalungelo ami njengomhlanganyeli 
ocwaningweni, noma uma ngithinta isici socwaningo noma abacwaningi 
ngingaxhumana ne:  
 
Biomedical Research Ethics Administration  
Research Office, Westville Campus  
Govern Mbeki 
Building  
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Private Bag X 
54001  
Durb
an  
40
00  
KwaZulu-Natal, SOUTH 
AFRICA  
Tel :27 31 2604769 – Fax: 27 31 2604609  
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APPENDIX XV: Information letter in Tswana 
Karolo X:  Leqephe la tlhaiso-leseling 
 
Mokhatlo oa Boholo ba Baetlohi 
 
Porofense ………………………. 
 
Letsatsi…………………………………….. 
Mohlomphehi, 
 
KOPO EA HO NKA KAROLO HO DIPATLISISONG 
 
Lebitso laka ke Frimpong Ebenezer Kwabena ketswa UKZN, Sekolo sa Mahlale a Bophelo, 
le Karolo ea Saense ea Bongaka with nomoro boitsebahatso ea moithuti 215068623. 
Boikopanyo: pharmeben@gmail.com (0630439675);nlooto@ukzn.ac.za (031 2607030. Ke 
kopa litho tsa mokhatlo oa hau li memeloe ka boikokobetso hore li nahane ka ho nka karolo 
lipatlisisong tse kenyelletsang lipatlisiso mabapi le nts'etsopele ea moralo oa taolo ea kalafo 
ea lefu la tsoekere le khatello ea mali har'a lingaka tsa setso liprofinseng tsa KwaZulu-Natal 
le North West. 
Phuputso e lebelletsoe ho ngolisa barupeluoa ba 1,116; Li-558 THPs ka bomong liprofinseng 
tsa KwaZulu-Natal le North West. E tla kenyelletsa lits'ebetso tse latelang: Lipuisano tsa 
Sehlopha sa Bareki (FGDs) har'a lingaka tsa setso liprofinseng tsa KwaZulu-Natal le North 
West mohatong oa 1. Mofuputsi ea tsamaisanang le lipotso tsa bongaka ba sefahleho le ba 
bongaka ba liprofinse tsa KwaZulu-Natal le North West o tla etsoa mohato oa 2.  
Lintlha li tla bokelloa ka matsatsi a tšeletseng ka beke. Nako ea ho nka karolo ha u khetha 
ho ingolisa le ho lula thutong e tla ba hora. Boithuto bona bo tšehelitsoe ke borutehi ba 
College of Health Science (CHS). 
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Lithuto li kanna tsa se kenye likotsi kapa ho hloka botsitso; e tla ba molemo haholo ho 
lingaka tsa setso mabapi le taolo ea mafu a lefu la tsoekere le khatello ea mali. Ha ho lebitso, 
ha ho na boitsebahatso ea barupeluoa e tla hlahisoa ho motho oa boraro kapa ho bonts'oa 
liphatlalatsong tsa lipotso le liforomo tsa pokello ea tsebo.  
Boithuto bona bo lekotsoe ka litekanyetso tsa boitšoaro bo bile bo amohetsoe ke Komiti ea 
Litekanyetso tsa Boithuto tsa Bongaka ea UKZN (nomoro ea tumello_____).  
Ketsahalong ea mathata kapa ho tšoenyeha / lipotso tseo u ka ikopanye le mofuputsi ho tsona 
 pharmeben@gmail.com (0630439675) kapa Komiti ea Litekanyetso tsa Boithuto tsa 
Bongaka ea UKZN, lintlha tsa puisano ka tsela e latelang: 
 
TSAMAISO EA DIPATLISISO TSA BONGAKA 
Ofisi ya Diplatlisiso, Khamphase ya Westville 
Moaho wa Govan Mbeki  
Private Bag X 54001 
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 
Mohala: 27 31 2604769 - Fekse: 27 31 2604609  
Lengolo-tsoibila: BREC@ukzn.ac.za  
Phindile Nene, Mohlanka wa baithuti, Sekolo sa Mahlale a Bophelo, Khamphase ya 
Westville 
031 2608280, Nenep1@ukzn.ac.za  
Mohlokomeli: Dr. Manimbulu Nlooto at nlooto@ukzn.ac.za, Mohala 031 2607030 
Ke ts'epa hore tumello e tla fanoa ka tumelo e ntle. 
Oa hau ka hlompho, 
Ebenezer Frimpong  
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APPENDIX XVI: Consent to participate in Tswana 
SEBOPEHO (Fetola joalo ka ha ho hlokahala) 
Nna (…………..) ba tsebisitsoe ka phuputso e bitsoang "Ntlafatso ea moralo oa maemo a 
taolo ea lefu la tsoekere le khatello ea mali: Nyeoe ea Tswanas le Zulus ea Afrika Boroa ka 
(fana ka lebitso la mofuputsi / mosebetsi oa masimong). 
Ke utloisisa sepheo le lits'ebetso tsa boithuto (eketsa tsena hape haeba ho loketse) 
 
Ke filoe monyetla oa ho araba lipotso ka thuto mme ke bile le likarabo tsa khotsofalo ea ka. 
Ke phatlalatsa hore ho nka karolo ho ithuteng hona ho ithaopa ka boithatelo le hore nka tsoa 
ka nako efe kapa efe ntle le ho ama kalafo kapa tlhokomelo eo ke neng ke tla ba le tokelo ea 
ho e fumana. 
Ke tsebisitsoe ka puseletso leha e le efe e fumanehang kapa kalafo ea bongaka haeba ke 
lemetse ka lebaka la lits'ebetso tse amanang le thuto 
 
Haeba ke na le lipotso kapa ho tšoenyeha kapa lipotso tse amanang le thuto ke utloisisa hore 
nka ikopanya le mofuputsi ho (fana ka lintlha). 
Haeba ke na le lipotso kapa ho tšoenyeha ka litokelo tsa ka ke le karolo ea thuto, kapa haeba 
ke amehile ka karolo e 'ngoe ea thuto kapa bafuputsi, nka ikopanya le: 
TSAMAISO YA MOTSE EA DIPATLISISO TSA BONGAKA 
Ofisi ya Diplatlisiso, Khamphase ya Westville 
Govan Mbeki Building 
Private Bag X 54001 
Durban  
4000 
KwaZulu-Natal, AFRIKA BOROA 
Mohala: 27 31 2604769 - Fekse: 27 31 2604609  
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APPENDIX XVII: Email from plant scientist in KZN province 
 
 
APPENDIX XVIII: Email from plant scientist in North West province 
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APPENDIX XIX: Ayurveda treatment guidelines for the management of diabetes 
 
Guidelines for prevention and 
management of Diabetes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Central Council For research in Ayurvedic Sciences 
MINISTRY OF AYUSH, GOVRNMENT OF INDIA 
NO. 61-65, institute Area, Opp. D-Block Janakpuri, New Delhi 110058
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General Guidelines for the users 
 The prescriptions in this document should be judiciously used after proper consultation with 
Ayurvedic  Physicians  for  diagnosis  of  the  condition  and  understanding  of  the treatment. 
        This document provides a selective list of medicines which are developed by research. 
 
However, the physician may use the medicines which are easily available or well-known 
even though not mentioned in this book. 
 
 The  prescriptions  are  provided  for  the  specific  type/phase/symptoms  of  a  particular 
disease in this document on the basis of classical reference, research outcome or the ingredients 
of the formulation. It is advised that the physician may choose single or combination of 
formulations or procedures as per the need. 
 
 Dose and duration of the treatment though specified in the document, should be decided by 
the physician based on the clinical findings, tolerance and individual condition of the patient. 
 
        The diet and lifestyle may be advised to the patients as per the need. 
 The references of the publication are given for each prescription and anybody interested in 
detail results of the clinical trials may log on to http://ayushportal.ap.nic.in or refer to the 
respective journals. 
 
 In general, too spicy, salty, chilly, sour, preserved items, fried food, heavy, indigestible, too 
cold & hot, stale food and the food that do not suit the individual should be avoided. 
 
 Too much tea, coffee, etc. should be avoided. Tobacco, alcohol and drugs should not be 
taken. 
 
 Mental  stress  should  be  tackled  by  recreation  such  as  medication,  prayer,  sports, 
exercises, yoga & other activities of individual's choice. 
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Background 
The history of diabetes (madhumeha) can be traced back in 1000 BC (Caraka Samhita). 
Descriptions concerning the disease and its management are available in Ayurvedic literature. 
Caraka Samhita (1000 BC) and Susruta Samhita (1000-600 BC) defined madhumeha as the disease 
in which the patient passes frequent urine characterized as astringent and sweet The high blood        
sugar        produces        the        classical        symptoms        of        polyuria (frequent urination), 
polydipsia (increased        thirst)        and polyphagia (increased        hunger).        The word diabetes 
comes  from Latin “diabetes”,  which  in  turn  comes  from Ancient  Greek word which literally 
means “a passer through” and the word mellitus comes from the classical Latin word mellitus, 
meaning "mellite" (i.e. sweetened with honey; honey-sweet). Indian physicians identified the 
disease and classified it as madhumeha or "honey urine". 
 
Ayurveda attributes multi-factorial etiology to the causation of diabetes. It has been described as 
one among the eight major diseases (asthamahagada) in Ayurveda, which are difficult to cure and 
refractory in nature. 
 
Diabetes mellitus (madhumeha) is a group of metabolic diseases marked by high level of blood 
glucose resulting from defects in insulin production, insulin action or both. Diabetes may lead to 
serious complications in multiple organ systems. Diabetes is of two types- type I or Insulin 
Dependent Diabetes Mellitus (IDDM) & type II or Non Insulin Dependent Diabetes Mellitus 
(NIDDM). Complete or near total insulin deficiency is found in type I while type II diabetes 
mellitus is characterized by variable degree of insulin resistance, impaired insulin secretion and 
increased glucose production. Types II diabetes mellitus is increasing more rapidly due to obesity 
caused by sedentary life habits and changed life style. Insulin is the only treatment for type I 
diabetes and conventional modern medicine provides a number of drugs for controlling the blood 
sugar level in the patients of diabetes mellitus type II. However, with the prolonged treatment doses 
of the drugs often needs to be increased to control the blood sugar level and a time comes when 
patient has to be switched over to insulin. Such patients become cases of insulin dependent diabetes 
mellitus. To handle such a situation time tested treatment available in ayurveda may be adopted 
 
Prevalence 
 
Diabetes is undoubtedly one of the most challenging health problems in the 21st  century 
.It is increasing globally with a rise from about 30 million cases in 1985 to 177 million cases in 
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2000 and worldwide estimates project that more than 360 million individuals will have diabetes by 
the year 2030 (Harrison’s principle of Internal medicine, 2002). The prevalence of the disease 
increases with the age. 
 
Introduction 
Diabetes mellitus (DM) is one of the most common non-communicable diseases 
(NCDs) globally. It is the fourth or fifth leading cause of death in most high-income 
countries and there is substantial  evidence  that  it  is  epidemic  in  many  economically  
developing  and  newly industrialized countries. 
 
It has been narrated in ayurveda that, the long periods of physical inactivity, 
laziness, sleeping for long hours, excess use of food which is heavy to digest like dairy 
products, aquatic and marshy animals, sugar/jaggery preparations, fresh grains etc. and 
similar foods that increase kapha are generalized causes of prameha. 
 
Clinical Features 
Common symptoms of diabetes include: 
                    Polyuria - increased urination 
                    Polyphagia - excessive appetite 
                    Polydyspia - excessive thirst 
                    Unusual weight loss or weight gain 
                    Fatigue 
                    Nausea, perhaps vomiting 
                    Blurred vision 
                    In women, frequent vaginal infections 
                    In men and women, yeast infections 
                    Dry mouth 
                    Slow-healing of sores or cuts in the skin / mucosa 
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                    Itching of the skin, especially in the region of groin or genitals 
 
Complications 
Complication occurring due to diabetes may be broadly categorized as: 
A.  Acute complications 
                    Diabetic ketoacidosis (DKA) 
                    Hyperglycemia hyperosmolar state 
                    Hypoglycemia 
                    Diabetic coma 
                    Respiratory infections 
B.  Periodontal disease Chronic complications 
                    Physical disabilities 
                    Cognitive decline 
                    Retinopathy 
                    Macroangiopathy 
                    Neuropathy 
                    Nephropathy 
Laboratory 
Investigations 
                    Measurements of the 
plasma glucose 
   Fasting blood sugar 
(FBS) 
   Post prandial blood sugar (PPBS) 
   Random blood sugar 
(RBS) 
        Oral glucose tolerance test (OGTT) 
        Glycosylated haemoglobin (HbA1c) 
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        Urine test - Urine glucose, albumin, ketones etc. 
 C-Peptide  –  c-peptide  is  a  simple,  cost-effective  and  non-invasive  method  
in  the assessment of beta-cell capacity 
        Insulin test 
                    Blood Urea 
                    E.C.G. 
                    Lipid profile 
                    Serum electrolytes etc. 
Diagnosis 
As defined by WHO (recommendations 
2006): 
1.   Fasting  plasma  glucose  ≥  7.0mmol/l  (126mg/dl).or  >=110mg/dl  blood  
glucose  (Ref: Diabestes India.com) 
2.   2–h plasma glucose ≥ 11.1mmol/l (200mg/dl).or >180mg/dl(Ref: Diabestes 
India.com) 
Premonitory signs and symptoms 
        Sweet taste in the mouth 
        whitish urine with sweetish odor 
        Attraction of insects and ants to the urine / person 
        Dryness in mouth, palate and throat 
        Thirst/drowsiness 
        Excessive sweating and foul smelling of the body 
        Lethargy 
        Unhygeinic body 
        Excessive deposition of waste products in palate, tongue and teeth etc. 
        Matting of the hair 
        Abnormal appearance of the urine 
        Numbness and burning sensation in hands and feet etc 
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Treatment Modalities 
Management Approaches  
Prevention  
Ayurveda emphasized that the first and foremost principle of prevention as well as the treatment 
of any disease is avoidance of causative factors. This is called the principle of nidana Parivarjanam 
in Ayurveda. 
 Restrict the excessive use of curds, flesh of domestic / aquatic animals and of marshy 
places, use of milk and milk preparations, water of rivers and tanks during rains and floods, 
new grains, puddings made of jaggery /sugar and consumption of kapha Dosha 
exaggerating factors. 
        Restrict heavy diets, fatty foods which increase body weight and lipids / cholesterol. 
        Avoid sleep during daytime and laziness. 
 Various  preparations  of  rice  which  crops  within  60  days    yava  (barley),  Godhuma 
(wheat), Kodrava (grain variety –Paspolum scrobiculatum) Adhaki (red gram-Cajamus 
cajan), Kulattha (horse gram-Dolichos biflorus) and Mudga (green gram) with bitter and 
astringent leafy vegetables should be taken. 
 Use the oils of Nikumba (Danti-Baliospernum montanum), Ingudi (Balanitis egyptica), 
Atasi (Linum usitatisimum), Sarsapa (Mustard-Brassica campesteris) is useful. 
 Use the meats of animals, which are having anti diuretic properties (badha mutrat¡), 
forest animals, forest birds are recommended. 
 Navapatala  (Tricosanthus  dioica),  raw  banana,  Tanduleyaka  (Amaranthus  spinosus), 
Vastukam (Bathuva-Chenopodium album), Matsyakshi (Alternanthera sessilis), bitter 
vegetables like Methika (Trigonella foenum-graecum), Karavellaka (Momordica 
charantia); Bimbi (Coccinia Indica), Marica (Piper nigrum), Saindava lavana (rock salt) 
should be used. 
 Practice  regular  exercise/yoga,  increase  calorie  consuming  activities  (brisk  walking, 
swimming, cycling, etc.) 
 Avoid fruits with high simple sugars like banana, cheeku (sapodilla), grapes, and mango 
etc. 
        Use fruits like orange, watermelon, apple, guava, Jambu  (Syzigium cumini), Kapitha 
(Feronia limonia), Amlaki (Phyllanthus emblica) etc. 
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Line of Treatment 
        Nidan parivarjana (avoidance of etiological factors) 
        Sodhana cikitsa (bio-cleansing therapies) 
Cleansing of the body by using bio-purification measures is advocated in case of obese 
diabetics. The selection of the bio-cleansing strategy / measure depends upon 
doshapredominance   (kapha   predominant   patients   are   advised   emesis,   whereas   
Pitta predominant patients are advised purgation). 
          Palliative therapy 
The following drugs /formulations have been found to be useful in type II diabetes mellitus. 
It is hypothesized that most of these drugs work by improving the insulin production and / 
or increasing the insulin sensitivity. These drugs may be used as an adjuvant to conventional 
insulin therapy in case of type-I diabetics also with an objective to improve the glycemic 
control and overall quality of life and to prevent long term complications. 
Diet recommended in diabetes 
Type of Diet                                                                  Name 
Cereals            Purana shali (old rice), Shastic Shali (rice which crops within 60 days), Yava 
(Barley) (Hordeum vulgare), Godhum (wheat), Kodrava (grain variety – Paspolum 
scrobiculatum) 
Pulses              Adhaki (red gram-Cajamus cajan), Kulattha (horse gram) and Mudga (green 
gram) should be taken with bitter and astringent leafy vegetables. 
Vegetables       Navapatola (young Tricosanthus dioica), young vegetables variety of banana, 
Tanduleyaka (Amaranthus spinosus), Vastukam (Bathuva), Matsyakhshi 
(Alternanthera sessilis) all bitter vegetables (tiktasakam) like Methica 
(Fenugreek leaves), Karavellaka (Bitter gourd) 
Fruits               Orange, watermelon, apple and guava, Jamb£ (Syzigium cumini) Kapitha 
(Feronia limonia), Amalki (Phyllanthus embilica) etc fruits. 
Flesh                Harina (deer), birds like Kapota (pigeon), Titira (Grey Francolin) 
 
Oils                  Nikumba (Danti-Baliospernum montanum), Ingudi (Balanitis egyptica), Atasi 
(Linum usitatisimum), Sarsapa (mustard).
 
 
Drugs 
Amlaki (Phyllanthus emblica) -Fruit 
Dosage (per dose) 
3-6 gm 
MOA/Vehicle 
Warm Water 
Duration 
90 days 
Haridra (Curcuma longa)-Rhizome 1-3 gm Luke Warm 
Water 
90 days 
Jambu (Syzigium cumini)-seed 3-6 gm Water 90 days 
Mesharangi (Gymnema sylvestre)-Leaf 3-6 gm Water 90 days 
 
seed 
Kumari (Aloe vera) swarasa-leaf  Pulp 
3-6 gm 
 
10-15 ml 
Water 
 
-------- 
90 days 
 
90 days 
 
and stem bark 
Vijayasara (Pterocarpus marsupium)-stem 
3-6 gm 
 
3-6 gm 
Water 
 
Water 
90 days 
 
90 days 
Karavellaka (Bitter gourd-Momordica 
charantia)-seeds 
3-6 gm Water 90 days 
 
DRUG THERAPY 
Single Drugs 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methika (Trigonella foenum)-leaves and 
Neem (Azadirachtha indica)-seeds, Leaf 
Compound Formulations 
Drugs 
Triphala Churna 
Dosage (per dose) 
3-6 gm 
MOA/Vehicle 
Warm Water 
Duration 
90 days 
Amalki swarasa 10-15 ml -------- 90 days 
Phalatrik¡di kv¡th 25-50 ml -------- 90 days 
Gokhuradi guggulu 3-6 gm Water 90 days 
Vyoshadi guggulu 3-6 gm Water 90 days 
Chandraprabha Vati 250-500 mg Water 90 days 
Lodhrasava 
Deodarvarishta 
Dhanvantara ghrita 
10-20 ml 
10-20 ml 
20-40 gm 
Water 
Water 
Warm water 
90 days 
90 days 
10 days 
Kshira Baba  taila 3-6 gm (orally) also 
used for abhya´ga 
Warm water 10 days 
Saptamrita lauha 250-375 mg Milk/ghrita 10 days 
 
 
 
Some research based drugs 
   
The safety and efficacy of Ayurvedic interventions have been demonstrated through several 
experimental and clinical studies and extract of few studies  are as follows: 
 
Experimental studies 
Aegle marmelos 
 Biochemical  studies  in  streptozotocin-induced  diabetic  rats  confirmed  the  potent 
hypoglycaemic activity of an aqueous extract Aegle marmelos Diabetes Mellitus and 
Ayurvedic Management: An appraisal Research on Bilba leaves and suggested it to be an 
oral substitute for insulin.(Bhavapriya, 2000) 
 
  Albino rats were treated with ethanol extract of two varieties (sweet and bitter) of 
(Bilva)leaves and their blood glucose lowering effect was studied using glucose oxidase 
assay method. Both the varieties exhibited hypoglycaemic activity in a dose dependent 
manner. Sweet variety (250 and 500 mg/kg) produced maximum blood glucose reduction 
at 6 hour, while the bitter variety at the same dose levels showed maximum reduction at 8 
hour and this continued upto 24hour (Rao, Babu, Rao, Nimmi, 2002). 
 
  Oral administration of aqueous extract of Aegle marmelos (Bilva) seeds (250 mg/kg) was 
found to decrease blood glucose level by 35.1% in normal healthy rats 6h after 
administration, by 41.2% in subnormal and by 33.2% in mild diabetic rats in glucose 
tolerance test after 2h. Treatment of severely diabetic rats for 14 days with a dose of 250 
mg/kg reduced the fasting blood glucose level by 60.84%. It also brought about a fall in 
the level of total cholesterol with an increase in HDL-Cholesterol and a decrease in 
LDLCholesterol and triglycerides. 
 
 
 
 Aqueous  extract  of Aegle  marmelos  (Bilva)  seeds  was  thus  proved  to  possess  anti- 
diabetic and  hypolipidaemic  effects  in  diabetic rats  (Kesari,  Gupta,  Singh,  Diwakar, 
Watal, 2006). • 
Cinnamomum tamala (Tejapata) 
 
 Oral Administration of an ethanol (50%) extract of Cinnamomum tamala (Tejapata) 
leaves significantly lowered the plasma glucose levels in normoglycaemic and 
streptozotocin-induced hyperglycaemic rats. The extract also showed anti- 
hypercholesterolaemic and antihypertriglyceridaemic activity in streptozotocin-induced 
diabetic rats (Sharma, Dwivedi, Swarup, 1996). 
 
Cinnamomum zeylanicum (Tvak) 
 
 Water extract of Cinnamomum zeylanicum (Tvak) bark significantly reduced blood 
glucose value at 1h during glucose tolerance test. When diabetic animals with fasting blood 
glucose were treated with cinnamon extract (200mg/kg, b.w.) once daily for 2 weeks, 
the fasting blood glucose level came down (Prachi, Murali, Murthy, Tandon, Chandra, 
2004). 
 
Coccinia indica (Bimba) 
 
 The juice and decoction of leaves and stems of  Coccinia indica (Bimba) (20ml/kg) 
showed significant hypoglycemic response in fasting rabbits. The decoction of the fruits 
of the plant also showed similar activity (Pillai, Ghosh, Uma, Kumar, 1980). 
 
 The blood sugar lowering effects of ethanol extracts of whole plant and root of Coccinia 
indica (Bimba) were tested in different experimental models. While the plant-extract 
 
 
reduced the blood sugar levels of fasted, glucoseloaded and streptozotocin-induced diabetic 
albino mice to different degrees, root extract reduced the blood sugar only of glucose-
loaded animals (Mukherjee, Chandrasekar, Mukherjee, 1988). 
 
Gymnema Sylvestre (Meshasringi) 
 Administration of Gymnema Sylvestre (Meshasringi) extract decreased serum glucose 
concentration in dexamethasone induced hyperglycaemic animals. The effects were 
comparable to  the standard  corticosteroidinhibiting  drug,  ketoconazole (Gholap,  Kar, 
2003). 
 
Momordica charantia (Karavellaka). 
 
 Experimental and clinical studies revealed anti-diabetic and adaptogenic properties of the 
aqueous extract of Momordica charantia (Karavellaka). The aqueous extract of the fruit 
was more effective in diabetes than the powder of the dried fruit (Srivastava, 
Venkatakrishna-Bhatt, Verma, Venkaiah, 1993). 
 
 The effect of varying doses of alcoholic and aqueous extracts of Momordica charantia 
(Karavellaka) on body weight, serum glucose, insulin and triglycoside was investigated 
in fructose fed rats. Serum glucose and insulin levels were significantly increased following 
feeding of fructose for 15 days. 
 
 Administration  of  an  aqueous  extract  of  Momordica  charantia  (400mg/d)  markedly 
prevented high fructose diet-induced hyperglycaemia and hyperinsulinaemia (Vikrant, 
Grover, Tandon, Rathi, Gupta, 2001). 
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 Administration of ethyl acetate-soluble fraction of ethanol extract of P.marsupium wood 
to alloxan-induced diabetic rates for 5 days significantly reduced the blood sugar levels 
along with an increase in insulin levels (Ahmad et al., 1991). 
 
  The  effect  of  the  anti-diabetic  plant,  Pterocarpus  marsupium  (Vijayasar),  on  the 
development of cataract was assessed in rats. An aqueous extract of Pterocarpus 
marsupium (Vijayasar (1g/kg/day) was given to alloxan (120 mg/kg)-induced diabetic 
rats until the development of cataract. 
 
 
 
 Administration of the plant extract exerted a favorable effect on body weight, blood 
glucose and anti-cataract effect as evident from decreased opacity index (Vats, Yadav, 
Biswas, Grover, 2004) 
 
Tinospora cordifolia(Guduchi) 
 
 Oral administration of the root extract of Tinospora cordifolia(Guduchi) for 6 weeks 
resulted in significant reduction of blood and urine glucose and of lipids in serum and 
tissues in alloxan-induced diabetic rats (Prince, Menon, 2003). 
 
Trigonella foenum graecum (Methi) 
 
 Extracts of Trigonella foenum graecum (Methi), tested for their hypoglycaemic effect 
in rabbits, the alkaloid-rich fraction showed maximum effect within two hours of its 
administration (Jain, Lohiya, Kapoor, 1987). 
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Clinical Studies: 
 Supplementation of the diet with Trigonella foenum graecum (Methi) leaves showed 
a significant effect on hyperglycaemia, hypoinsulinaemia and glycosylated haemoglobin 
in streptozotocin- induced diabetic rats. 
 
 Methi leaves improved the body weight and liver glycogen and also showed a significant 
effect on key carbohydrate metabolic enzymes in diabetic rats. 
 
 The effect of fenugreek leaves was found to be similar to that of glibenclamide (Devi, 
Kamalakkannan, Prince, 2003). 
 
 Oral administration of an alcoholic extract of Trigonella foenumgraecum(Methi) seeds 
significantly reduced the blood sugar levels of normal as well as of alloxan-induced 
diabetic rats (Vats, Grover, Rathi, 2002) 
 
 
• Vijayasara  (Pterocarpus  marsupium)  in  NIDDM:  A  flexible  dose  open  trial  
was conducted in four centres in India to evaluate the efficacy of Vijayasara in the 
treatment of newly diagnosed or untreated NIDDM. By the 12 weeks, control of blood 
glucose had been attained in 69% patients studied. The mean Hb Ac was decreased 
significantly (P<0.001) to 9.4% at 12 week from the initial mean of 9.8%. Other 
laboratory parameters remained stable and no side effects were reported (Flexible dose 
open trial of Vijayasara in cases   of   newly   diagnosed   non-insulin   dependent   
Diabetes   mellitus–ICMR collaborating  centers,  Central  Biostatistical  Monitoring  
Unit,  Chennai  and  Central technical Coordinating unit, ICMR, New Delhi) 
 
 
• Ayush-82 and Shuddha Shilajit : In a clinical trial (n=80) of NIDDM, an Ayurvedic 
formulation named Ayush-82, 5gm thrice daily and Shuddha Shilajit, 500mg twice daily 
was given for 24 weeks. Fasting and postprandial blood sugar levels were estimated at 6 
th 
weekly intervals. There was statistically significant reduction in both fasting and 
postprandial blood sugar (Pandey et al., 1995) 
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• Coccinia indica :In a controlled clinical trial (n= 30)of NIDDM, tablets  made from 
aqueous extract of Coccinia indica twice daily were given before meal for 3 months. 
The drug was found to be significantly attenuated the lipid fraction almost to normal 
range with the control of hyperglycemia (Kamble et al., 1996) 
• Ayurvedic Therapy in Diabetes Retinopathy: A Combination of therapy viz.tarpana 
with Patoladi ghrita and internal administration of Dhanvantara Kwatha 20ml, 
Punarnavasava 25ml, Candraprabhavati 250mg and Nisamalaki 5 gm twice a day in 
the subjects of Diabetes retinopathy showed remarkable improvement in visual acuity. 
There was no further visual loss, no further focal haemorrhages and no 
neovascularisation was observed (Srikanth, 2005). 
 
 
• Ayush-82 –An Ayurvedic Hypoglycemic formulation :  Consisting of Amra bija (seeds 
of Mangifera indica), Karavellaka bija (seeds of Momordica charantia), Jambu beeja (seeds of 
Syzygium cumini), Gudmara (leaves of Gymnema sylvestre) was tried on a fairly large sample 
size (n=350) in a control clinical study revealed statistically significant reduction in fasting and 
postprandial blood sugar in Non insulin Dependent Diabetes Mellitus (CCRAS Research–An 
Overview, 2002). 
 
 
•    Nishamalaki : In a open clinical trial 100 patients of NIDDM (n=100) in the age range of 
31-70 years with normally blood sugar elevated cases i.e. 100mg or more in FBS were 
put on the drug Nishamalaki 1 gm twice daily with water for 6 weeks between. The 
results showed that the drug has got moderately good hypoglycemic effect (Nanda, 
Chopra, Sahu, and Padhi, 1998). 
 
 
• Amrita-Pippali-Nimba Yoga :A series of 50 patients of diabetes mellitus divided 
into three  groups  Group A (n=15): Amrita-Pippali-Nimba  Yoga;  Group  B(n=14): 
Add  on treatment with Amrita Pippali, Nimba Yoga and Group C(n=8): Placebo were 
studied .The Amrta-Pippali-Nimba Yoga has showed significant improvement in both 
fasting and postprandial blood sugar levels in group A and B when compared to placebo 
(Mehra, Singh, 2001). 
 
 
• Coccinia cordifolia extract on Newly Detected Diabetic Patients: In a double-blind, 
placebo-controlled, randomized trial Sixty newly detected type 2 diabetic patients (n=60) 
were randomly assigned into the placebo and experimental group (1 g alcoholic extract of 
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Coccinia cordifolia administered for 90 days). The significant decrease (at day 90) in fasting 
blood glucose and postprandial blood glucose was observed with a mean change of 15.6% 
and18.5% respectively in the experimental group (Rebecca, Ramaswamy, Ganapathi, Anura, 
2008). 
 
 
Counseling – Advise the patient to: 
 
   Do physical exercise according to body condition, at least 30 – 60 minutes daily. 
 
   Restrict intake of sweets containing refined / white sugars. 
   Increase the use of barley, wheat, green gram and roasted bengal gram in diet. 
   Limit the use of potato, rice, milk products and oily foods. 
   Take utmost care of personal hygiene especially of feet and hand. 
   Avoid injuries and immediately consult in case it happens. 
   Avoid alcohol and tobacco consumption in any form. 
   Regular medical checkup and monitoring of blood glucose level 
a)    Glycosylated haemoglobin (HbA1c) test at least twice in a year 
b)    Eye examination annually, especially fundus examination 
c)    Foot examination at least twice in year 
d)    Renal function screening at least yearly 
e)    Blood pressure assessment at least monthly 
f)    Lipid profile at least annually 
g)    Cardiac checkup at least annually 
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Introduction 
 
Hypertension is a condition in which the blood pressure is chronically elevated. 
It is considered to be present when a person's systolic blood pressure is 
consistently 140 mm Hg or higher, and/or their diastolic blood pressure is 
consistently 90 mm Hg or higher. Various epidemiologic studies had 
consistently demonstrated that increasing levels of systolic BP correlate directly 
with the risk of developing cardiovascular events and stroke leading to mortality. 
In old age systolic blood pressure becomes a stronger predictor of risk than 
diastolic blood pressure or other standard risk factors besides age. Based on 
WHO definition the incidence of hypertension in urban population is around 
40% and rural around 18%. High blood pressure is dangerous because it 
makes the heart work harder to pump blood to the body and it contributes to 
hardening of the arteries or atherosclerosis. 
 
However, there is no doubt that this disease must have been existed in the past 
as well, though may not in the same form, incidence and severity due to 
different kind of life style in those days. The change in social and economic 
conditions, life style, dietary habits and an increasing stress and strain in 
earning the livelihood have increased the prevalence of this disease. Though 
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a suitable term for the disease condition hypertension is not directly mentioned 
in the Ayurvedic classics, its symptomatology can be found in the chapters of 
vata vyadhi, prameha and hridroga. A disease condition vyanabala vaishamya, 
which can be correlated with hypertension, seems to be resulted from the 
vaishamya / vikriti of vyana vayu. Thish condition of 
vaishamya(Disharmony/Disproportion) can be of two types either 
vriddhi(Increase) or kshaya(Decrease). Hypertension comes under vriddhi type 
of vaishamya. 
 
Types of Hypertension 
 
Primary or essential hypertension - The hypertension of unknown origin. 
 
Secondary hypertension - Hypertension with an identifiable cause secondary to 
another disease such as renal disease or tumor. 
 
Isolated systolic hypertension - Most common in old age due to reduced 
vascular compliance, systolic B.P > 160 mm of Hg with Diastolic pressure < 90 
mm of Hg. 
 
Neurogenic hypertension - It can be caused by strong stimulation of 
sympathetic nervous system. (e.g. when a person becomes excited for any 
reason or state of anxiety). 
 
Classification of Hypertension 
 
  Systolic B.P. Diastolic B.P. 
Optimal B.P < 120 < 80 
Normal B.P. < 130 < 85 
High normal 130-139 85-89 
Stage 1 Hypertension 140-159 90-99 
Stage 2 Hypertension 160-179 100-109 
Stage 3 Hypertension 180 > 110 
 
 
 
Aetiology 
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1. Hereditary 
 
2. Excess 
salt intake 
 
3. Sleep 
apnea 
 
4. Secondary to disease (e.g. polycystic kidney disease or chronic 
glomerulonephritis,adrenal disease, cushing's syndrome and 
coarctation of aorta etc.) 
 
5. Certain medication (e.g. NSAIDS, steroids, throat lozenges and peptic 
ulcer medicines)
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Pathogenesis 
 
It is incorrect that hypertension is a simple physiological feature of ageing. 
Blood pressure tends to be normal or even low in the aged population. 
Development of Hypertension more depends on environmental factors, rather 
than simple ageing. Pathophysiological mechanism includes an increase in 
peripheral vascular resistance, secondary to arteriolar smooth muscle 
vasoconstriction with the lower plasma renin activity and low aldosterone levels. 
 
Risk factors 
 
1. Child of Hypertensive parents 
 
2. Obese person 
 
3. Age > 45 years 
 
4. Gender (men and postmenopausal women) 
 
5. Diabetes mellitus, dyslipidaemia 
 
6. Physical inactivity 
 
7. Smoking, alcoholism 
 
Clinical features 
 
Hypertension is usually found incidentally by healthcare professionals during 
a routine checkup, usually produces no symptoms although there may be 
 
1. Headache 
 
2. Fatigue 
 
3. Dizziness 
 
4. Transient insomnia 
 
5. Difficulty in sleeping due to feeling of hot or flushed 
 
6. Tinnitus 
 
Complications 
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While elevated blood pressure alone is not an illness, it often requires 
treatment due to the following short and long term effects like: 
 
1. Cerebrovascular accidents (CVA) or strokes 
 
2. Myocardial infarction 
 
3. Hypertensive cardiomyopathy (heart failure) 
 
4. Hypertensive retinopathy, nephropathy and encephalopathy 
 
5. Congestion in the lungs 
 
6. Left ventricular hypertrophy 
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7. Epistaxis 
 
8. Blurring of vision owing to retinal changes 
 
9. Impotence 
 
10. Angina pectoris 
 
Investigations 
 
1. 24 hour ambulatory blood pressure monitoring 
 
2. Urine for protein, blood and glucose 
 
3. Serum electrolytes 
 
4. Serum creatnine 
 
5. Renal function test 
 
6. Blood sugar fasting 
 
7. Lipid profile 
 
8. Electro cardiogram (ECG) 
 
9. Chest X Ray (PA view) 
 
Management approaches 
 
a. Prevention 
 
1. Consume plenty of fruits and vegetables such as apple, banana, blackberrie, broccoli,cabbage, 
carrot, garlic, grape fruit, green leafy vegetable, onion, pea, tomato etc. 
 
2. Consume preferably vegetarian, low fat, low calory diet rich in whole grain, high fibre and nuts 
 
3. Use of garlic and onion in regular diet 
 
4. Practice physical exercises such as brisk walking daily for 30 - 45 minutes 
 
5. Weight reduction (in obese) 
 
6. Limit use of salt (<5 gm/ day), fats and sweets 
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7. Avoid day sleep, anger, anxiety, hyper activity, over exertion 
 
8. Avoid use of caffeine, alcohol and tobacco 
 
b. Medical management 
 
Line of treatment (Charaka Chikitsa.28/92) 
 
1. Nidana parivarjana (avoidance of aetiological factors) -According to Ayurveda, avoidance of the 
causative factor is the first line of treatment for all diseases. Excess intakes of salt and fatty 
substance should be avoided and certain medicines such asNSAIDS, steroids, cough syrups etc. 
are also to be taken carefully. 
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2. Samshodhana chikikitsa (Bio-cleansing therapies) followed by Samana chikitsa (Palliative 
therapy) should be advocated. 
 
i. Lekhana Vasti 350-500 ml for 8 days. 
 
ii. Virechana karma (Purgation) with Eranda taila 15 - 30 ml with half glass of milk at night 
 
iii.Shirodhara with medicated liquids (milk/ water/ oils (Narayana taila) daily 
45-90 minutes for 21 days 
 
iv. Takra dhara daily 45 minutes for 14 days 
 
Note.Decision for Dhara and its medicies are required to be taken by the 
physician only dependinding upon its benefit3. Drug Therapy 
 
Common medicinal pants 
 
Plant name Dosage(perdose) Vehicle Duration 
    
Sarpagandha    
(Rauwolfia 
1 -3 gm water 15 days serpentiana  Benth 
ex. Kurz.)Powder    
    
Ashvagandha    
(Withania somnifera 3-6 gm Milk 15 days 
Dunal) Powder    
    
Jatamansi    
(Nardostachys 
1-3 gm Water 15 days 
jatamamasi    
DC.)Powder    
     
Arjuna (Terminalia   
arjuna W.and  A.) 3-6 gm Water 15 days 
Bark Powder    
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Arjuna (Terminalia   
arjuna W.and 10 -30ml  15 days 
A.)Bark     
ksheerapaka    
     
Rasona (Allium   
stivum Linn.) 10-30 ml  15 days 
ksheerapaka    
     
 
 
Ksheerapaka is an easy preparation in which the milk is processed with the 
desired plant part. 
 
Method of preparation of Ksheerapaka: 
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Prescribed amount of the Dravya (medicament) is taken. 
 
Milk is taken in a quantity of 4 times that of the medicine. 
 
Water is taken 4 times that of milk. 
 
All are mixed together and heated on mild fire until all the water evaporates and 
only the milk remains and milk is now filtered which is taken lukewarm. 
 
Every time the preparation shall be prepared fresh. It should neither 
be preserved nor refrigerated nor reused after a long time. 
 
FORMULATIONS 
 
Drug Dosage (per Vehicle Duration 
 dose    
     
Mamsyadi kvatha 10-20 ml  Water 15 days 
     
Sarpagandha 
125-250 mg 
 
Water 15 days 
ghana vati 
 
    
     
Brahmi vati 125-250 mg  Water 15 days 
     
Prabhakara vati 125-250 mg  Water/Milk 15 days 
     
Arjunarishta 10-15 ml  Water 15 days 
     
Abhayarisha 10-15 ml  Water 15 days 
     
Pravala pishti 250-500 mg  Water 15 days 
     
shveta parpati 125-250 mg  Water 15 days 
     
Nagarjun!bhra rasa 125-250 mg  Water/Honey 15 days 
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Hridayarnava rasa 125-250 mg 
 Honey/ Triphal! 
15 days  
kv!tha     
     
 
Thease above mentioned medicines are prescribed Initially 2 times in a day 
after meal for 15 days followed by condition of patient and physician's direction. 
 
NOTE: Formulations mentioned above any one of them or in combination may be 
prescribed by the physician.The duration of the treatment may vary from patient to 
patient. Physician should decide the dosage (per dose) and duration of the therapy 
based on the clinical findings and response to therapy. 
 
Lekhana Vasti (medicated enema), containing Arjuna heart wood decoction. 
and . Arjunavachadi yoga have shown improvement in the hypertensive 
patients. 
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Yoga Therapy- The following yogic practices are beneficial in hypertension; 
however, these should be performed only under the guidance of qualified Yoga 
therapist. Duration of every yogic practices should be decided by the Yoga 
therapist.1. Breathing exercises -hand strech breathing, hand in and out 
breathing. 
 
2.Asana- Shavasana, Vajr!sana, Bhujangasana, Vakrasana, Gomukhasana, 
Pavanmuktasana,Katichakrasana, Ardhakati chakr!sana, Tadasana. 
 
3. Pranayama -Chandra anulomaviloma,Nadisodhana, Ujjayi, Bhramari. 
 
Counselling - Advice for, 
 
1. Regular blood pressure monitoring 
 
2. Maintenance of weight in ratio of height 
 
3. Practice of regular aerobic exercises (e.g. brisk walk, jogging, weight lifting etc.) 
 
4. Increase intake of potassium, calcium and magnesium in diet 
 
5. Relax mind and body by yoga, meditation and other methods 
 
6. Consumption of fruits and vegetables such as apple, banana, broccoli, cabbage, carrot, garlic, 
grape, green leafy vegetables, onion, pea, tomato etc in plenty. 
 
7. Wise Use of anti-inflammatory medicines. 
 
8. Avoidance of cheese, animal fat, aged / stored meat, chocolate, cream, wine , yogurt and 
artificial sweeteners. 
 
9. Avoid the use of antihistaminic drugs unless knowingly prescribed by qualified a physician. 
 
10. Restricted use of sugar and salt in diet 
 
11. Discontinuation of tobacco and alcohol in any form. 
 
Indications for referral 
 
Ppatients may be reffered in following conditions 
 
1. Refractory hypertension - suboptimal control of blood pressure in spite of appropriate therapy 
 
2. Target organ damage 
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3. Secondary hypertension not responding to medication 
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